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Abstract. Westgate J. An evaluation of electronic fetal monitoring with clinical 
validation of ST waveform analysis during labour. 
Dissatisfaction with the electronic recording of fetal heart rate and uterine contractions (the cardiotocogram 
or CTG) has resulted in a search for new techniques of monitoring the fetus during labour. It is important 
that each method has a sound physiological and pathophysiological basis, that a model for the interpretation 
of changes is elucidated and that each method is thoroughly evaluated before introduction into clinical 
practice. Analysis of the ST waveform of the fetal electrocardiogram (FECG) is the most advanced of the 
new techniques under investigation. Experimental studies have shown that elevation of the ST waveform 
occurs with a switch to myocardial anaerobic metabolism and a negative waveform occurs during direct 
myocardial ischaemia. Human observational studies have suggested that a combination of ST waveform and 
CTG analysis may improve the specificity of intrapartum monitoring and reduce unnecessruy intervention. 
A high quality FECG signal is necessruy for waveform analysis. The FECG can be recorded from a scalp 
electrode (FSE) during labour. The suitability of 5 commonly available FSEs for ECG waveform analysis 
was compared. Single spiral FSEs had the most favourable physical and electrical properties and produced 
the best quality signals in a randomised clinical trial of 50 fetuses in labour. 
Intervention rates and neonatal outcome in labours monitored with CTG alone were compared with those 
monitored with the combination of ST waveform analysis plus CTG (ST+CTG) in a randomised clinical 
trial of 2434 high risk labours in a large district general hospital over an 18 month period. There was a 46% 
reduction in operative intervention for fetal distress in the ST+CTG group (p<0.001, OR 1.96 [1.42-2.71]). 
There was a trend to less neonatal metabolic acidemia (p = 0.09, OR 2.63 [0.93-7.39]) and fewer low five 
minute Apgar scores (p = 0.12, OR 1.62 [0.92-2.85]) in the ST+CTG arm. 
All recordings were reviewed retrospectively, blind to outcome and the CTG classified as normal, 
intermediate or abnormal according to the trial protocol. There was no significant difference in the 
proportion of recordings in each categocy between the trial arms. Operative intervention in the ST+CTG 
arm was significantly reduced in recordings classified as normal and intermediate by the review (12/1043 
ST+CTG arm versus 48/1066 CTG arm, p <0.001). Three patterns of ST+CTG change were identified. 1. 
Normal CTG, persistent stable ST waveform elevation. These fetuses had good outcome and a 
significantly higher mean pH (7.29) and lower base deficit (1.1 rnmol/1) at delivecy. The raised ST 
waveform may reflect sympathoadrenal stimulation from the general arousal of labour or a response to mild 
but compensated hypoxaemia and is in keeping with experimental data. 2. CTG abnormal, progressive 
elevation in ST waveform. All cases occurred towards the end of second stage. These fetuses had a 
significantly lower mean pH (7.05) and higher base deficit (7.6 mmol/1) than all other groups. This 
combination identified fetuses who were developing a metabolic acidosis as a result of significant hypoxia. 
3. Abnormal CTG and a negative ST waveform. All cases with persistently negative waveforms were 
depressed at birth, required resuscitation and had low arterial pHs (where available). This high risk group 
probably had depleted myocardial glycogen reserves and suffered direct myocardial hypoxia, as seen in 
animal studies. These findings indicate that ST waveform analysis can discriminate CTG change during 
labour, the combination can result in a reduction in unnecessary intervention and has the potential to more 
accurately identify fetuses at risk ofneonatal morbidity. 
The term 'monitoring' implies a degree of automatic surveillance but this is not the case as CTG and 
ST+CTG records are subjectively interpreted, frequently by junior, inexperienced staff. The retrospective 
review of cases in the trial revealed significant errors in the use of fetal blood sampling and the 
interpretation of both CTG and ST+CTG recordings during the study. The feasibility of representing expert 
clinical knowledge in a decision support tool to provide consistent, accurate interpretation of the CTG was 
demonstrated in two clinical studies. The full potential of ST+CTG analysis may only be achieved with 
some degree of automatic data processing and interpretation. 
The randomised trial also demonstrated the lack of appropriate measures of neonatal outcome with which to 
judge the effectiveness of fetal monitoring. Analysis of cord artecy and vein blood gas status at delivecy can 
provide useful information about fetal oxygenation prior to delivecy but currently the information is poorly 
used, if at all. Use of erroneous data, inappropriate measures of 'acidemia', failure to distinguish between 
respiratocy and metabolic components and unphysiological expectations about relationships to other 
measures of neonatal outcome were some of the problems highlighted. The use of generic terminology such 
as 'birth asphyxia' or 'acidosis' which have varying definitions has caused much confusion and should be 
avoided. There is unlikely to be one 'gold standard' measure of neonatal condition at delivecy. 
Abstract, page 3 
Contents 
Title page ...................................................................................................... 2 
Abstract. ........................................................................................................ 3 
Contents ........................................................................................................ 4 
Acknowledgements ........................................................................................ 9 
Author's declaration ....................................................................................... lO 
Chapter 1. Introduction 
Health technology assessment ..................................................................... 13 
Physiology offetal responses to labour ....................................................... 14 
Oxygen supply ............................................................................................... 14 
Fetal defence mechanisms .............................................................................. 17 
Hormonal adjustments 
Cardiovascular adjustments 
Metabolic adjustments 
Behavioural adjustments 
The central nervous system 
Conclusions ................................................................................................... 20 
The present state ofCTG monitoring during labour ................................. 21 
Physiology and pathophysiology .................................................................... 21 
Technology .................................................................................................... 21 
Model of interpretation .................................................................................. 21 
Clinical evaluation ......................................................................................... 22 
Operative intervention rates 
Fetal blood sampling 
Neonatal outcome 
Cerebral palsy rates 
Cost effectiveness .......................................................................................... 23 
Summary ....................................................................................................... 24 
Alternatives to CTG monitoring ................................................................. 24 
Do nothing .................................................................................................... 24 
Use intermittent auscultation only .................................................................. 25 
Continue the search for new indices of fetal wellbeing .................................... 26 
The ST waveform of the fetal electrocardiogram ....................................... 27 
Pathophysiology ............................................................................................ 28 
ST waveform elevation 
Negative ST waveform 
Summary 
Technology .................................................................................................... 33 
Signal noise 
Filtering 
Signal processing 
Systems for fetal ST waveform collection and analysis 
Clinical studies ............................................................................................... 35 
Model of interpretation .................................................................................. 3 5 
Objectives and structure of thesis ............................................................... 37 
Contents, page 4 
Chapter 2. Optimising the acquisition of the fetal 
electrocardiogram in clinical practice. 
Part I. Comparison of commonly available fetal scalp electrodes 
Introduction ................................................................................................. 39 
Electrode function in body tissue ................................................................... 39 
Electrode offset potential 
Movement artefact 
Fetal scalp electrodes ..................................................................................... 40 
Development 
Design 
Methods ....................................................................................................... 42 
Physical characteristics .................................................................................. 42 
Electrical characteristics ................................................................................ .42 
In-vitro experiment 
Digital filter model 
Randomised clinical trial ............................................................................... .43 
Results ......................................................................................................... .46 
Physical characteristics .................................................................................. 46 
Spiral FSEs 
Copeland FSEs 
Electrical characteristics ................................................................................. 48 
Clinical trial ................................................................................................... 50 
First stage 
Second stage 
Reapplications 
Cost comparison 
Discussion .................................................................................................... 54 
Part 11. Examination of the fetal ECG data acquisition system 
lntroduction ................................................................................................. 57 
Observation and investigations ................................................................... 58 
Location ofthe maternal skin electrode .......................................................... 58 
FECG lead configuration ............................................................................... 58 
An investigation ofFECG electrode configurations ........................................ 59 
Method 
Results 
Discussion 
Cables and leads ............................................................................................ 63 
Data acquisition electronics ........................................................................... 63 
Amplification and gain settings 
Signal processing ........................................................................................... 63 
Display and printout ...................................................................................... 64 
Summary ...................................................................................................... 64 
Contents, page 5 
Chapter 3. Randomised trial of CTG Alone or with ST 
waveform analysis for intrapartum monitoring. 
Introduction ................................................................................. : ............... 67 
Method ............................................................................................... : .......... 67 
Calculation ofsample,size .............................................................................. 67 
Study entry & randomisation ......................................................................... 68 
Preparation for the trial ........................................................................•.....•... 68 
Protocols for management .•...... , ....................•..•.....•....••...•.......•........•.......•.•. 68 
CTGarm 
ST+CTGarm 
FBS pH guidelines 
Measurement of outcome .............................................................................. 68 
Intervention 
Neonatal outcome 
Retrospective quality assessment .......... , .•. , ....• , ...........................•.......•.........• 70 
Retrospective blinded review .................. , ... , ................... , .. , . , ..................... , ... 71 
Statistical methods ................................................................................... , ..... 71 
Results .......................................................................................................... 71 
Trial entries ................................................................................................... 71 
Non-compliance with allocated recorder ........................................................ 72 
Intervention ................................................................................................... 73 
Fetal blood sampling 
Operative delivery 
Neonatal outcome .... : ........................................... : ......................................... 74 
Retrospective review ..................................................................................... 76 
Intervention for fetal. distress 
Negative ST waveform 
Cord artery pH and BDecf at delivery 
Statistical analysis 
Quality assessment ........... ~ ............................................................................. 86 
Discussion ..................................................................................................... 87 
Intervention and outcome ....................................................... : ...................... 87 
Fetal blood sampling 
Operative deliveries 
Patterns of ST +CTG change ............................................ : ............................. 89 
Persistent stable Sl" elevation 
Rapid rise in ST waveform 
Negative ST waveform 
Previous observational studies .......................... , ........ , ...... , ............................ 94 
Randomised trial methodology .......................•..................... , .... , ..... , .... , .... , .. ,. 9 5 
The randomisation process 
Observer bias 
The analysis of trial results 
Protocol criticisms 
Education and training 
The Hawthome effect 
Revised guidelines for clinical.action .............................................................. 98 
Future :development of the. ST AN recorder .................................................... 99 
Summary ...................................................................................................... IOO 
Contents, page 6 
Chapter 4. An assessment of current monitoring practice. 
Introduction ................................................................................................. 102 
Methods ....................................................................................................... 1 02 
Results .......................................................................................................... 103 
Fetal blood sampling ...................................................................................... 103 
Selection of cases for FBS 
pH at FBS and FBS response times 
Interpretation of results and subsequent management 
Operative delivery for fetal distress ................................................................ 106 
Selection of cases for monitoring ................................................................... 107 
Birth asphyxia review .................................................................................... 107 
Discussion .................................................................................................... 109 
Fetal blood sampling ...................................................................................... 109 
Low risk/high risk .......................................................................................... Ill 
CTG (mis)interpretation ................................................................................ 112 
Chapter 5. The assessment of acid-base status at birth. 
Introduction ................................................................................................. ll5 
Methods .. : .................................................................................................... 118 
Results .......................................................................................................... 119 
Reliability of cord blood results ...................................................................... 119 
Errors identified by the Blood Gas Analyser 
Arteriovenous differences 
pC02 errors 
Identification of'normal' ranges ..................................................................... 123 
The relationship between BDecf & BDblood .................................................. 126 
The relationship between pH & BDecf... ........................................................ 129 
The relationship between arterial & venous results ......................................... 131 
Cord gases & Apgar scores ............................................................................ 132 
Cord gases & neonatal encephalopathy .......................................................... 134 
Discussion .................................................................................................... 136 
Reliability of cord results ............................................................................... 136 
Interpretation of results .................................................................................. 13 7 
Cord gas results & Apgar scores .................................................................... l40 
Cord gas results and neonatal encephalopathy ................................................ 140 
Is there a 'gold standard' measurement for neonatal outcome? ........................ 142 
Contents, page 7 
Chapter 6. Future approaches to intrapartum fetal monitoring. 
Introduction ................................................................................................. 145 
Computer assisted decision support ............................................................... 145 
Background 
Expert systems 
Methods ....................................................................................................... 147 
Off line assessment of the Knowledge Base .................................................... 148 
Preliminary on-line evaluation ........................................................................ 150 
Results .......................................................................................................... 151 
Off-line study ................................................................................................. 151 
On-line study ................................................................................................. 152 
Discussion .................................................................................................... 154 
Future work ................................................................................................... 155 
Chapter 7. Summary and conclusions. 
Summary ...................................................................................................... 157 
Conclusions .................................................................................................. 160 
Appendices 
1. Summary of new and existing methods for intrapartum surveillance ........... 162 
2. Case record form from the randomised trial ............................................... l64 
3. Secondary analysis of randomised trial entries ............................................ 169 
4. Cases of birth asphyxia which occurred during the trial period .................... 171 
5. Blood gas analysis ..................................................................................... 173 
6. List of tables, figures and abbreviations ...................................................... 176 
References . ............................................................................................ 183 
Contents, page 8 
Acknowledgements 
Keith Greene, whose extraordinary vision and drive has led to the establishment of a 
research group in a district general hospital. The ideas for the ST wavefonn randomise.d 
trial and the expert system were his originally; I have been privileged to run with them. He 
has given invaluable support and guidance during the work and write-up of this thesis, for 
which I am extremely grateful. 
Korgi Rosen, whose enthusiasm and belief in the concept of ST wavefonn analysis has not 
only been maintained for 18 years but has stimulated many others, myself included. I am 
very grateful for the large amount of time and effort he has spent helping me understand 
basic physiology and acid-base balance and discussing the work in this thesis. 
Emmanuel Heachor, eo-founder of the Perinatal Research Group, for help with the 
electrode and Expert Systems work and valuable advice about research work in general. 
South West Regional Health Authority for the research grant which funded much of my 
research salary. Thanks also for extra support provided to the Perinatal Research Group 
from the Northcott Devon Medical Foundation and Telethon Southwest. 
The consultants in the Department of Obstetrics, Freedom Fields Hospital, Plymouth 
who allowed their patients to participate in the studies and the other medical and midwifery 
staff for co-operation and support. A special thanks to the auxiliaries and midwives who 
'extended' their roles to take the cord blood samples during the randomised trial. 
Dave Wright, Principal Lecturer, Department of Mathematics and Statistics, University of 
Plymouth, for statistical advice. 
Rob Keith, eo-worker for the last four years. The engineering work on fetal scalp electrode 
assessment and the development of the CTG Expert System is the basis ofRob's PhD thesis. 
If someone told me what a truly nice, calm, helpful, generous and clever chap I've had to 
work with all these years, my only reply could be- "I knew that!". 
All present and past members of the Perinatal Research Group; 
John Curnow, for technical support during the studies (assisted by Laurie Barron) and for 
advice on Chapter 2. 
Mo Harris for her sterling contribution to the randomised trial and wonderful baking. 
Jeremy Smith for help in setting up the randomised trial and help with initial data 
collection. 
Jon Garibaldi for thesis-saving computing support, keeping the phone engaged and for 
reading the manuscript with engineering precision. 
Sarah Beckley for stepping into the clinical breach so many times to enable this thesis to 
get written, for reading the manuscript and endless cups of tea. 
GeoiTHughes (honorary member) for being anAl (and A2) expert reviewer. 
Yvonne Q, Liz, Steve, Trudy, Anna, Yvonne B, Wendy & Phillip for helping to keep 
body, soul and spirit together over the last four years. 
My father for always expecting the best instead of accepting the ordinary and for his 
consistent encouragement with everything over the years from times-tables to hockey 
training. 
Acknowledgements, page 9 
Author's declaration 
This study was financed with the aid of a grant from the South West Regional Health 
Authority Locally Organised Research Fund while the author was a Research Fellow in the 
Plymouth Perinatal Research Group. 
The work in this thesis was performed in the Department of Obstetrics, Plymouth General 
Hospital, under the supervision ofDr Keith Greene, in collaboration with other members of 
the Perinatal Research Group; Robert Keith, Research Engineer, School of Electronics, 
Electronic Engineering & Communications, University of Plymouth (work in chapters 2 & 
6, which also forms part of his PhD Thesis) and John Cumow, Biomedical Engineer, 
Department of Medical Physics, Plymouth General Hospital (work in Chapter 2}. 
Publications arising from the work; 
Refereed Papers. 
Westgate J Keith RDF, Cumow JSH, Ifeachor EC, Greene K.R. Suitability of fetal scalp electrodes 
for monitoring the fetal electrocardiogram during labour. Clinical Physics and Physiological 
Measurements 1990;11:297-306. 
Ifeachor EC, Keith RDF, Westgate J, Greene K.R. An expert system to assist in the management of 
labour. The World Congress on Expert Systems Prom:dings 1991;2615-2622. 
Westgate J, Harris M, Cumow JSH, Greene KR. Randomised trial of cardiotocography alone or 
with ST waveform analysis for intrapartum monitoring. Lancet 1992;340:194-198. 
Westgate J, Harris M, Cumow JSH, Greene KR. Plymouth randomised trial of cardiotocogram only 
versus ST waveform analysis plus cardiotocogram for intrapartum monitoring; 2400 cases. 
American Journal of Obstetrics & Gynecology, in press, 1993. 
Westgate J, Greene K.R. How weD is fetal blood sampling used in clinical practice? Accepted by the 
British Journal of Obstetrics and Gynecology, 1993. 
Keith RD, Westgate J, Ifeachor E, Greene K.R. Suitability of artificial neural networks for feature 
extraction from the cardiotocogram during labour. Accepted by Medical and Biological Engineering 
and Computing, 1993. 
Keith RD, Westgate J, Hughes GW, Ifeachor E, Greene K.R. Evaluation of a knowledge-based 
decision support tool for the management of labour. Accepted by Journal of Perinatal Medicine, 
1993. 
Invited Chapters or reviews. 
Westgate J, Rosen KG. Acid Base assessment at birth. In 'A critical appraisal of fetal surveiUance'. 
F Copray & H van Geijn eds. Elsevier Science Publishers BV, Amsterdam. In press, 1993. 
Greene KR, Westgate J. The ST waveform. In 'A critical appraisal offetal surveillance'. F Copray 
& H van Geijn eds. Elsevier Science Publishers BV, Amsterdam. In press, 1994. 
Greene KR , Westgate J. The fetal ECG with particular reference to the ST waveform. Proceedings 
of the 26th Royal College of Obstetricians and Gynaecologists Study Group on Intrapartum fetal 
Surveillance. RCOG, London. In press, 1994. 
Declaration, page 10 
Presentations; refereed. 
Suitability of fetal scalp electrodes for monitoring the fetal ECG in labour. Physical Science 
Techniques in Neonatal and Paediatric Care 25 Aprill990, Birmingham. UK. 
Plymouth randornised controlled trial of ST +CTG waveform analysis versus CTG; results of the 
first 1200 cases. 4th International Conference on Fetal and Neonatal Physiological Measurements. 
12-15 May, 1991, Noordwijkerhout, The Netherlands. 
Plymouth randomised controlled trial of 2400 cases - ST waveform plus CTG versus CTG alone for 
intrapartum monitoring. 26th British Congress of Obstetrics and Gynaecology, Manchester 7-10 
July 1992. 
Development of an intelligent decision support tool for the management of labour. Poster. 26th 
British Congress of Obstetrics and Gynaecology, Manchester 7-10 July 1992. 
INFANT - an intelligent support tool for the management of labour. Poster. Vlllth International 
Congress The fetus as a Patient, Oulu, Finland, 15-18 September, 1992. 
An assessment of the reliability and analysis of cord blood gas data. Society for the Study of Fetal 
Physiology, 20th Annual Meeting, Plymouth, 16- 19th May, 1993. 
Expert systems in medicine. Poster. Society for the Study of Fetal Physiology, 20th Annual Meeting, 
Plymouth, 16- 19th May, 1993. 
Presentations; invited. 
Fetal ECG waveform analysis in labour. South West Regional Obstetrics and Gynaecology Society 
Meeting. 18 May, 1990, Plymouth, UK. 
Plymouth randornised controlled trial of CTG alone versus ST +CTG for intrapartum fetal 
monitoring. 1200 cases. 1st International Perinatal Asphyxia Meeting. December 12-13, Plymouth, 
1991. 
The introduction and clinical validation of a microprocessor based monitor for intrapartum fetal 
ECG analysis in a randomised clinical trial of 2400 cases. 3rd world symposium of Computers in 
Obstetrics, Gynecology and Perinatology, Anchorage, Alaska, June 6-10, 1992 
Analysis of the fetal ECG during labour. Vlllth International Congress The fetus as a Patient, Oulu, 
Finland, 15-18 September, 1992. 
Plymouth Randornised controlled trial of CTG alone versus ST+CTG for intrapartum fetal 
monitoring: 2400 cases. 2nd International Perinatal Asphyxia Meeting, 25, 26 September, 1992. 
Fetal ST waveform analysis during labour. Workshop on fetal 02 monitoring sub partu. Munich, 
Germany, June 4, 1993. 
n.t ............ C0!iJ. ........................ . 
Declaration, page 11 
Chapter One 
Introduction 
Health technology assessment ............................................................. 13 
Physiology of fetal responses to labour ............................................. 14 
Oxygen supply ............................................................................................... 14 
Fetal defence mechanisms .............................................................................. 17 
Conclusions ................................................................................................... 20 
The present state of CTG monitoring during labour .................... 21 
Physiology and pathophysiology .................................................................... 21 
Technology .................................................................................................... 21 
Model of interpretation .................................................................................. 21 
Clinical evaluation ......................................................................................... 22 
Cost effectiveness .......................................................................................... 23 
Summary ....................................................................................................... 24 
Alternatives to CTG monitoring ......................................................... 24 
Do nothing .................................................................................................... 24 
Use intermittent auscultation only .................................................................. 25 
Continue the search for new measures of fetal condition 
during labour ................................................................................................. 26 
The ST waveform of the fetal electrocardiogram .......................... 27 
Pathophysiology ............................................................................................ 28 
Technology .................................................................................................... 33 
Clinical studies ............................................................................................... 35 
Model of interpretation .................................................................................. 36 
Objectives and structure of thesis ...................................................... 37 
Chapter One, page 12 
Health technology assessment. 
Praise without end the go ahead zeal, 
Of who ever it was who invented the wheel. 
But never a thought for the poor souls' sake, 
Who thought ahead and invented the brake. 
Howard Nemerov, New York Times, 1989. 
The technological achievements of the last 30 years have been immense; space travel, 
satellite communications and the microprocessor to name but a few. Advances in health 
care technology have been impressive too, for example, doppler ultrasound, computer aided 
tomography, and nuclear magnetic resonance imaging are now virtually routine diagnostic 
techniques. It seems that scarcely a medical journal is published without reference to a new 
technology which, it is frequently claimed, will revolutionise some aspect of medical 
practice. However, there is growing recognition that new techniques need to be thoroughly 
evaluated before introduction into clinical practice if patients and the health service are not 
to be endangered by unsafe, unhelpful and costly treatments (Jennett, 1992). For years now 
pharmaceutical companies have followed a standard procedure for the introduction of new 
drugs into clinical practice. This is based on a progression from animal studies to 
observational studies in man and finally to randomised clinical trials. The United States 
requires a similar formal assessment of new health care technology through the Federal 
Drug Administration Bureau. As yet, no such provisions exist in Europe, but they are not 
far away. Recently, an Advisory Group convened by the Department of Health, concluded 
that "rigorous assessment of both new and existing technologies is essential to evaluate their 
effectiveness and safety, their cost effectiveness and their social, ethical and organisational 
impacts." (Health Care Advisory Group, 1992). 
It is against this background of an increase in technology and calls for proper assessment of 
that technology that intrapartum fetal monitoring needs to be re-evaluated. Despite the 
major technological advances alluded to above, intrapartum monitoring has changed very 
little in the last 25 years. Intermittent auscultation of the fetal heart rate was performed 
regularly in the 1950s, fetal scalp blood sampling was introduced in the early 1960s (Saling 
& Schneider, 1967) and continuous electronic recording of the fetal heart rate and uterine 
contractions (the cardiotocogram or CTG) began in the late 1960s (Beard et al, 1971). Use 
of the CTG has never quite fulfilled its promise to reduce long-term neurological handicap 
and is regarded by many as a "disappointing" (Editorial, N Eng J Med, 1990) or an 
"unsatisfactory" technique (Neilson, 1993). Many alternatives to the CTG have been 
considered in the past and currently many new techniques are under investigation. Before 
these technologies can be evaluated, requirements for methods of intrapartum surveillance 
need to be considered. These are listed in the following Table. 
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Table 1.1 Requirements for methods of intrapartum surveillance. 
1. A sound physiological and pathophysiological basis for measurement of the variable. 
2. Technology which is robust enough to allow reliable measurement of the variable 
in clinical practice. 
3. A model of interpretation which identifies both the normal and the abnormal. 
4. Evidence from clinical studies and randomised trials to show that the new technique is 
as good as, or better than, existing techniques. 
5. Cost-effectiveness. 
The requirement for a sound physiological and pathophysiological basis for measurement of 
any variable used to assess fetal condition is most important. Knowledge of fetal responses 
to labour should form the basis of the search for new indices of fetal condition and for the 
assessment of indices already in use or under investigation. These responses will be 
reviewed in the following section. 
Physiology of fetal responses to labour. 
The fetus lives and grows down-stream from maternal oxygen supply in partial pressures of 
oxygen which are so low that the term 'Mount Everest in utero' was coined to describe its 
supposedly perilous existence (Barcroft, 1946). Yet the fetus has a number of special 
adaptive mechanisms which enable it to cope so well with this situation that it normally has 
a surplus of oxygen for its requirements. In the event of a further reduction in oxygen 
supply, important defence mechanisms are activated, mediated by beta-adrenergic receptors, 
to maintain the function of high priority organs; blood flow is redirected to the priority 
organs and organ function can be maintained by anaerobic metabolism. These mechanisms 
will be reviewed in more detail. 
Oxygen supply. 
The placenta is the organ of gas exchange for the fetus. Oxygenated maternal blood enters 
the intervillous spaces from spiral arterioles and flows around the fetal chorionic villi. 
Deoxygenated fetal blood reaches the villi via the two umbilical arteries. Oxygen diffuses 
from maternal blood into fetal blood across the placental membrane whilst carbon dioxide 
passes readily in the opposite direction. Oxygenated fetal blood returns to the fetus in the 
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single umbilical vein. A number of mechanisms active both before and during labour may 
alter this process and result in a reduction in fetal oxygen supply (Figure 1.1 ) . 
Maternal 
shock 
epidural anaesthesia 
fever 
anaemia 
respiratory depression 
- opiates 
- anaesthesia 
acidosis & dehydration 
vascular disease 
drugs 
Also: 
perfuslon pressure 
haematocrit 
Uterine wall 
exc:esalve uterine activity 
uterine abnormalities 
artery 
vein 
Placental Organ 
poor placentatlon 
premature separation 
toxaemic states 
~ 
prolapse 
compression 
entanglement 
Figure 1.1 Mechanisms by which fetal oxygen supply may be impaired. 
Infection 
fetal bleeding 
anaemia 
myocardial depression 
by LA agents 
antibodies 
Labour is a critical time for the fetus. During labour maternal blood supply to the placenta is 
normally interrupted during uterine contractions so that oxygen levels in fetal blood fall 
during contractions and recover once placental blood flow resumes (Figure 1.2). Thus a 
relative oxygen deficiency is a part of normal labour. 
maternal placental 1 ' 
perfusion + + + + + + + + -f! 0 0 0 0 0 0 0 0 4- + + + + + + + + 
fetal oxygen 
supply 
I ! 
I I 
I 
: j 
! ! 
30 mmHg ----------------------~ ---····------------·-·····--·-- i -------------
Intrauterine 
pressure 
Time (mins) 
Figure 1.2 The effect of uterine contractions on placental perfusion and fetal oxygen supply 
(modified from Steer, 1977b). 
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Frequently, reduced oxygen supply is described by the terms hypoxaemia (reduced oxygen 
in the blood), hypoxia (oxygen supply does not meet tissue demands) and asphyxia (hypoxia 
plus acidosis causing impairment of organ function). A more helpful physiological approach 
is illustrated in Figure 1.3 and 1.4. Figure 1.3 summarises how the fetus aims to balance 
oxygen supply and requirements so as to maintain aerobic metabolism. 
p02 
OXYGEN 
REQUIREMENT 
tissue obligatory physical 
mass functions activity 
haemoglobin saturation blood now 
I I I 
OXYGEN 
SUPPLY 
AEROBIC 
METABOLISM 
Figure 1.3 The factors which determine oxygen supply and requirement. Aerobic 
metabolism occurs when these are in balance. 
The oxygen available to the fetus is not just dependent upon the partial pressure of oxygen 
in the blood (p02) but also on the haemoglobin concentration, the type of haemoglobin and 
the oxygen saturation. The increased oxygen-carrying capacity of fetal blood is partly due to 
its higher haemoglobin concentration and the greater affinity of fetal haemoglobin for 
oxygen. This enables it to become saturated with oxygen at low partial pressures of oxygen. 
The amount of blood flow to an organ will also determine its oxygen supply. Fetal cardiac 
output is approximately four times higher than that of the adult per kilo of body weight 
(Cohn et al, 1974, Peeters et al 1979). As a result fetal organs are normally supplied with 
more oxygen than they require. 
Oxygen requirement is determined by fetal size, fetal activity and essential fetal metabolic 
processes. If supply and requirement are in balance the fetus has adequate oxygen to 
metabolise glucose aerobically to produce the energy required for organ function. If oxygen 
supply is inadequate the fetus can produce energy by anaerobic metabolism (Figure 1.4). 
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Figure 1.4 Anaerobic metabolism. When oxygen supply is insufficient to meet requirements 
energy is produced by the anaerobic metabolism of glycogen and glucose. 
Fetal defence mechanisms. 
The fetus is able to adjust to periods of reduced oxygen supply in order to maintain the 
balance illustrated in Figure 1.3 by means of a number of hormonal, cardiovascular, 
metabolic, and behavioural mechanisms. However, it is important to recognise that the time 
of onset, duration and severity of oxygen deficiency may vary greatly from fetus to fetus 
and will affect the success offetal compensatory mechanisms. The effect of an acute oxygen 
lack during labour in a healthy fetus may be different from the same insult in a fetus who has 
already experienced a chronic oxygen deficiency throughout pregnancy. 
Honnonal adjustments. The important cardiovascular and metabolic adjustments which 
will be described in the following sections are mediated by neural and humoral mechanisms. 
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Hypoxia results in an increase in sympathetic and parasympathetic (vagal) nervous system 
activity initiated by an increase in autonomic activity (Dawes, 1968, Parer, 1983, 1984) and 
an increase in the secretion of catecholamines, vasopressin, adenine, adenosine, and 
prostaglandins (Comline et al, 1965, Jones & Ritchie, 1978a, 1978b, Rurak, 1978, 
LaGamma et al, 1982, Lagercrantz & Slotkin, 1986). Large amounts of catecholamines are 
released from the adrenal medulla in response to both direct hypoxia and increased 
sympathetic activity (Comline et al, 1965, Jones & Robinson, 1975). They stimulate specific 
adrenergic receptors which induce both cardiovascular and metabolic responses (Phillippe, 
1984). After an uneventful vaginal delivery catecholamine levels in umbilical cord arterial 
blood are far higher than levels found in adults performing heavy exercise. Levels in 
asphyxiated infants are higher than those found in patients with phaeochromocytoma 
(Lagercrantz & Bistoletti, 1977). The surge of catecholamines during labour and delivery 
probably have an important role in facilitating postnatal adaptation to extrauterine life 
(Lagercrantz & Slotkin, 1986). In experimental studies beta-adrenergic receptor blockade 
significantly impaired fetal ability to survive during periods of hypoxia (Dagbjartsson et al, 
1985). 
Cardiovascular adjustments. As fetal organs are relatively over perfused in relation to 
their oxygen requirements, they have a certain oxygen reserve. Fetal haemoglobin has a high 
affinity for oxygen and chronic hypoxaemia results in increased erythropoiesis to further 
increase the oxygen carrying capacity offetal blood (Soothill et al, 1987). Fetal tissues can 
also increase the amount of oxygen they extract from the blood. In fetal sheep this 
compensatory increase in fractional oxygen extraction can maintain tissue oxygenation until 
oxygen delivery is reduced by 50% (Richardson, 1989). Blood flow is preferentially 
distributed to vital organs (brain, heart, adrenals) to maintain their oxygen supply at the 
expense of peripheral organs (gut, skin, liver, muscles, kidneys) while placental blood flow 
is maintained (Cohn et al, 1974, Rudolph, 1984}. Chronic redistribution of blood flow away 
from peripheral organs can result in peripheral organ dysfunction in the neonate. Renal 
failure, necrotising enterocolitis, hepatic damage, coagulopathy and respiratory distress are 
all recognised sequelae of chronic hypoxaemia and can be used in an overall assessment of 
its severity (Portman et al, 1990, Shankaran et al, 1991 ). 
Unlike the brain, the heart cannot reduce its oxygen requirements during hypoxia and, 
indeed, is forced to work harder as a result of the catecholamine surge. Indeed, unlike the 
adult, the fetal heart is often the last organ to fail during hypoxia. The result of severe 
myocardial hypoxia is bradycardia, hypotension and, ultimately, cardiac standstill. Neonatal 
cardiac dysfunction is a recognised complication of severe hypoxia and may manifest itself 
as cardiogenic shock, left ventricular failure as a result of global myocardial ischaemia or, 
particularly, right-sided failure as a result of tricuspid papillary muscle necrosis (Setzer et al, 
1980, Walther et al, 1985}. Ischaemic myocardial damage is relatively common in infants 
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who have suffered a severe oxygen deficiency and die in the first seven days of life 
(Donnelly et al, 1980). 
Metabolic adjustments. If these cardiovascular adjustments fail to maintain adequate 
oxygen delivery, glucose and glycogen are metabolised anaerobically to provide the energy 
required to maintain cell and organ function (Figure 1.4). The lactic acid formed during 
anaerobic glycolysis releases hydrogen ions which are buffered primarily by bicarbonate ions 
but also by haemoglobin and proteins. As hydrogen ion concentration increases these 
buffers are consumed and a progressive metabolic acidosis develops with a fall in pH and a 
rise in the base deficit of the extracellular fluid. Glycogen stores are consumed rapidly 
during this process; 1 mole of glucose provides only 4 moles of ATP compared to the 38 
moles available from aerobic metabolism (Ganong, 1983). The importance of anaerobic 
metabolism to the maintenance of myocardial function (and survival of the fetus) is long 
established and depends on the prehypoxic glycogen content of the myocardium (Dawes et 
al, 1959). 
Anaerobic glycogenolysis results in the rapid depletion of glycogen stores which places the 
neonate at risk of hypoglycaemia and may accentuate hypoxic ischaemic brain damage 
(Vannucci & Yager, 1992). Damage to liver enzymes or hyperinsulinism may prevent 
adequate neonatal gluconeogenesis resulting in persistent hypoglycaemia (Collins & 
Leonard, 1984, Sann, 1990). These metabolic events may also contribute to difficulty with 
thermoregulation as a result of a depletion of brown fat (Hull, 1966). 
Behavioural adjustments. Other adjustments can be made to reduce oxygen requirements 
such as reduced physical activity, behavioural state alterations and reduced growth rate. 
Knowledge of these adjustments is the rational for the biophysical assessment of fetal well-
being (Manning et al, 1980), however there is recent evidence that a significant reduction in 
fetal activity may be a relatively late sign of fetal hypoxia. It has been found that 
electrocortical activity, electroocular activity and breathing movements in fetal sheep during 
4 days of prolonged, graded hypoxaemia did not change significantly until fetal arterial 
oxygen saturation was less than 30% and fetal acidemia had occurred (Richardson et al, 
1992). 
The central nervous system. The brain's first response to severe hypoxia is cerebral 
vasodilatation and a redistribution of blood flow to the brainstem, midbrain and cerebellum 
(Kjellmer, 1988). Control of FHR variability originates from higher centres in the cerebral 
cortex, so loss of variability may be one of the first signs of cerebral hypoxia (Court & 
Parer, 1982, Parer, 1984). The brain can also reduce its oxygen consumption during 
hypoxia (Kjellmer, 1988, Richardson et al, 1989). Damage can occur as a result of both 
neural necrosis and ischaemic lesions and appears to involve 3 mechanisms; the release of 
ex citatory amino acids, activation of the arachidonic cascade and the production of oxygen 
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free radicals (Kjellmer, 1991, Espinoza & Parer, 1991). In addition, damage occurs in two 
phases; firstly during hypoxia and secondly, and perhaps more significantly, during 
resuscitation and reoxygenation (Kjellmer, 1988). The neonate who has suffered from 
intrapartum oxygen deficiency severe enough to cause cerebral damage would be expected 
to show evidence of depression at birth which required active resuscitation (American 
Academy of Pediatrics, 1986, Gilstrap et al, 1989, Freeman & Freeman 1992). The 
occurrence of subsequent neonatal neurological disturbance and, ultimately, long term 
damage would depend on the degree of both primary and secondary neuronal damage. 
Many fetuses who have experienced chronic hypoxaemia seem to have significant short and 
long term alterations in the way they develop and interact with their environment. Growth 
retarded fetuses have altered cerebral evoked potentials at birth (Kjellmer et al, 1992), an 
increased risk of perinatal complications and long term neurological abnormalities {Harvey 
et al, 1982, Chiswick, 1985). In addition they are at increased risk of developing arterial 
hypertension later in life (Gennser et al, 1988) and of dying from ischaemic heart disease 
(Barker et al, 1989). Recently it has been shown that under basal conditions, compared to 
normally grown rats, the brain tissue of growth retarded rats had lower concentrations of 
serotonin and aspartate, two factors which sustain trophic function in brain development 
(Thordstein, 1991). Growth retarded fetuses display an inappropriate increase in serotonin 
synthesis and an increase in lipid peroxidation in response to hypoxia (Thordstein, 1991). 
These findings suggest that brain development in growth retarded fetuses may be delayed 
and that their central nervous system is more vulnerable to the effects of hypoxia. 
Conclusions. 
The response of any individual fetus to the stress of labour will be determined by the 
duration and severity of hypoxaemia encountered before and during labour, balanced by the 
effectiveness of its cardiovascular responses and its energy reserves. Given the complexity 
of this situation it is unlikely that any single variable will totally reflect fetal condition 
during labour. Ideally, measurement of variables which reflect the function of the heart and 
brain and which indicate the level of hypoxaemia at which compensatory mechanisms come 
into play and then begin to fail is required. 
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The present state of CTG monitoring during labour. 
The term 'electronic fetal monitoring' (EFM) has been used to describe both CTG 
monitoring alone (Haverkamp et al, 1979, Leveno et al, 1986) and CTG monitoring plus 
fetal blood sampling (Banta & Thacker, 1979, MacDonald et al, 1985). This term now also 
encompasses most of the alternative technologies under investigation. In order to avoid 
confusion, use of the term EFM will be avoided; the CTG will be used to describe 
continuous electronic recording of fetal heart rate and additional use of fetal blood sampling 
(FBS) will be specified separately. 
The present state of CTG monitoring during labour can be summarised according to the 
points listed in Table l.l. 
Physiology and pathophysiology. 
Although the heart is a vital central organ, fetal heart rate (FHR) changes during labour 
occur as the result of a complex interaction of many factors which act on the heart. Present 
understanding of the physiological and pathophysiological basis of these changes is limited 
(Court & Parer, 1984, Ball & Parer, 1992). As a result it can be difficult to separate FHR 
changes which indicate appropriate fetal compensatory responses from those which indicate 
decompensation. 
Technology. 
The CTG was introduced in the late 1960s and the instruments soon became widely 
available. FHR can be measured directly from a fetal scalp electrode (FSE) applied to the 
fetal presenting part or indirectly from a doppler ultrasound transducer applied to the 
maternal abdomen. Both methods are susceptible to signal noise (particularly doppler 
techniques) which primarily affects estimations of FHR variability. Improvements in signal 
processing and the introduction of wide range ultrasound transducers and autocorrelation 
have improved the accuracy of FHR detection although artefacts may still occur (Carter, 
1986, Dawes et al, 1990). However, generally, the technology is robust and user-friendly 
but requires subjective interpretation. 
Model of interpretation. 
The model of interpretation of CTG changes was largely based on empirical observations of 
thousands ofhours of recordings during human labour (Hon & Quilligan, 1967, Beard et al, 
1971) and is still reproduced in modern textbooks (Liewellyn-Jones, 1986, Miller & 
Callander, 1989). The detailed knowledge these early workers gained from their 
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observations has not been represented in the simplistic classifications used and even their 
original tenninology has become corrupted with time (Donker, 1991). 
Clinical evaluation. 
In the late 1960s and early 1970s there were a large number of observational studies which 
favourably compared the CTG with intermittent auscultation using historical or non-
randomised concurrent controls (e.g. Paul & Hon, 1974, Tipton & Lewis, 1975, Lee & 
Baggish, 1976, Neutra et al, 1978). It is impossible to be sure that other factors did not 
contribute to the improvements noted (e.g. a fall in high parity pregnancies, earlier diagnosis 
of congenital abnormalities, improvements in neonatal resuscitation). The results of the first 
randomised controlled trial which compared the CTG with intermittent auscultation ofFHR 
did not appear until 1976 (Renou et al, 1976) and supported the use of the CTG in high risk 
labours. Since then 7 other randomised trials have been published. Their findings can be 
summarised as follows; 
Operative intervention rates are increased with the use ofCTG alone (Kelso et al, 1978, 
Haverkamp, et al, 1979, Leveno et al, 1986, Neldam et al, 1986, Luthy et al, 1987). 
The addition of fetal blood sampling to assess fetal acid-base status during labour can 
reduce operative intervention (Haverkamp et al, 1979, Young et al, 1980, MacDonald et al, 
1985) but is an intermittent procedure which is used in less than 45% of UK hospitals 
(Whebble et al, 1989). Furthermore, there is very little information on how frequently and 
how effectively it is used in clinical practice (Murphy et al, 1990). 
Neonatal outcome. Only two of the randomised controlled trials have shown an 
improvement in neonatal condition with use of the CTG (Renou et al, 1976, MacDonald et 
al, 1985). The main effect appears to be a reduction in neonatal seizures (Grant, 1991), but 
follow-up of a proportion of cases from the Dublin study (MacDonald et al, 1985) has 
shown no difference in outcome at 4 years of age (Grant et al, 1989). 
There is no accepted definition for 'birth asphyxia' and many different measures of neonatal 
outcome have been used in various studies. However, hypoxia is not the only cause of 
neonatal seizures (Nelson & Leviton, 1992), a low Apgar score or neonatal ventilatory 
requirements (American Academy ofPediatrics, 1986). Routine measurement of cord artery 
and vein blood gas parameters are recommended as objective measures of neonatal 
condition (Thorp et al, 1989, Johnson et al, 1990) but there is much confusion about their 
value (Ruth & Raivio, 1988, Dennis et al, 1989). There is no longer any consensus of 
opinion as to which measures of outcome are appropriate, or more appropriate than others. 
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Two other important points can be noted from the large number of additional clinical 
studies which have investigated various aspects of CTG monitoring. 
Large intra- and inter-observer differences in the interpretation of CTG recordings 
have been reported (Trimbos & Keirse, 1982, Lotgering et al, 1982, Lidegaard, et al, 1992} 
and apparently even 'experts' cannot agree (Donker, 1991}. There is growing evidence that 
the interpretation of CTG changes is a major problem for practising obstetricians and that 
improper interpretation and management is implicated in a large proportion of 'birth 
asphyxia' cases (Murphy et al, 1990) and is the cause of a substantial proportion of litigation 
for birth related events (Ennis & Vincent, 1990, Chamberlain & Orr, 1990). 
Cerebral palsy rates have not decreased. When the CTG was introduced in the 1960s, 
there was much optimism that it would prevent fetal death in labour and reduce long term 
neurological handicap. Despite the dramatic decline in intrapartum stillbirth rates in 
developed countries (Parer, 1979, Shepherd et al, 1983, Errkola et al, 1984, Georgsdottir et 
al, 1989), cerebral palsy rates in both preterm and term fetuses have increased (Nelson & 
Ellenburg, 1986, Stanley & Watson, 1988, Dowding & Barry, 1988, Hagberg & Hagberg, 
1989, Pharoah et al, 1990}. Given the fall in intrapartum stillbirth rates, it is possible that 
use of the CTG has caused a shift from death to handicap. This implies that intrapartum 
events may only exacerbate existing damage and is consistent with both the physiology and 
pathophysiology just reviewed and with recent evidence that less than 10% of cerebral palsy 
is related to intrapartum events (Nelson, 1988, Blair & Stanley, 1988}. 
Cost effectiveness. 
The cost-effectiveness of the CTG to the health service has rarely been addressed. In their 
review of electronic fetal monitoring published in 1979, Banta & Thacker estimated that 
EFM cost the country $411 million in 1977-78. Their calculations were challenged by 
Hobbins et al (1979) who claimed the cost ofEFM was closer to $80 million. In 1991 it 
was estimated that the cost for an emergency caesarean section was £1172, 3 times that of a 
normal vaginal delivery and double that of an operative vaginal delivery (Clark et al, 1991 ). 
It is obvious that use of this technology results in a significant increase in cost to the health 
service. The increased incidence of repeat caesarean section in subsequent pregnancies also 
needs to be included in any financial equation. Other important factors are more difficult to 
put a figure on, for example, the impact of an operative delivery on the psyche of the 
mother and its effect on maternal-infant bonding. In comparison, the cost-effectiveness of 
CTG monitoring for commercial companies was obvious at an early stage. By 1976 one 
commercial company had sold over 800 CTG monitors at a cost of over 2 million pounds, 
provoking the comment that the technique had moved from the realms of research into big 
business (Steer, 1977a). 
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Consideration of cost-effectiveness is now complicated by the issue of litigation. If the FHR. 
is not recorded during labour and there is a poor infant outcome, it is becoming increasingly 
difficult to mount a defence against accusations of mismanagement. The growing numbers 
and escalating costs of these cases threatens the financial stability of the entire health 
service. The number of claims against obstetricians and gynaecologists has trebled in the last 
5 years and in many cases successful settlements exceed £1 million (Symonds, 1991). As the 
costs for these cases are now being absorbed by district health authorities, it is inevitable 
that local health services will be affected by a diversion of funds to cover settlement of these 
cases. 
Summary. 
The CTG was introduced into clinical practice without a clear understanding of the 
physiological and pathophysiological basis of interpretation and without a thorough 
assessment of its value in clinical practice. As a result the whole area of intrapartum fetal 
monitoring is in confusion. On the one hand clinicians know that use of the CTG will result 
in unnecessary operative deliveries, whilst on the other, failure to monitor may leave them 
open to litigation, as may its inappropriate use. 
Alternatives to CTG monitoring. 
There seem to be three possible responses to the confusion about the value of CTG 
monitoring during labour. 
Do nothing. 
Should we abandon all forms of intrapartum monitoring? Perinatal mortality rates in third 
world countries where intrapartum care is not widely available do not encourage much 
confidence in this approach. As the general standard of nutrition, health and hygiene in these 
countries is far below that enjoyed in most western countries, the comparison may not be 
entirely valid. However, comparable data is available from a religious sect in Indiana in the 
United States who do not believe in medical care. Their women receive no antenatal care 
and deliver at home without trained attendants. From 1975 to 1982, a conservative estimate 
of the perinatal mortality in this group was three times higher than that of the whole state. 
These findings were unexplained by demographic data as sect members were predominantly 
white, aged 24 to 35, married, and had at least a high school education (Kaunitz et al, 
1984). It is salutary to note that the maternal mortality rate in this group was 100 times 
higher than the whole state population. 
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Use intermittent auscultation only. 
Another simple, but less extreme alternative, is to abandon the CTG in favour of 
intennittent auscultation of FHR. Whilst results of the randomised trials indicate that this 
approach may be suitable for low risk labours, the only study of high risk labours 
demonstrated a significant advantage for the CTG (Renou et al, 1976). A number of other 
points also need to be considered. 
Firstly, there is evidence that the performance of a randomised trial may have influenced the 
use of intennittent auscultation during the Dublin randomised trial of intennittent 
auscultation versus CTG (MacDonald et al, 1985). Figure 1.5 shows the intrapartum 
stillbirth and perinatal mortality rates in the National Maternity Hospital, Dublin before, 
during and after their trial. Before the trial intennittent auscultation was used exclusively. 
The CTG was only introduced into the hospital a few months before the randomised trial 
began (an interesting point which raises questions about staff inexperience with the 
technology). 
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Figure 1.5 Intrapartum stillbirth and perinatal mortality rates at the National Maternity 
Hospital in Dublin from 1976 to 1989. (Figures obtained from Dr P Boylan, personal 
communication). 
There was a clear decrease in total hospital mortality rates during the trial period (a 
Hawthome effect). This not only reduced the chance of detecting a difference between the 
two monitoring techniques but also suggests that the quality of intennittent auscultation 
was improved by the performance of the trial. 
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Secondly, it is has been repeatedly demonstrated that errors in counting FHR by 
auscultation can be significant. Obsetvers were more likely to bias baseline estimations 
towards normal when the FHR is fast or slow (Day et al, 1968, Schifrin et al, 1992) and a 
significant proportion of decelerations were missed (Miller et al, 1984, Schifrin et al, 1992, 
Strong & Jarles, 1993). 
Thirdly, a very important practical problem is that most labour wards cannot provide the 
one to one staffing level required to perform auscultation as frequently as required. One 
group only managed to successfully monitor 7.5% of 423 labours by intermittent 
auscultation (Morrison et al, 1991). Staff unavailability was the main reason for failure. The 
immediate response to this problem is to suggest that health care funding would be better 
spent on personnel and not machines. But despite a one to one midwife:patient ratio in a 
highly motivated group of mothers (and midwives), there was a two to sevenfold increase in 
asphyxia related perinatal deaths in home delivery cases in South Australia where 
intrapartum monitoring is only by intermittent auscultation (Henderson-Smart, 1991 ). 
Continue the search for new measures of fetal condition during labour. 
Over the last 30 years there have many attempts to investigate new variables; 
transcutaneous measurements ofp02 (Huch et al, 1980), continuous tissue pH (Weber & 
Hahn-Pedersen, 1979, Nickelsen & Weber, 1991), pC02 (Schmidt et al, 1982, Schmidt & 
Sating, 1987), systolic time intetvals (Robinson et al, 1978), fetal oxygen saturation by 
pulse oximetry (Johnson, 1991), changes in the ST waveform (Rosen et al, 1991) and time 
constants (Murray, 1986) of the fetal electrocardiogram (Greene, 1987), and cerebral blood 
flow by near infrared spectroscopy (NIR) (Peebles et al, 1992a &b) . 
The majority of these approaches must overcome considerable technical problems to 
reliably obtain the required signal. The techniques currently under investigation are 
summarised in Appendix 1 according to the present state of pathophysiological knowledge, 
the available technology and potential clinical usefulness. 
One of the most advanced of these new methods of intrapartum fetal sutveillance is analysis 
of changes in the ST waveform of the fetal electrocardiogram (ECG). It reflects the 
function of a central organ, the heart, and, over the last 18 years the physiological basis for 
changes in the waveform have been determined in a series of animal experiments A number 
of preliminary human obsetvational studies have been performed with promising results. 
This information will now be reviewed in detail. 
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The ST waveform of the fetal electrocardiogram. 
The fetal electrocardiogram (FECG), like that of the adult, consists ofP, QRS and T waves 
separated by PR and ST intervals (Figure 1.6). These represent the summation of the 
electrical events within the heart as seen from the body surface. The P wave represents 
atrial contraction, the QRS complex ventricular contraction, and the ST waveform (ST 
segment and T wave) ventricular repolarisation. 
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Figure 1.6 The ECG waveform. 
Changes seen on the surface ECG occur as a result of changes in the relationships of the 
action potentials in different parts of the ventricular muscle at different points in time. The 
ST segment is usually isoelectric because the ventricular cells come simultaneously to nearly 
the same depolarised potential and no current flows between them. As some areas 
repolarise before others, current flows between cells to produced the T wave. Normally the 
base of the heart and the endocardium depolarise before the apex and epicardium but, as 
their action potentials last longer, repolarisation proceeds in the reverse direction which 
results in the positive ST waveform shown in Figure I. 7 A. 
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Figure l. 7 The relationship between action potentials in the endocardium and epicardium 
which give (A) a positive and (B) a negative T wave. The ST segment reflects the plateau 
phase of the action potential and the T wave the time difference between repolarisation of 
different parts of the myocardium (after Wohlfart, 1987). 
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If the endocardium depolarises before the epicardium, or the base before the apex, as for 
example during an extrasystole, the T wave will be negative (Figure 1. 7B). The shape of the 
action potentials, and therefore the ST waveform, are affected by pressure gradients across 
the ventricular wall (Kirk & Honig, 1964) and by metabolic and ionic events around the 
myocardial cell which influence the sodium/potassium pump and probably calcium and 
chloride currents (Noble, 1979). The ST waveform can be assessed qualitatively by its 
shape, and quantitatively by measurement of the T wave height relative to that of the QRS 
complex (T/QRS ratio, Figure 1.8). 
QRS 
Figure 1.8 The T/QRS ratio. 
In adults the ST waveform is affected by a number of normal and pathological conditions. 
Clinical analysis of the waveform is used to determine the size and progress of myocardial 
infarcts (Braunwald & Maroko, 1976) and to diagnosis coronary insufficiency during an 
exercise ECG (Sokolow & Mcllroy, 1981). Over the last 18 years a series of experimental 
animal and clinical observational studies have provided a basis for understanding ST 
waveform change in the fetus (reviews by Greene, 1987, Greene & Westgate, 1993). 
Pathophysiology. 
There have been many incidental observations of ST segment and T wave change in the 
fetus in the past; with acute asphyxia by cord occlusion in goats (Towell, 1971), by 
maternal aortic occlusion or abnormal uterine activity in monkeys (Myers, 1972, Morishima 
et al, 1975) and in human fetuses before death (Hon & Lee, 1963) and in association with 
an abnormal CTG (Pardi et al, 1971). Initially, these changes were thought to be too 
variable to be useful but then a number of acute experiments performed specifically to 
examine the ST waveform showed that this may not be the case. 
Acute preparations. In 1975, Rosen noted that hypoxia with acidemia caused a 
progressive increase in the amplitude of the ST waveform in the exteriorised fetal lamb 
(Rosen & Kjellmer, 1975). These changes preceded heart rate changes and a steadily 
increasing T wave height (T/QRS ratio > 1.0) always preceded signs of failing 
cardiovascular function (Rosen et al, 1976a) and occurred contemporaneously with serial 
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changes in the somatosensory evoked electroencephalogram (EEG) (Rosen et al, 1976b). A 
strong correlation was also demonstrated between the T/QRS ratio and the depletion of 
myocardial glycogen and creatine-phosphate (Rosen & lsaksson, 1976) and between 
T/QRS ratio and lactate rise (Rosen et al, 1976a). Later HokegArd et al (1981) 
demonstrated a strong correlation between the increase in T wave amplitude during hypoxia 
with the rate of myocardial glycogenolysis as measured by a decrease in myocardial 
glycogen, creatinine phosphate and ATP measured on serial biopsies from the hearts offetal 
lambs. 
Chronic preparations. The evidence from acute experiments strongly linked ST elevation 
with myocardial glycogenolysis which was already known to be of great importance for the 
maintenance of myocardial function and fetal survival during hypoxia (Dawes et al, 1959). 
The study of ST waveform in chronically instrumented fetal lambs added further 
information. 
ST waveform elevation. Fetal lambs with a normal baseline ST waveform had different 
responses to hypoxaemia (Greene et al, 1982, Greene, 1983). Despite similar falls in the 
partial pressure of oxygen (p02) (to 1.8 kPa or 13.5 mmHg) some lambs displayed little 
change in ST waveform or lactate while others had marked ST elevation which was related 
to the rate of lactate accumulation. These findings were confirmed by Rosen et al (1986a) 
who also demonstrated that an elevation of catecholamine levels during hypoxia only 
occurred in fetuses with lactate and ST waveform changes (Figure 1.9). The different 
responses to hypoxia seen in these fetuses were clearly important. It was postulated that 
fetuses that did not display ST waveform, lactate or catecholamine changes were able to 
compensate for decreased p02 with increased myocardial blood flow and hence were able 
maintain myocardial oxygen supply (Greene, 1983). Oxygen supply is the product of blood 
flow and oxygen content. Myocardial blood flow can increase by 350-500% to maintain 
oxygen supply despite a 70-80% reduction in arterial oxygen content (Peeters et al, 1979). 
In comparison, it seems that the group of Iamb fetuses that were unable to fully compensate 
for hypoxia with increased blood flow switched to anaerobic metabolism to maintain 
myocardial function. As a result their ST waveform, as measured by the T/QRS ratio, and 
lactate levels rose, in keeping with the acute experimental data. The degree of ST waveform 
elevation may also provide information about the effectiveness of fetal compensatory 
mechanisms. Dagbjartsson (1989) found a linear correlation between T/QRS ratio increase 
and myocardial workload in exteriorised lambs and recently a correlation between the 
degree of ST elevation and the development of fetal acidosis during repetitive cord 
compressions in chronic fetal sheep preparations has been reported (Watanabe et al, 1992). 
A T/QRS ratio >0.5 during cord compression was associated with fetal hypotension, 
lowered catecholamine levels and fetal acidosis. 
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Figure 1.9 Alterations in the mean values ofPa02, arterial oxygen content, fetal heart rate 
(FHR.), mean arterial blood pressure (MAP), lactate, noradrenaline, adrenaline and T/QRS 
before, during and after a 1 hour period of hypoxia. Dashed lines indicate a group of fetuses 
with no changes in ST waveform during hypoxia; solid lines indicate the group with an 
increase in T wave amplitude. The level of significance between the 2 groups is indicated 
( .. p<0.01). Reproduced from Rosen et al, 1984, with permission. 
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As a result of these investigations, a mechanism for ST waveform elevation was proposed 
(Figure 1.10). Anaerobic metabolism results in an alteration in ionic currents about the 
myocardial cell which affects the cell membrane potential and thus ST waveform shape. 
02 
requirement 
aerobic 
metabolism 
glycogen 
glucose 
02 
supply 
insufficient 0 2 supply 
l 
j anaerobic metabolism 
lactate 
W--- pH fall 
extracellular K• leak 
altered 
membrane 
potential 
STwaveform 
elevation 
Figure 1.10 A schematic representation of the mechanisms underlying ST waveform 
elevation (modified from Greene, 1987). 
Circulating catecholamines and the autonomic nervous system play a vital part in the fetal 
responses to hypoxaemia. ST waveform elevation was produced by infusion of the 
beta-agonist isoprenaline in the exteriorised lamb (Hokegard et at, 1979). Increasing doses 
(0.04 to 9.0 IJ.g/kg/min) produced a progressive increase in T/QRS ratio but the value never 
exceeded 0.60. Propranolol blocked these changes and those produced during mild hypoxia, 
but not during severe hypoxia. Hypoxia and isoprenaline infusion had an additive effect on 
ST waveform change and produced higher T/QRS ratios than those seen with isoprenaline 
alone. In the chronic fetal lamb adrenaline infusion did not cause ST elevation (Greene, 
1983) but this may have been related to the lower dose ofbeta-mimetic (0.3-0.71J.g/kg/min) 
and/or the use of a less cardioselective agent (adrenaline). Dagbjartsson (et al, 1989) 
showed that exteriorised lamb fetuses subjected to maternal infusion of varying doses of 
terbutaline had a much more marked response in heart rate, myocardial contractility, blood 
pressure, and ST waveform change with hypoxia than did control fetuses. This suggests that 
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hypoxia may increase myocardial beta-receptor sensitivity. The observation that ST 
waveform change promptly returned to normal following hypoxia even though circulating 
catecholamines were still raised (Greene, 1983) supports this hypothesis. Mild hypoxia may 
induce ST change by beta-receptor activation whilst severe hypoxia may have a more direct 
effect on myocardial cells. 
In some chronically instrumented fetal lambs a persistently elevated waveform (T/QRS ratio 
0.48) was associated with chronic hypotension and/or anaemia despite normal blood gases 
(Greene, 1983). No fetus with these changes survived labour (Greene & Rosen, 1989). In 
one fetus the chronically elevated ST waveform became markedly negative with a sinusoidal 
heart rate and blood pressure pattern at the onset of a hypoxic insult for one hour during 
labour and the fetus died shortly afterwards. 
Negative ST waveform. The unilateral uterine artery ligation model (Lafaber et al, 1984) 
was used in the guinea pig to examine the ST waveform of growth retarded fetuses 
compared with their normally grown littermates (Widmark et al, 1991 ). The majority of 
runted guinea pigs showed ST depression with and without negative T waves whilst their 
normally grown litter mates showed ST elevation (Figure 1.11). 
Normal Sized Growth Retarded 
normoxia hypoxia normoxla hypoxia 
+++ 
Figure 1.11 ST waveform change during hypoxia in normal sized and growth retarded 
guinea pig fetuses (modified from Widmark et al, 1991 ). 
Normal sized controls showed a 4 to 7 fold increase in plasma catecholamines compared to 
the 2 to 3 fold increase seen in runted fetuses. These runted fetuses probably had depleted 
myocardial glycogen reserves, a blunted sympathoadrenal response to hypoxia and 
consequently ineffective myocardial anaerobic metabolism. This data fits well with much 
earlier observations by Gelli & Gyulai ( 1969). They examined the effects of pre-delivery 
glucose loading in rabbits subject to anoxia by complete placental separation. In untreated 
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controls the ECG initially showed high peaked T waves after the onset of anoxia which 
subsequently became depressed with negative T waves after 49 minutes. Half of the glucose 
loaded fetuses continued to show large positive T waves for 87 minutes before demise and 
although the remainder developed negative T waves, this occurred 13 minutes later than 
controls. So it would seem the development of a negative ST waveform is related to a lack 
of substrate and failing myocardial function. In the sheep fetus, negative T waves were 
associated with reduced myocardial contractility and a reduction in stroke volume (Rosen, 
personal communication). 
The finding of negative ST waveforms can be explained by the effect of hypoxia on 
myocardial cell action potentials (Wohlfart, 1987). If energy balance cannot be maintained 
either by myocardial vasodilatation and aerobic metabolism supplemented by anaerobic 
metabolism, ischaemic hypoxia occurs first in the deeper layers of the myocardium 
(endocardium) compared with the epicardium. This alters the sequence of repolarisation to 
produce a negative ST waveform (Figure 1.7B). ST depression with T wave elevation (a 
biphasic ST waveform) is also seen when myocardial ischaemia occurs in adults and may 
represent an earlier stage in the development of myocardial ischaemic hypoxia when the 
action potential change is not uniform throughout the myocardium. 
Summary ST waveform elevation indicates compensated hypoxic myocardial stress and a 
switch to anaerobic myocardial metabolism. A progressive rise in T/QRS ratio represents 
continuing anaerobic metabolism with a risk of eventual decompensation due to depletion of 
myocardial glycogen stores and a progressive metabolic acidosis. Biphasic and negative 
waveform changes probably indicate myocardial decompensation as a result of direct 
myocardial ischaemic hypoxia. 
Technology. 
The FECG in the Greene and Rosen animal experiments was recorded from subcutaneous 
silver/silver-chloride precordial chest leads. In contrast the human FECG is recorded from 
an electrode attached to the fetal scalp. This results in a number of problems. 
Signal noise is increased significantly as attachment of a FSE to the scalp is not as secure as 
implanted precordial leads. This adds movement artefact to the signal. Several different 
types and designs of FSE are available in clinical practice. The ideal FSE for ECG 
waveform analysis has not been previously determined. Signal noise affects the shape of the 
ECG waveform (Figure 1.12) and must be removed before ST waveform analysis can 
reliably be performed (Greene, 1989). 
Filtering is the easiest way to remove unwanted signal noise. Conventional CTG recorders 
heavily filter FECG signals to obtain a stable baseline from which QRS complexes are easily 
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counted to obtain the heart rate. However, the frequency content of the FECG is 0.05 to 
100 Hz and high pass filtering to remove baseline noise will also remove the low frequency 
components of the slow moving parts of the waveform (the P wave, ST segment and T 
wave) and distort waveform shape. Early investigators used considerable filtering (e.g. Hon 
& Lee, 1963, bandpass 8-50 Hz) which would have obscured all but gross waveform 
changes. Others failed to quote the filter characteristics of their recording systems (e.g. 
Hioki, 1975). This may explain the inconsistencies in early reports of ST waveform change 
in the human fetus. 
A B 
Figure 1.12 A strip of raw FECG recorded from a fetal scalp electrode. The baseline noise 
results in apparent alterations in ST waveform shape (compare complexes A and B). 
Reproduced from Greene, 1987, with permission. 
Signal processing. Improvements in signal processing and the development of smaller, 
faster computers allowed signal noise to be removed with minimal filtering with the use of 
signal averaging (Marvell et al, 1980, Wickham, 1982, Lindecrantz, 1983). This technique 
recovers a wanted repetitive signal from background noise by averaging several signals. The 
repetitive signal is enhanced by n, the number of signals averaged, but random background 
noise is only enhanced by .,Jn. A transient rejection algorithm was added to prevent 
obviously aberrant complexes from affecting the average (Greene, 1983). Signal averaging 
relies on a software algorithm to detect the QRS wave in every complex. If the signal 
contains too much noise the detection point will vary Gitter) and misalignment of the 
complexes will result in a distortion of the average. This will tend to reduce the height of 
the QRS complex and increase the calculated T/QRS ratio. This was overcome by 
producing parallel signals and filtering one to obtain a clean trigger from which to average 
the raw signal (Greene, 1983, Rosen & Lindecrantz, 1989). Inconsistencies between the 
QRS trigger and the rest of the signal such as may occur with physiological variation in 
heart rate may cause a smoothing of the T wave but this is unlikely to be a significant 
problem if the averaging period is kept short (Greene, 1983). 
Systems for fetal ST waveform collection and analysis. A dedicated on-line 
microprocessor-based system for ST waveform analysis has been developed in Sweden as a 
result of the investigations detailed above (Rosen & Lindecrantz, 1989). It filters the signal 
for waveform analysis between 0.05 and 100Hz at a sampling frequency of 500Hz with 8 
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bit resolution. The electrode lead configuration used is different from that used by a 
conventional CTG recorder. A maternal skin electrode is used as the reference electrode in 
order to standardise the T wave vector so that it is unaffected by fetal rotation (Lindecrantz 
et al, 1988). This ST Analyser (ST AN, Cinventa, AB, Sweden) has been used successfully 
in a number of observational studies (Arulkumaran et al, 1990, Rosen et al, 1992}. 
Another system for on-line FECG analysis has been designed in Nottingham (Marvell et al, 
1980) and used in several studies (Jenkins et al, 1986, Murray et al, 1986). The FECG is 
recorded with a conventional lead system by a CTG recorder. The signal is initially filtered 
from 3 to 250 Hz with subsequent enhancement of low frequencies down to 0.16 Hz. It 
analyses many other features of the FECG in addition to ST waveform amplitude. On-line 
analysis was initially performed by a computer in a separate room but a PC-based bedside 
version has recently been developed. The technology is patented and there are no published 
reports of its performance or clinical value. 
An off-line ST waveform analysis system has been developed in Southampton (Newbold et 
al, 1989). It uses a conventional lead system and collects the FECG from a CTG recorder 
(bandwidth 0.3 to SO Hz). The FECG and uterine contraction data are recorded onto an FM 
tape recorder for subsequent analysis. The low frequency components of the FECG are 
electronically enhanced down to 0.16 Hz. The sampling frequency is 1000Hz with 12 bit 
resolution. It has been used in two studies (Newbold et al, 1989, 1991). 
Clinical studies. 
Human intrapartum studies with appropriate filter characteristics (Pardi et al, 1974, Marvell 
et al, 1980, Lilja et al, 1985, Jenkins et al, 1986) showed the fetal scalp ECG has a T wave 
which is usually isoelectric or has a positive T wave no larger than the P wave. These, and 
other studies confirmed that the FECG could be recorded from a FSE for on-line analysis 
and helped to develop the technology to the stage where larger observational studies could 
be performed (Lilja et al, 1988, Lilja et al, 1989). Normally the ST waveform and T/QRS 
ratio remain relatively stable throughout labour for a given fetus (Newbold et al, 1989) and 
reported mean values are similar; 0.15 (SD 0.05) Lilja et al, 1988, and 0.10 (SD 0.05) 
Newbold et al, 1989. 
Initial studies suggested that a combination of ST waveform and CTG change identified 
fetuses at risk of poor outcome. All 3 cases of asphyxia reported by Arulkumaran et al 
(1990) had acute ST elevation and CTG change. All had a metabolic acidosis at delivery 
(arterial pH <7.05, BDecf >12 mmoVI) and all had low Apgar scores at delivery. The 
development of negative ST changes in association with CTG changes has been reported in 
two cases (Rosen et al, 1989, Rosen et al, 1992). Both were growth retarded and 
asphyxiated and one died. 
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It has been speculated that the addition of ST waveform analysis to the CTG may help 
prevent unnecessary operative intervention. One of the first clinical studies (Lilja et al, 
1985) showed only 26% of 48 high risk cases had a continuously normal CTG, whereas 
67% had a continuously normal ST waveform. The operative delivery rate for fetal distress 
was 20% but fetal outcome was good in all cases. In another study, 12 of 44 cases with an 
abnormal CTG were delivered for fetal distress, but none were significantly acidotic and 
none had ST waveform change (Newbold et at, 1991). The CTG was abnormal in 55% of 
201 cases studied by Arulkumaran et al, (1990) but the T/QRS was abnormal in only 27%. 
Twenty-seven had an operative delivery for fetal distress but only 11 had T/QRS changes 
and all fetuses with a cord artery pH<7 .15 or a standard bicarbonate < 15 mmol/1 were 
identified by ST waveform change. 
The technology of the ST ANalyser appeared sufficiently advanced to allow clinical 
research. Arulkumaran et al (1990) reported 77% of their cases had continuous T/QRS 
ratios available and the other 23% had intermittent values recorded. 
Model of interpretation. 
The evidence from these clinical observational studies supported the animal experimental 
findings and enabled us to develop a model of interpretation based on the combination of 
CTG and ST waveform change (Figure 1.13). The next step was to examine the value of ST 
waveform analysis in randomised clinical trials using this model of interpretation. 
FBS or deliver 
no action STwaveform 
___---r----._ 
noyal . _ T/QRSI >0.25 T/Q~S >0.5 
no action FBS FBS or deliver 
STwavetorm 
___---r----._ 
T/QRS >0.25 T/QRS >0.5 
I I 
FBS or deliver deliver or FBS 
Figure 1.13 Model of interpretation for CTG plus ST waveform changes. Action on the 
basis of ST change alone is only recommended for persistently negative waveforms. 
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Objectives and structure of thesis. 
It had always been proposed that ST wavefonn analysis of the fetal ECG should be 
appropriately validated before introduction into clinical practice (Greene, 1983, Rosen et al, 
1986, Greene, 1987). Since 1975 a steady, progressive line of experimental and clinical 
investigations have detennined the pathophysiological basis for ST wavefonn change, 
developed the required technology and gathered enough clinical infonnation for a model of 
interpretation to be developed. This thesis examines and reports the final stages of that 
validation process from validation of a collection system from the fetal scalp electrode 
through to the final monitor output and, then a randornised trial to test the clinical value of 
the addition of ST wavefonn analysis to the CTG using this equipment. 
The randomised trial also provided an opportunity to examine how CTG monitoring was 
used in clinical practice and to assess the value of umbilical cord blood gas analysis as an 
objective measure of neonatal outcome. 
The work will be presented in the following chapters; 
Chapter 2. 
Chapter 3. 
Chapter 4. 
Chapter 5. 
Chapter 6. 
Part I. An investigation of fetal scalp electrodes. 
Part II. Validation of the data collection system. 
Randomised clinical trial of CTG alone or with ST wavefonn 
analysis for intrapartum monitoring. 
Assessment of current monitoring practice. 
Assessment of umbilical cord blood gas analysis. 
Future developments in intrapartum fetal monitoring. 
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Optimising the acquisition of the fetal ECG in clinical 
practice. 
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Analysis of the ST waveform of the fetal ECG is a more technically demanding method for 
intrapartum fetal assessment than CTG analysis. Considerable signal processing is 
necessary to extract the signal from unwanted background noise without distorting its 
biological components. Any system for signal analysis is only as good as the quality of data 
it receives; or to put it more plainly, rubbish in, rubbish out. It was therefore important to 
validate the FECG collection system to be used before further clinical studies were 
attempted. 
The work will be presented in two parts; Part I deals with fetal scalp electrodes (FSEs) 
and Part II with examination of the remaining aspects of data collection and analysis with 
particular reference to the ST ANalyser {STAN, Cinventa AB, Molndal, Sweden). 
Part I. An examination of currently available fetal scalp 
electrodes. 
Introduction. 
Electrode function In body tissue. 
The patient-electrode interface is the first stage of any biological signal recording system 
and is frequently the factor which most limits the performance of these systems (Gatzk:e, 
1974). Physiological signals are carried by ionic currents in the body, whilst electrical 
currents are carried by electrons in cables. An electrode must act as a transducer to change 
ionic currents into electrical currents. Some materials are better suited for this purpose 
than others. Two important factors which determine the function of an electrode in body 
tissue are, firstly, the electrode's offset potential and, secondly, its susceptibility to 
movement artefact. 
Electrode offset potential. When an electrode is placed in a conducting solution metal 
ions transfer from the metal into the solution and from the solution onto the metallic 
surface to form a bipolar layer. One polarity of charge becomes dominant on the surface of 
the metal and the opposite polarity is distributed in excess in the electrolyte immediately 
adjacent to the electrode (Figure 2.1 ). This cloud or double layer of charged ions at the 
electrode surface allows electron transfer between metal and tissues but results in a 
difference in electrical potential between the electrode/electrolyte interface and the rest of 
the electrolyte solution {Geddes, 1972). This is referred to as the electrode offset potential. 
Ideally, the offset potential of an electrode should be as low as possible as changes in the 
potential add noise to the signal being measured (Cooper et al, 1974). Different metals 
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have different offset potentials and thus some are more suited to use as electrodes than 
others. Metals such as stainless steel which do not ionise readily form a large double layer 
of ions and have a high offset potential. In comparison, silver-chloride coated silver 
electrodes (silver/silver-chloride) have a low offset potential as the silver-chloride 
dissociates to silver and chloride ions which move freely between electrode and electrolyte, 
allowing electron transfer without the formation of a double layer of charge. 
electrode 
+ + + 
+ + + 
+ + + 
+ + + 
electrolyte 
Figure 2.1 The electrode offset potential. 
A double layer of charged ions forms at the electrode 
/electrolyte interface and results in a difference in 
electrical potential between the interface and the rest of 
the electrolyte solution. This is the electrode offset 
potential. 
Movement artefact. Movement at the electrode/electrolyte interface results in a 
disturbance of ions in the double layer which alters the electrode potential, affects electron 
transfer and adds artefacts to the recorded signal. Electrodes with a high offset potential 
have more disturbance of their large ionic cloud during movement and thus produce more 
movement artefact than low offset potential electrodes. Susceptibility to movement artefact 
is also determined by the security of electrode attachment to the body surface. The less 
secure the attachment, the more movement at the electrode/electrolyte interface and the 
more artefact is likely to be added to the signal. 
Ideally, the electrodes used for FECG recording should have a low offset potential and a 
secure method of attachment to the fetus. 
Fetal scalp electrodes. 
FSE Development. FSEs were first designed to record the fetal ECG. The first FSE was 
made from a nickel-silver surgical skin clip which had to be attached to the fetal scalp 
through an amniscope with a long-handled forcep {Hon, 1963). The metal used for the 
electrode was later changed to silver/silver-chloride with a marked improvement in signal 
quality {Hon, 1967). The design was also changed to a single wire spiral which was 
attached to the fetus by a disposable plastic applicator. However, problems with the silver-
chloride coating process frequently resulted in flakes of the material being deposited in 
fetal scalp tissues. This was obviously unsatisfactory but, at that time, choice of an 
alternative material was influenced by Hon's observations on heart rate and ECG changes 
in the dying fetus {Hon et al, 1959). Hon only detected FECG waveform changes 
immediately prior to death and concluded that FHR changes would be more useful for fetal 
monitoring purposes. As a result the material used for the FSEs was changed to stainless 
Chapter Two, page 40 
steel. Hon acknowledged this produced a far noisier ECG signal but showed it was still 
suitable for heart rate detection when used with a band pass filter of 1. 5 to 100 Hz (Paul & 
Hon, 1973). 
FSE Design. All FSEs have the same basic design; an active electrode which attaches to 
the fetal presenting part (scalp or bottom) and a reference electrode which makes contact 
with the vaginal vault via cervical secretions and amniotic fluid. Each electrode is attached 
to a wire which runs to a connecting device attached to the mother's leg. On the back of 
this device is a metal plate which rests on the mother's leg and acts as the signal reference 
point. 
There are two major types ofFSE in use today; the spiral types, which are attached to the 
fetus with either a single or double spiral and the Copeland types which are attached with a 
semicircular clip (Figure 2.2). Both types are made from stainless steel. 
A 
B 
Figure 2.2 A. Corometrics single (left) and Hewlett-Packard double (right) spiral FSEs. 
B. Copeland Reusable (top) and Disposable (bottom) FSEs. 
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As all the FSEs now used to coUect FECG signals are made from stainless steel, they are 
particularly susceptible to movement .artefact. Their different designs, different means of 
attachment to the fetus and different effects on the primary ECG signal have not previously 
been considered. Given the renewed interest in FECG waveform changes and their 
significance during labour, it was important that these differences be investigated. In view 
of this, a study was designed to compare and contrast five commonly available FSEs by 
examining their physical and electrical characteristics and then assessing the quality of the 
fetal ECG signal obtained from each in a randomised clinical trial. 
The five types of FSE investigated were the single spiralled Corometrics (Corometrics 
Medical Systems Inc. USA) and Cetro (Cetro AB, Sweden), the double spiralled 
Hewlett-Packard (Hewlett-Packard Medical, UK) and both the Copeland Reusable and 
Disposable (Surgicraft Ltd, UK). 
Methods. 
Physical characteristics. 
The construction of each FSE was examined under a hand lens and the clinical method of 
application to the fetus critically reviewed. 
Electrical characteristics. 
An in-vitro experiment was designed to record and compare the FSE frequency responses 
and then the frequency responses were modeUed using digital filters to assess the effect of 
the FSEs on the ECG waveform shape. The work for this section was performed in 
conjunction with R. Keith and is also presented in his PhD thesis (Keith, 1993). 
In-vitro experiment. The frequency responses of the FSEs were obtained in an in-vitro 
experiment in order to assess the ability of the electrodes to faithfuUy reproduce the ECG 
waveform (Figure 2.3). Optimal attachment was ensured for each electrode. The Solatron 
1170 Frequency Response Analyser was used to produce input signals between 0.01 and 
200 Hz which were passed through each FSE. The output signal from each was fed back 
to the Solatron and compared with the input signal. Any change in amplitude (gain) or 
timing (phase) was measured. 
Chapter 1Wo, page 42 
I 
I 
I 
L.. 
return signal 
Solatron 1170 
analyser 
input signal 
(_ 
I \ Liver 
/ 
fetal scalp 
electrodes 
/ 1'-- }-f'-
area immersed in 
1 cm of saline 
Figure 2.3 Experimental set-up for in-vitro measurement ofFSE frequency responses. 
Digital filter model. A digital filter with a frequency response equivalent to that of each 
FSE was obtained using the frequency sampling method (Lockhart and Cheetham, 1989). 
The digital filter was used to process ECG data obtained from 4 neonates within 1 hour of 
birth. The neonate data was collected using precordial silver/silver-chloride skin electrodes 
to avoid the influence of the FSEs under investigation. The data acquisition system used 
for this purpose had a bandwidth of 0.05 -200Hz, with a 12-bit resolution and a sampling 
frequency of 1000 Hz. The lower frequency of 0.05 Hz was chosen to conform to the 
recommendations of the American Heart Associations Committee on Electrocardiography 
(1975). 
Randomised clinical trial of FSEs. 
The five types ofF SE were randomly allocated to a group of 50 women in labour. Women 
were entered into the trial after the decision to use a FSE was made by Labour Ward staff 
and informed consent obtained. The electrode to be used was detennined by opening a 
sealed opaque envelope. Only new electrodes of each type were used. All spiral electrodes 
and most Copelands were applied by one investigator (the author). The others were 
applied by experienced midwives. 
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The ST ANalyser was used as the FECG recorder for this study. The FECG signal was 
recorded differentially between the electrode on the scalp and a standard skin electrode 
placed on the maternal thigh with the vaginal electrode as the common mode point for the 
amplifier. The data collection system and processor was assessed prior to the FSE clinical 
trial and the findings will be presented in Part IT of this chapter. 
An example of a ST AN recording is shown in Figure 2.4. The FHR and uterine activity are 
displayed as on a standard CTG recording and the T/QRS ratio is plotted continuously just 
above the contraction channel. Averaged ECG complexes and their T/QRS ratio are 
printed every 2 to 2.5 minutes to allow waveform shape and signal quality to be assessed. 
' • I~ -I· -- - - - - ·- -- ... - - ;·2 
ECG complexes · 
I - i 
I 
T/QRS ratio plot 
Figure 2.4 An example of a ST AN recording. 
A subjective assessment of signal quality was made at the bedside at intervals through-out 
data collection. If the FHR or ECG recordings showed excessive signal loss or interference 
the electrode was reapplied . At a later stage the complete ST AN CTG and ECG waveform 
trace was divided into 30 minute epochs and analysed. The first and second stages of 
labour were considered separately. 
Each FHR record was graded I (excellent), 2 (fair- adequate for monitoring purposes), or 
3 (poor - inadequate for clinical use, Figure 2.5). These gradings were based on the 
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amount of signal loss and interference seen on the trace. 
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Figure 2.5 Fetal heart rate quality grades I (excellent), 2 (fair - adequate for clinical use) 
and 3 (poor- inadequate for clinical use). 
The ST AN prints the average of 30 ECG complexes every 2Y2 minutes. The number of 
complexes printed reflects the time taken to accept 30 ECG complexes into the average 
and shape of these complexes gives a measure of signal quality. The total number of 
complexes in each epoch was counted (maximum = 14) and each complex graded as 
follows: 
I optimal, no baseline shift, no high frequency components; 
2 fair, some interference from high frequency components but waveform components 
still well-defined; 
3 bad, baseline shift or excessive high frequency components or very low amplitude 
signals (Figure 2.6). 
The ratio of the T wave height to the QRS complex height is plotted continuously as the 
T/QRS ratio. The number of minutes that this ratio was plotted in each 30 minute epoch 
was measured from the trace. On 13 patients the raw ECG data from the ST AN was 
recorded and stored onto a PC-based Optical Disc (Reflections Systems Ltd, Essex) for 
later analysis 
Chapter Two, page 45 
Grade 1 Grade 2 
I I 
I I 
.,----··-··--' 
I I I 
- . 1 4 - ·'---- - ...-..!. 
Grade 3 
Figure 2.6 ECG quality grades 1 (optimal), 2 (fair - some high frequency noise but 
waveform components still well-defined) and 3 (poor - excessive high frequency noise, 
wandering baseline or very low amplitude ECG). 
Statistical analysis was by One Way Analysis of Variance using the "Minitab" Version 7 
statistical software package run on a prime mainframe computer. 
Results. 
Physical characteristics. 
Spiral FSEs. The spiral electrodes are attached to the fetus with the aid of two PVC 
plastic tubes - a driving tube and a guide tube. These slip respectively onto and over the 
electrode facilitating safe introduction into the vagina and rotation of the spiral into the 
fetal scalp. These tubes are withdrawn once the electrode is applied leaving only the 
electrode wires emerging from the vagina. All of these FSEs are designed for a single use 
and then are discarded. 
The applicator tubes for the Hewlett-Packard double spirals are larger and more rigid than 
the single spiral applicators. This made ideal positioning and application to the fetal head 
difficult, especially early in labour with a posterior cervix. Despite providing a large surface 
area for signal collection, the double spiral only allowed a 180 degree clockwise rotation 
for attachment compared to the 360 degree rotation of the single spiral. As a result double 
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spirals were more likely to become detached during labour than single spirals. Interestingly, 
it was found that the wires from both the Corometrics and Hewlett-Packard electrodes 
were wound in the opposite direction to the needle rotation which tended to encourage 
un-winding with maternal movement. This was especially noticeable with the 
Hewlett-Packard. 
Copeland FSEs. The Copeland FSEs are either reusable or disposable and have a spring 
action - twisting the base of the electrode anticlockwise rotates the needle semi-circle at 
the electrode head into a recess. Once the head of the electrode is pressed firmly against 
the fetus, the base is twisted clockwise causing the round-bodied needle to emerge from 
the recess and rotate into the fetal scalp (Figure 2.7). The length of electrode which 
protrudes from the vagina increases as descent of the fetal head occurs through the 
maternal pelvis. The Reusable Copelands are cleaned, tested for electrical continuity and 
re-sterilised before reuse. 
Figure 2. 7 Copeland FSE showing the round- bodied needle half rotated out of the recess 
in the FSE head. 
The long, semi-rigid design of the Copelands made them susceptible to movement artefact 
as the entire length of the electrode was suspended from its point of insertion into the fetal 
scalp (Figure 2.8). Furthermore, it was found that the round-bodied needle of the Copeland 
FSE approached the tough fetal scalp at an oblique angle and often failed to penetrate 
completely or merely pinched the skin without penetrating it. This not only increased 
susceptibility to movement artefact but also resulted in only a small area of electrode 
coming into contact with fetal subcutaneous tissues. 
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Figure 2.8 A serendipitous X-ray taken in early labour (because of a mistaken diagnosis of 
a breech presentation). A Copeland FSE has been applied to the fetal head. There is a gap 
between the fetal head and the shaft of the FSE because the plastic head of the FSE is not 
visible on the X-ray. Note the cuiVe on the ~haft of the FSE as it follows the axis of the 
vagina which is likely to cause tension at the electrode/scalp interface. 
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Electrical characteristics. 
The magnitude frequency response for each electrode is shown in Figure 2.9. The phase 
response of the FSEs was considered negligible as the maximum phase change measured 
was only 14 degrees (Copeland Reusable). 
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Figure 2.9 FSE frequency responses. 
The electrodes could be divided into two groups on the basis of their frequency responses. 
It was found that the magnitude response for the spiral FSEs approached the ideal 
electrode response, being nearly flat within the frequency band of interest (0.05-100 Hz). 
The Copeland FSEs attenuated the higher frequency FECG components by 4 to 8 dB more 
than the spirals but only attenuated the very low frequency components (which are 
responsible for baseline shifts) by an extra 2 to 4 dB. 
Typical filtered and unfiltered sections from a Corometrics single spiral and a Copeland 
reusable FSE simulation are shown in Figure 2.10. As expected, visual examination 
showed that both FSEs attenuated the signal, but the peak to peak amplitude of the 
Copeland signal was only 54% of that of the Corometrics. Whilst there did not appear to 
be any major changes in the waveform shape, there were small modifications in the P and T 
wave regions with the Copeland FSE. 
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Figure 2.10 Effects of simulated FSE frequency responses on a segment ofneonatal ECG 
recorded with precordial silver/silver-chloride electrodes; A. raw neonatal ECG, B. after 
the Corometrics single spiral filter, C. after the Copeland Reusable filter. 
Clinical trial. 
First stage. The first stage results are summarised in Table 2.I. The Copeland Disposable 
electrode had a significantly lower proportion of Grade I FHR epochs compared to the 
spiral FSEs (p<O.OS) and a significantly higher proportion of Grade 2 epochs compared to 
the Corometrics single spiral and Hewlett-Packard double spiral (p<O.OS). There were no 
significant differences in first stage total ECG complex numbers but differences are 
apparent in the quality of the complexes. The Copeland Disposable FSE had a significantly 
lower proportion of Grade I complexes than all spirals (p<O.OOS) and a significantly higher 
proportion of Grade 3 complexes than the single spirals (p<O.OOS) and double spirals 
(p<O.OI). Copeland Reusables had significantly less Grade I and more Grade 3 complexes 
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than the single spirals (p<0.05). Copeland Disposable FSEs had a significantly lower 
average duration of T/QRS ratio plots than all the spirals (p<0.005) and the Copeland 
Reusable FSEs (p<0.05). 
Second stage. The results from the second stage of labour followed the same trend with 
single spiral FSEs producing the best quality heart rate and ECG signals (Table 2.2). 
Overall second stage quality was not as good as first stage quality for each FSE type. 
Reapplication rates. Only one reapplication of a Corometrics single spiral FSE was 
required in one patient during the study because the FSE became dislodged during a 
vaginal examination. The Cetro single spiral required two reapplications in two patients in 
attempts to improve poor signal quality. The Hewlett-Packard double spiral required four 
reapplications in four patients - two because the FSE fell off, two to improve poor signal 
quality. In comparison reapplication rates on account of poor signal quality were much 
higher with the Copeland types; 11 in four patients for the Reusable and 17 in six patients 
in the Disposable groups respectively. 
Cost comparisons. The Corometrics single spirals were the least expensive disposable 
FSE at £3.20 each; the Hewlett-Packard double spirals cost £4.50 each and the Copeland 
Disposables £6.50 each (the Cetro FSE was not available in the UK). The Copeland 
Reusables cost £18 each but had an average life of 10 patients. They cost 30 pence to 
clean, package and resterilise making the total cost £2.10 per patient. However, because of 
their design it was difficult to ensure that all fetal material was removed from the recess in 
the head of the device. The Central Sterilisation Unit manager could not guarantee that all 
material was removed and recommended a change to a disposable FSE (J Barker, personal 
communication). 
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Table 2.1. First stage FHR and ECG signal quality for each fetal scalp electrode type. 
10 recordings for each type, each record assessed over 30 minute epochs and averaged. 
Averaged results for each FSE type shown. 
Fetal scalp Total no. FHR Quality 
Electrode 30 min. 
epochs %of epochs 
Grade 1 Gradel Grade3 
Corometrics 81 84.0 6.1 9.9 
Cetro 69 85.5 14.5 0.0 
Hew1ett-Packard 65 83.1 10.8 6.1 
Copeland Reusable 73 51.5 23.3 19.2 
Copeland Disposable 64 39.12 39.lj 21.8 
1 p<0.05 compared to Corometrics and Cetro single spirals 
2 p<0.05 compared to Corometrics, Cetro and Hewlett-Packard spirals 
3 p<0.05 compared to Corometrics and Hewlett-Packard spirals 
4 p<0.005 compared to Corometrics, Cetro and Hewlett-Packard spirals 
No. complexes 
per30 min. 
12.5 
13.2 
13.2 
12.2 
10.7 
5 p<0.005 compared to Corometrics and Cetro, p<0.01 compared to Hewlett-Packard spirals 
ECG complexes 
% of complexes 
Grade 1 Gradel 
87.8 8.9 
80.3 17.3 
76.5 11.6 
61.61 18.9 
39.14 22.2 
6 p<0.005 compared to Corometrics, Cetro and Hewlett-Packard spirals, p<0.05 compared to Copeland Reusables 
All by One Way Analysis of Variance. 
T/QRS ratio 
Dnration 
of plot per 
Grade3 30 min. ±SD 
3.3 23.8 ±6.0 
2.4 25.5 ±3.8 
11.9 24.9±2.9 
19.51 21.5 ±6.1 
38.1-~ 15.0 ±6.56 
Table 2.2. Second stage FHR and ECG signal quality for each fetal scalp electrode type. 
Available recordings for each type, each record assessed over 30 minute epochs and averaged. 
Averaged results for each FSE type shown. 
Fetal scalp Total no. FHRQuality ECG complexes 
Electrode 30 min. 
(number) I epochs %of epochs No. complexes % or complexes 
Grade 1 Grade 2 Grade3 per30 min. Grade 1 Grade2 
Corometrics (8) 12 61.52 23.1 15.4 8.3 64.62 19.2 
Cetro (7) 9 66.72 22.2 11.1 10.2 71.72 17.4 
Hewlett-Packard (8) 10 50.0 0.0 50.0 6.8 44.1 20.6 
Copeland Reusable (7) 13 53.83 23.1 23.1 9.3 28.9 37.2 
Copeland Disposable (7) 9 11.1 55.6 33.3 7.6 45.0 27.5 
T/QRS ratio 
Duration 
of plot per 
Grade3 30min. ±SD 
16.2 16.7 ± 7.5 
10.9 15.7 ± 11.2 
35.3 12.9 ± 9.3 
33.9 14.9 ± 6.6 
27.5 9.0 ± 7.3 
1 Details of missing numbers; Corometrics & Cetro -operative delivery before second stage (2 and 3 cases respectively), Hewlett-Packard- FSE fell off in 
second stage (2 cases), Copeland Reusable - abandoned poor quality (2 cases) & LSCS in first stage (I case), Copeland Disposable - abandoned poor quality 
(1 case) & LSCS first stage (2 cases). 
Q 2 p<0.05 compared to Hewlett-Packard, and both Copelands. 
~ ~ 3 p<0.05 compared to Copeland Disposable 
... 
_( All by One Way Analysis of Variance. 
~ 
~ 
.. 
t:: 
Discussion. 
These investigations showed that single spiral FSEs were the most suitable for ECG 
waveform collection. They were the easiest to apply optimally, appeared to produce the 
most stable attachment and were least prone to movement artefact problems. They had a 
near ideal signal transfer function and, although they produced more signal attenuation 
than the double spirals, their greater security of attachment produced a more favourable 
signal to baseline noise ratio. They were also the cheapest of the disposable types. 
Double spiral FSEs showed the least signal attenuation in the in-vitro experiment. 
However, despite their near ideal frequency response, problems in applying and 
maintaining attachment in-vivo made them less suitable for data collection. Some of these 
problems could be overcome by the simple expedient of twisting the lead wires in the same 
direction as the spiral needles so the FSE is not so easily dislodged by traction on the wires 
during maternal movement. 
The Copeland FSEs showed most signal attenuation in-vitro. Their frequency response 
indicated that they attenuated the low frequency noise less than the principle ECG signal. 
This resulted in the poorest signal to noise ratio of all the FSEs; the smallest ECG signal 
with the largest baseline swings. Their long, semi-rigid design and the difficulty in 
obtaining optimal attachment resulted in increased signal noise. Fixation problems could 
immediately be improved by making the point of the needle taper-cut rather than round-
bodied and by meticulously ensuring optimal attachment, though movement artefact is 
likely to remain a problem. 
The subjective results of the clinical trial have been confirmed by an automatic analysis of 
signal quality performed on the 13 traces which were recorded onto optical disc (Keith, 
1993). The most important determinants of signal quality were found to be the amount of 
baseline noise and signal size. Baseline noise is related to security of attachment, as already 
discussed, and signal size is related to the surface area of the active electrode in contact 
with the fetal tissues. Double spiral FSEs had the largest surface area but their poor 
attachment negated this advantage. Copeland FSEs had the smallest surface area which 
compounded their problems of signal attenuation and high baseline noise. 
Spiral FSEs are used extensively throughout Europe, Australasia and America while 
Copelands are most popular in the UK. Disposables are now used more than Reusables 
due to concerns about cleaning and re-sterilisation. The geographical difference in use may 
relate to a DHSS Safety Bulletin (1985) produced in response to a number of case reports 
concerning improper application or removal of spiral electrodes (e.g. Sharp and Couriel, 
1985) or inappropriate application sites (e.g. Thomas and Blackwell, 1975). It discussed 
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certain design features and the necessity for correct application techniques, and although 
not intended to discourage the use of spiral electrodes, it effectively did so in the UK. 
The one randomised clinical trial of FSEs reported prior to the present study compared the 
quality of fetal heart rate recordings and found no difference between Copeland 
Disposable and Corometrics FSEs in complication rates. There was less heart rate signal 
loss in the second stage of labour with the Copeland but no difference in the first stage of 
labour (Nickelsen et al, 1989). A second trial, published since the work of this thesis, 
compared fetal heart rate quality with 2 double spirals (Rocket-Rolon and Hewlett-
Packard) and the Copeland disposable (Needs et al, 1992). The Copeland was least likely 
to become detached, the Rolon-Rocket most likely. There was no difference in scalp 
trauma. The heart rate records in the Hewlett-Packard group were more likely to be of 
good quality and these FSEs were least likely to be replaced because of poor signal quality. 
These findings are entirely consistent with those reported here for FECG signal quality and 
also with our experience with Rocket-Rolon double spirals during preparation for the 
study. They appeared to be quite poorly made compared to the Hewlett-Packard double 
spirals and as every one applied fell off at some stage, they were not considered worthy of 
study. 
In theory, a significant improvement in ECG signal quality could be obtained if 
silver/silver-chloride FSEs could be used. New membrane coating techniques developed by 
Surgicraft Ltd may make this possible (Penman et al, 1990). This technique silver plates, 
partly chloridises and then coats a conventional stainless steel Copeland FSE with a 
biocompatible electrically conducting polymer which should prevent silver-chloride 
deposition in tissues without affecting the electrical properties (Figure 2.11 ). 
Stainless steel 
~~I 
I I 
0 .5 
Sliver/sliver-chloride sec 
Figure 2.11 Comparison of a recording from a stainless steel FSE and from a silver/silver-
chloride coated FSE (from Penman et al, 1992, reproduced with permission). 
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As can be seen from the figure, the ECG recording from a conventional Copeland showed 
large baseline swings whilst that from the new low resistance Copeland had a very stable 
baseline. Although a promising idea, this data is somewhat misleading as the recordings 
were not made simultaneously from the same patient (the RR intervals are different). 
Several prototypes of the low resistance Copeland have been tested by our group using the 
model described in the in-vitro experiment. Overall signal attenuation was increased by 2 
to 4 dBs compared to conventional Copelands but 2 of the 4 prototypes displayed much 
flatter frequency responses. The thickness of the membrane coating may have contributed 
to the increase in attenuation. A small number of these FSEs were used in the clinical 
situation on a trial basis without much success even though the needle was taper cut rather 
than round-bodied. This is probably related to the basic Copeland design with its long 
semi-rigid arm which predisposes to movement artefact. This technology, however, has 
promise but may be more applicable to single spiral FSE designs. 
There has been renewed interest in non-penetrative FSEs recently because of the increasing 
incidence of AIDS. Suction FSEs have been developed in the past (Walker et al, 1969, 
Goodlin & Fabricant, 1970) but never achieved widespread use probably due to difficulty 
in maintaining attachment to the presenting part. More recently, one group has designed a 
40 cm long multichannel sensor which uses surface electrodes for FECG detection (Allman 
et al, 1991). The quality ofFECG signal obtained has not been reported. Another design 
where suction is applied through holes drilled in a metal plate has been reported (Hofineyer 
et al, 1992). This is apparently suitable for fetal heart rate detection but no assessment of 
ECG quality has yet been made. The use of a silver/silver-chloride disc might make this 
design particularly useful for FECG recording. 
In summary, a single spiral FSE was the best of the available fetal scalp electrodes for ST 
waveform analysis of the FECG and was used in all further studies in our hospital. 
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Part IT. Examination of a Fetal ECG Data Acquisition 
System 
Introduction. 
A data collection system for ST waveform analysis has been designed based on the work of 
Greene and Wickham and Rosen and Lindecrantz reported in Chapter One. Before this 
system was used in a randomised trial to test the clinical value of ST waveform analysis, it 
was important to validate the collection system itself A block diagram of the ST AN 
system is shown in Figure 2.12. 
Patient Processor LED crystal 
Isolating display 
Box adaptive line filter digitisation 
filtering FHR calculation amplification STwaveform 
analysis Printer 
Figure 2.12 Block diagram ofSTAN system . 
The signal recorded differentially from a FSE and a maternal skin electrode is collected by 
the Patient Isolating Box (Pill) where it ·is high pass filtered at 0.05 Hz (1st order high-
pass filter), amplified, isolated from the patient and transmitted down a cable to the STAN 
processor where an adaptive line filter (operating at 50 Hz in the UK) removes mains 
frequency noise (Rosen & Lindecrantz, 1989). The signal for ECG waveform analysis is 
low pass filtered at 100 Hz (4th order Butterworth low-pass filter), and bandpass filtered 
for heart rate analysis between 4 and 26 Hz. The signal is digitised at 8 bits at a sampling 
frequency of 500 Hz. 
The FSE, the first step in the collection system, was investigated in Part I. In this second 
part other aspects of the collection system which may influence signal quality and 
ultimately affect the clinical usefulness of the system were considered. The following 
observations were made during preparation for the randomised trial of fetal scalp 
electrodes reported in Part I of this chapter. 
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Observations and Investigations. 
Location of the maternal skin electrode. 
The original instructions suggested that this electrode be placed on the lower abdomen, 
just above the inguinal ligament. However, this resulted in the recording of such large 
maternal ECG signals that the smaller FECG signals were swamped. This was probably 
due to the close proximity of the electrode to the femoral vessels. Placing the skin 
electrode on the lateral thigh resolved the problem but increased signal artefact due to 
muscle movement. During the clinical FSE trial it was observed that signal quality was 
better in patients with epidural analgesia than without (although this was not significant 
because of small numbers) and deteriorated in the second stage. These observations would 
be consistent with the effect of muscle movement artefact. 
FECG lead configuration. 
It is possible to minimise noise recorded with a biological signal by the technique of 
common mode amplification where only the difference between the voltage recorded at 
two points on a preparation is amplified. A conventional CTG lead system records one 
signal from the active element on the fetal scalp, the other from the vaginal element of the 
FSE and uses the metal leg plate as the common mode reference point. In this way noise 
from the leg plate connection will be present on both signals but its effect will be minimised 
as only the difference between the two signals is amplified. In the ST AN system the vaginal 
element is used as the common mode reference point so that any muscle artefact from the 
maternal skin electrode will not be removed by common mode rejection. This means that 
the ECG signal recorded with the ST AN lead configuration may be more susceptible to 
maternal movement artefact and would fit with the deterioration in signal quality seen in 
the second stage recordings during the randomised FSE study reported earlier. 
This alteration in lead configuration arose because of uncertainty as to where the vaginal 
element of an FSE makes its contact. Any instability of contact would be a source of signal 
noise. Lilja et al (1985) obtained a signal with a more stable baseline than the conventional 
lead system by recording differentially from two scalp electrodes attached to the presenting 
part with the common mode reference point either on an intrauterine catheter or on the 
maternal thigh. However, Lindecrantz & Widmark (1989) claimed that both this and the 
conventional CTG lead arrangement was only sensitive to changes in the ECG vector in 
the horizontal plane - parallel to a line through the two electrodes - and that rotation of the 
fetal head could cause changes in the shape of the FECG recorded by the electrodes 
(Figure 2.13A). They reported one case where the FECG became completely inverted as 
labour progressed as a result of rotation of the fetal head. They suggested recording the 
FECG differentially from the active element of the FSE and from a skin electrode placed 
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on the maternal thigh with the vaginal element of the FSE as the common mode reference 
point. This configuration could be sensitive to FECG changes in the longitudinal axis of the 
fetus and therefore may be more appropriate for detecting T wave changes (Figure 2.13B). 
This configuration could also minimise noise from the vaginal element. 
senitivity vector 
B 
FSE 1 FSE 2 
Figure 2.13 .. Possible ECG sensitivity vectors obtained by recording FECG differentially~ 
A. from two FSEs attached to the fetal head. The vector may be in the horizontal plane 
(similar to leads I and II of an ECG recorded from limb leads)~ 
B. from one FSE and from a maternal leg electrode. The vector may be in the longitudinal 
plane (similar to leads m and A VF from an ECG recorded from limb leads). 
After Lindecrantz & Widmark, 1989. 
The theoretical considerations which led to the choice of this lead configuration have never 
been examined further, nor has signal quality with different configurations been compared. 
Given the importance of FECG signal quality, it was clear that this area required further 
investigation. 
An investigation of FECG electrode configuration connections. 
In an attempt to clarify the questions raised by the ST AN configuration, a study was 
designed to investigate different lead configurations and their effect on signal quality and 
FECG waveform shape and to attempt to detect changes in the ECG shape with rotation of 
the fetal head during delivery. This work was performed in conjunction with John Cumow, 
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Biomedical Engineer, Department of Medical Physics, Plymouth General Hospital. 
Method. Informed consent to apply two single spiral FSEs to the fetal scalp was obtained 
from six women in early labour. Ethical Committee approval was obtained for the study. 
The data collection system is shown in Figure 2.14. 
fetal head 
Polygraph Optical 
vaginal1 PS-1600 disc 
vaginal2 data data 
active 2 collection storage 
and 
maternal skin electrode 1 analysis 
maternal skin electrode 2 
Figure 2.14 The data collection system used for the lead configuration study. 
Signals were collected independently from each element of each FSE (the active and 
vaginal elements) and from two maternal thigh skin electrodes and then passed to a 
multichannel data collection, analysis and storage system which combined the individual 
signals to produce the desired lead configurations (Polygraph PS-1600, Twenty 
Technology Transfer, Holland). Data was collected at a sampling rate of 500Hz with a 12 
bit Analogue to Digital Converter (ADC) and band pass filtered between 0.05 and 120Hz 
then archived on an optical disc for later analysis. The study aimed to compare three lead 
configurations; first the conventional (FECG recorded differentially from the active and 
vaginal elements of one FSE with the leg electrode as the common mode point, Figure 
2. l3A), second the ST AN configuration (FECG recorded differentially from active element 
of FSE and leg electrode with the vaginal element as the common mode point, Figure 
2. l3B) and third, a configuration suggested by Lindecrantz & Widmark (FECG recorded 
differentially from the active element of one FSEs and a leg electrode with the active 
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element of a second FSE as the common mode point). A 13 lead neonatal ECG was 
performed within 24 hours of birth to compare with the lead configurations recorded 
during labour. 
In order to compare the low, medium and high frequency content of the signal from each 
lead configuration, the first hour of data from the conventional and the ST AN 
configurations in every patient was filtered with simple first order filters to obtain the 
frequency content <1 Hz, from 1 - 50 Hz and > 50 Hz. 
Results. 
ECG shape during labour. The ECG complexes produced by each lead configuration 
were compared at five minute intervals throughout each labour. Rotation of the fetal head 
from a transverse position to an occipito-anterior position occurred in 4 of the 6 cases, one 
delivered vaginally in an occipito-posterior position and the other had a LSCS for failure 
to progress. There was no difference in waveform shape between the three lead 
configurations, nor were there longitudinal changes in either configuration during labour. 
Neonatal ECG comparison. The ECG shape recorded by all three lead configurations 
during labour was very similar to the neonatal waveform shape recorded in leads a VF, and 
Ill, i.e. in the longitudinal plane of the fetus. If the conventional lead configuration had 
recorded the fetal ECG in the transverse plane, the waveform shape should have been 
similar to that seen in leads I and II of the neon ate, but this was not the case. 
Frequency content The results of the signal filtering for the conventional and STAN 
configurations are shown in Table 2.3. As the STAN and Lindecrantz & Widmark 
configurations produced identical recordings a separate analysis has not been performed 
for the latter configuration. One of the patients generated two files so seven files were 
analysed. The mean power for each frequency range was calculated with and without File 6 
as visual inspection of the data indicated that a problem with electrode or lead attachment 
may have occurred during the recording in that case. 
The ST AN lead configuration signals contained proportionally more low frequency content 
and less high frequency content compared to the conventional configuration. This confirms 
that the ST AN configuration has an increased susceptibility to baseline noise. The increase 
in high frequency noise with the conventional configuration may be related to the vaginal 
element of the FSE which, on visual inspection of the recordings from that electrode 
element alone, did seem to contain more high frequency content. 
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Table 2.3 Percentage low, medium and high frequency content for each lead configuration 
in each patient for the first hour of recording. 
File Conventional configuration ST AN configuration 
number 
frequency content (%) frequency content (%) 
low medium high low medium high 
<1Hz 1-50Hz >50Hz <1Hz 1-50Hz >50Hz 
I 68.3 3.2 28.5 97.2 2.1 0.7 
2 80.2 9.9 9.9 83.3 10.8 5.9 
3 3.7 1.5 94.8 77.3 20.2 2.5 
4 4.8 2.0 93.2 74.3 23.2 2.5 
5 36.7 8.8 54.5 26.2 9.9 63.9 
6 85.4 14.6 0.03 42.7 44.1 13.2 
7 1.4 3.6 95.0 10.7 9.1 80.2 
Mean 40.1 6.2 53.7 58.5 17.1 24.1 
-of all 
-excluding 32.5 4.8 62.7 61.5 12.5 26.0 
File 6 
Discussion. This preliminary investigation has not revealed any differences in ECG 
waveform shape between the lead configurations. Unfortunately, none of the babies studied 
rotated 180 degrees from occipito-posterior to occipito-anterior during labour and delivery 
so the study is not conclusive. In the original work, Lindecrantz et al {1989} used two 
FSEs attached almost to opposite sides of the fetal head, whereas this study mimicked the 
clinical situation where the two elements of one FSE are less than 1 cm apart. This may 
also explain the lack of rotational changes seen here. 
Although the ST AN lead configuration is not obviously wrong, it does predispose to 
problems with low frequency baseline noise which is the most problematic for ECG 
waveform analysis. The high proportion of high frequency noise seen with the conventional 
lead configuration is not a major problem for signal analysis as high frequency noise is far 
easier to remove than low frequency noise. 
This is an area which requires further work in a larger number of labours over a spectrum 
of positive and negative ST waveform changes. A method of recording both lead 
configurations from a single FSE and two maternal leg electrodes has been devised which 
will improve patient recruitment rates. However, before this is done a method for 
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automatic analysis of ECG waveform shape is being developed to obviate visual 
assessment of the data (N. Outram, PhD project, University of Plymouth). A more refined 
method for signal noise analysis is also under investigation. Until this is complete, no 
change in the ST AN lead configuration can be recommended. 
Cable and leads. 
Cables and leads can add noise to a signal from mains interference or cable motion artefact. 
Electrode lead wires can act as antennae to pick up airborne electrical noise, particularly 
mains frequency noise (50Hz}. This can be minimised by keeping leads and cables as short 
as possible, using shielded cables or optical fibres as cables and by using differential input 
amplifier systems (Gatzke, 1974). The only problem found with the STAN system was 
with the lead to the maternal skin electrode. This was initially 20 cm long and unscreened 
and acted as a very effective aerial for airborne noise, especially 50 Hz noise. This was 
reduced by shortening the lead to 8 cm. 
Data acquisition electronics 
The ST AN uses a standard differential common mode amplifier and there was no evidence 
that the choice of amplifier itself contributed significantly to signal noise. 
Amplification and gain settings. The signal is amplified by a factor of 600 in the Pm 
before it is passed to the processor. The default gain setting of the processor was normally 
just over 2000 but could be halved or increased by a factor of 2 or 4 as judged by visual 
inspection of the FECG display. Frequent adjustment of the gain settings was necessary in 
some cases. This would be impractical in the routine clinical situation. An automatic gain 
setting was recommended and subsequently introduced. However, this automatic gain 
adjustment only took effect after amplification in the Pm. It was felt that the amplification 
factor was too large as saturation and signal dropout still frequently occurred as a result of 
large baseline changes. The Pm amplification was eventually reduced in June 1992 with 
immediate improvements in signal quality on subjective assessments of recordings. 
Signal processing. 
The signal from the Pm is transmitted down a cable to the ST AN for processing. An 
adaptive line filter (operating at 50 Hz in the UK) is used to eliminate mains frequency 
noise. The ECG is then split into two channels; one for QRS detection, the other for 
waveform analysis. Finally the signals are digitised by an analogue to digital converter 
(ADC) before heart rate calculation and waveform analysis. Each step of this process was 
examined as part of a report prepared for Cinventa (Plymouth Perinatal Research Group, 
1989). The filter characteristics quoted in the ST AN maintenance manual were confirmed 
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and were suitable for waveform analysis. 
The major problem identified by this work related to the resolution of the ST AN system. It 
is clear that baseline noise will remain the major problem of FECG waveform analysis as 
long as stainless steel FSEs and the ST AN lead configuration are used. The speed of the 
relatively old ST AN processor limits the system to only 8 bit resolution. This means that 
the whole signal - ECG and baseline noise - must be represented in 28 bits or 256 values. If 
very large baseline swings occur the size of the signal will have to be reduced to fit into 
256 values, so most values will be taken up representing baseline changes. This may leave 
only 50 values or so to represent the ECG waveform, and the T wave itself may only be 
represented by 2 or 4 values. This clearly causes problems for ST waveform analysis. The 
situation could be improved by a factor of 16 by increasing the resolution of the system to 
212 bits. 
Display and printout. 
Heart rate and T/QRS ratio were displayed on the liquid crystal display (LCD) but were 
too small to be read more than a half a metre away from the screen. This was clearly 
impractical and a larger numerical display was recommended and introduced. 
The first versions of STAN tested had a recorder which had different coloured pens in a 
rotating pen holder device. The fine parts involved were not robust enough for continual 
use and the rotating pen holders frequently became stuck with the pens lifted off the paper. 
All eventually broke. This mechanism was replaced by a single colour non-rotating pen 
which was satisfactory. The printer mechanism itself was very noisy and was replaced by a 
thermal printer in 1992. 
Summary 
This investigation identified several important areas where relatively simple improvements 
to ST AN design were possible; the maternal electrode lead wire, signal amplification, gain 
control, signal display and printout. This demonstrated the value of informed clinical input 
into the design of new technology. Engineers are not always aware of the requirements and 
restrictions of clinical monitoring equipment, especially in a high stress area such as the 
labour ward. Ideally, clinicians with some understanding of signal analysis technology 
should be involved at an early stage in the design of new technology and in early clinical 
studies. 
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The questions about the ST AN lead configuration were unable to be resolved and must 
await a larger, more detailed study. The lead configuration used is not wrong, but does 
rather disadvantage ST waveform analysis by increasing baseline noise which is a particular 
problem in the second stage of labour. It may be that an update of the now rather old 
ST AN processor to provide more signal processing capabilities would allow this noise to 
be removed more effectively without distorting the signal. However, processing can never 
add information to a signal and it would be better to maximise initial signal quality than 
rely on increased processing to cope with a poor quality signal. AJthough faster processors 
are now available, the expense and time required to incorporate these into a new model of 
ST AN could not be justified until data from a randomised trial demonstrated some actual 
clinical benefit for the new technology. 
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Introduction 
As discussed in Chapter One, a series of experimental studies over the last 17 years have 
identified a physiological basis for changes in the ST waveform shape of the fetal ECG. 
Human observational studies have indicated that a combination of fetal heart rate and ST 
waveform changes might be of clinical value by allowing a reduction in operative 
intervention without adversely affecting neonatal outcome (Lilja et al, 1985, Greene, 1987, 
Arulkumaran et al, 1990). The main purpose of this randomised clinical trial was to 
investigate the significance of any reduction in operative intervention by comparing 
intervention rates and neonatal outcome in labours monitored with CTG alone or in 
combination with ST waveform analysis. The results are presented and discussed in this 
chapter. 
The trial also provided an opportunity to examine current monitoring practice and to assess 
the value of cord blood gas analysis. These findings are presented and discussed in Chapters 
Four and Five respectively. 
Methods 
Plymouth General Hospital is one of the largest obstetric units in the UK with more than 
5,200 deliveries per annum. In 1989, prior to this trial, the total caesarean section rate was 
9.5%, the forceps rate 8.5% and the perinatal mortality rate was 6.1 per 1000 live births. 
The overall operative delivery rate for 'fetal distress' was 4.5% while the rate for those 
monitored continuously with a fetal scalp electrode was 11%. 
Calculation of sample size. 
It was calculated that a sample size of 450 in each arm would give a 90% chance (power) of 
detecting a 50% difference from an 11% 'fetal distress' delivery rate at the 5% level using a 
two sided test to compare proportions (Casagrande & Pike, 1978). The trial size required to 
assess an affect on neonatal morbidity was more difficult to calculate due to the lack of 
recognised endpoints. Objective assessment of immediate outcome was possible with 
umbilical cord acid-base assessment. If a 2% incidence of metabolic acidosis was assumed 
(Low, 1988) then a sample size of 1300 in each arm would give a 50% chance of detecting 
a 50% difference at the 5% level in a two-sided test. Based on the above calculations, the 
estimated recruitment rate and the available resources a total sample size of 2400 was 
chosen with an interim analysis at 1200. Although the power for neonatal outcome was 
relatively low, the sample size provided sufficient data to examine low incidence outcomes 
for exploratory purposes. 
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The recorders used were a HP 8040A CTG recorder (Hewlett-Packard Ltd, Boblingen, 
Gennany) for the CTG ann and a STAN 8801 recorder (Cinventa AB, MOlndal, Sweden) 
for the ST wavefonn plus CTG (ST+CTG) ann. 
Study entry and randomisation. 
All pregnancies of more than 34 weeks gestation with no gross fetal abnonnality were 
eligible for trial entry. Entry to either ann was decided by draw of a sealed opaque envelope 
once the decision to apply a scalp electrode was made. The hospital policy for continuous 
internal monitoring was selective for all high risk pregnancies (pre-eclampsia, antepartum 
haemorrhage, growth retardation, diabetes, previous caesarean section), an abnonnal 
antenatal or early labour external CTG, inductions or augmented labour, the presence of 
meconium liquor, epidural analgesia or breech presentation. The study was approved by the 
local Ethical Committee and all patients approached gave infonned consent before entry 
into the trial. 
Preparation for the trial. 
Extensive education and training of labour ward staff on the use of the ST AN recorder and 
the concepts of CTG and ST wavefonn analysis was provided before and continued 
throughout the trial on a weekly basis. A pilot phase of 100 cases using the trial protocol 
was run as a 'dress rehearsal' immediately before the trial commenced but none of the pilot 
data has been included in the analysis. 
Protocols for management in labour. 
All cases in the trial were managed by medical and midwifery staff and not by research staff. 
The following protocols for management were derived before trial commenced. 
CTG arm. The interpretation of CTG traces and management followed accepted clinical 
guidelines including an FBS option. These are summarised in Table 3.1. 
ST+CTG arm. The interpretation of first stage traces followed the same CTG classification 
as shown in Table 3.1 but included certain modifications based on the T/QRS ratio 
according to the model of interpretation shown in Figure 1.13 (Table 3 .2). In the second 
stage acutely emerging changes in the ST wavefonn over a five minute period were 
regarded as significant. 
FBS guidelines. A FBS pH of >7.25 was considered nonnal but if the pattern which 
prompted the FBS persisted, a repeat FBS was indicated in 60 minutes and if the pattern 
deteriorated the repeat FBS was to be obtained earlier. A pH of7.20 to 7.25 was suspicious 
and the FBS was to be repeated in 45 minutes or earlier if the trace deteriorated, while a pH 
of<7.20 was abnonnal and required immediate delivery. 
Measurement of outcome 
Intervention. The frequency offetal blood sampling (both total numbers ofFBS perfonned 
and numbers of cases with an FBS) was recorded as were the indications for FBS given in 
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the hospital notes. Operative deliveries were recorded according to the primary indication 
given by the operator. Deliveries for 'fetal distress' included both deliveries performed on 
account of an abnormal scalp pH and those performed because of concern about an 
abnormal trace. Deliveries for 'failure to progress' included deliveries for inadequate 
progress in either the first or second stage of labour and elective forceps deliveries 
performed on account of maternal condition (e.g. hypertension). 
Table 3.1 Protocol for CTG interpretation and recommended action. 
Classification Baseline Variability Decelerations Action 
Normal 110-160 bpm 10-25 bpm none Continue recording 
Intermediate 100-110 bpm >25 bpm early Anytwo>30 
160-180bpm <5bpm mild variable1 mins; FBS. 
Repeat 1 hour2. 
Abnormal < 100 bpm with <5 bpm. no severe Anyone> 30 
accelerations accelerations variable3 mins; FBS. 
>180bpm in the late Any two> 15 mins; 
absence of FBS. Repeat 
sedation. 1 hour2. 
Preterminal Persistent bradycardia, no accelerations exceeding 100 Deliver; if not 
bpm and believe this will be persistent. FBS. 
1. < 60 dropped beats, < 60 seconds duration. 
2. FBS earlier if CTG deteriorates. 
3. >60 dropped beats,> 60 seconds. 
Table 3.2 Protocol for ST waveform plus CTG (ST+CTG) interpretation and 
recommended action. 
Classification Normal ST Intermediate ST AbnormalST Negative ST l 
(f/QRS 0.05-0.24) (f/QRS >0.24 (f/QRS >0.5 
>30 mins) >15 mins) 
CTGnormal continue recording monitor closely FBS FBS or deliver 
CTG intermediate continue recording FBS FBS or deliver FBS or deliver 
CTG abnormal > 30mins FBS FBS or deliver deliver deliver 
CTG preterminal deliver deliver deliver deliver 
1. Negative T wave or ST segment depression with positive T waves. 
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Neonatal outcome. This was assessed by; 
1. Umbilical cord artery and vein blood gas analysis. A Coming 178 Blood Gas Analyser 
(CmA Coming Ltd, UK) was used throughout. In the first 400 cases cord blood gas 
analysis was restricted to those cases having an operative delivery or FBS. When a second 
and dedicated blood gas analyser became available analysis was performed on all deliveries. 
The cord was double clamped immediately after delivery and 1 to 5 ml of blood withdrawn 
from an artery and the vein into separate preheparinised syringes. If samples could not be 
analysed within 1 0 minutes of delivery they were placed on ice and were analysed within 40 
minutes of delivery. The base deficit (BD) calculated from the blood compartment was 
corrected to that in the extracellular fluid compartment (BDect) by using the Siggaard-
Andersen Acid Base Chart {Siggaard-Andersen, 1971) as this is more appropriate in the 
perinatal period (Rosen & Murphy, 1991). The methodology of cord blood sampling is 
discussed further in Chapter Five. 
2. Apgar scores at 1 and 5 minutes. 
3. Details of any resuscitation. 
4. Postnatal course- babies were followed up daily to discharge. Any abnormalities in the 
postnatal period were noted together with details of admissions to neonatal intensive care 
(Special Care Baby Unit or SCBU), treatment given and diagnosis at discharge. 
For the purposes of this study, a diagnosis of birth asphyxia was derived from the 
following references; Low et al, 1984, American Academy ofPediatrics, 1986, Gilstrap et 
al, 1989 and Murphy et al, 1990. It required all of the following; 
i. cord artery pH <7.05 and extracellular fluid Base Deficit (BDect) > 12 mmolll; 
ii. Apgar score at 5 minutes of~ 7; 
iii. active resuscitation for ~ 4 minutes; 
iv. one of the following problems in the postnatal period; 
-hypoglycaemia (BM stix < 1.6 mmol/l) within the first 12 hours (mild asphyxia), 
- neurological abnormalities or a requirement for assisted ventilation in the first 48 
hours (moderate asphyxia) 
- death (severe asphyxia). 
A copy of the Case Record Form used for the study is given in Appendix 2. 
Retrospective quality assessment 
All traces were reviewed by a single observer and given separate quality scores for heart 
rate and uterine contraction recordings according to how useful the recordings were for 
monitoring purposes {1 = excellent, 2= satisfactory, 3 =unsatisfactory). The ST+CTG traces 
were also given an additional score for the quality of the ECG complexes. 
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Retrospective, blinded review of traces. 
It is inevitable that clinical staff do not adhere to protocols on occasions. All traces were 
therefore reviewed retrospectively, blind to outcome, by the author. This enabled clinical 
CTG and ST +CTG interpretation and management to be compared with that recommended 
by the trial protocol as interpreted by an experienced clinician. It also allowed patterns of 
ST+CTG change to be recorded. The review started at the beginning of each trace and 
worked to the end in 30 minute segments without preview. Classification was strictly 
according to the trial protocol and blind to neonatal outcome. The CTG for each trace was 
classified as normal, intermediate or abnormal based on the classification shown in Table 
3.1. In addition the ST+CTG traces were also classified as normal T/QRS ratio (<0.25}, 
raised (>0.24} or negative. Finally it was noted whether any intervention had been 
performed on the basis of CTG or ST +CTG changes - either fetal blood sampling or an 
operative delivery for 'fetal distress'. 
Statistical methods. 
Tests of significance for continuous variables was by Student's 't' test and for discrete 
variables by Chi Squared analysis. Significance levels were taken at 'p' levels of< 0.05. The 
odds ratios and 95% confidence intervals were also calculated (Gardener et al, 1989). 
Multivariate analysis was performed using ANOV A with the Mini tab, Version 7.1 statistical 
software package running on a prime mainframe computer. Kruskal-Wallis and Mann-
Whitney U tests were performed on nonparametric data. 
Results. 
Trial entries. 
During the trial period (21.6.90 to 13.12.91) there were 6798 deliveries from pregnancies of 
at least 34 weeks gestation. Of these, 2434 (36%) fulfilled the entry criteria and were 
recruited to the trial (1215 CTG arm, 1219 ST+CTG arm). No patient approached refused 
entry. Thirty-four patients did not receive the allocated recorder and are discussed below. In 
total 1212 cases in the CTG arm and 1188 in the ST+CTG arm received the intended 
recorder. Results are given according to intention to treat by original randornisation. A 
secondary analysis by treatment received has been performed and does not alter the 
statistical significance of the results (See Appendix 3). 
Randornisation details are shown in Table 3.3. The CTG arm had significantly fewer 
inductions and trends to fewer post-dates pregnancies, total antenatal complications and 
epidural analgesia. These features are likely to be related. 
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Table 3.3 Randomisation details. 
CTG ST+CTG p value Odds ratio (95% Cl) 
n=l215 n=l219 
Maternal age (years) mean 26.5 26.2 >.05 (-0.13-0.73)1 
SD 5.4 5.3 
Gestational age (weeks) mean 39.6 39.6 >.05 (-0.13-0.13)1 
SD 1.6 1.6 
Primigravidae 822 825 .98 0.99 (0.84-1.18) 
Antenatal complications Total 230 262 .13 0.85 (0.70-1.04) 
- preclampsia 33 40 .82 0.82 (0 .52-1.31) 
- previous LSCS 17 19 .87 0.90 (0.46-1.73) 
- growth retardation 27 25 .88 1.09 (0.63-1.88) 
- antepartum haemorrhage 19 12 .27 1.60 (0.77-3.31) 
-post dates (~42 weeks) 76 99 .09 0.75 (0.55-1.04) 
-others2 58 67 .47 0.86 (0.60-1.24) 
Breech 25 30 .59 0.83 (0.49-1.42) 
Inductions 394 443 .05 0.84 (0.71-0.99) 
Epidural analgesia 673 712 .14 0.88 (0.75-1.04) 
Meconium liquor 202 201 .91 1.0 I (0.82-1.25) 
Birth weight (grams) mean 3363 3381 >.05 ( -58.6-22.6) 1 
SD 503 518 
Birth weight< lOth centile 43 39 .73 1.11 (0.71-1.73) 
1. For these continuous variables the 95% Cl for differences between means has been 
calculated. 
2. hypertension, diabetes, reduced fetal movements, urinary tract infection, asthma, 
polyhydramnios, anaemia. 
Non-compliance with allocated recorder. 
There were three cases in the CTG arm. In two a recording was unobtainable on the CTG 
recorder (although in one it was possible on a ST+CTG recorder.) In the third no CTG 
recorder was available. Two had normal deliveries and one had a caesarean section for 
'failure to progress'. All had normal neonatal outcome with no asphyxia. 
There were 31 cases in the ST+CTG arm. Ten of these were protocol failures and four were 
technical failures - two printer mechanisms and two broken cables. In 17 cases no 
satisfactory heart rate or ECG trace could be obtained despite reapplication of the scalp 
electrode and checking the recorder. In 13 of these a satisfactory CTG trace was obtained 
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on a CTG recorder whilst in the other four cases this also failed to produce a satisfactory 
heart rate. 
Of these 31, 20 had uneventful labours and normal deliveries, eight had operative deliveries 
for 'failure to progress', two had FBS followed by a normal delivery, and one had a forceps 
delivery for 'fetal distress'. All had normal neonatal outcome with no asphyxia. 
Intervention. 
Fetal blood sampling. The frequncy of fetal blood sampling is shown in Table 3.4. 
Although the FBS rate in the two arms is not significantly different (9.4% CTG, 7.6% 
ST+CTG), there were significantly more samples taken in the CTG arm (168 versus 129 in 
the ST+CTG arm). 
Table 3.4 Fetal blood sampling by numbers of cases and number of samples. 
CTG ST+CTG p value odds ratio 95%CI 
n=1215 n=1219 
Number of cases ll4 93 .14 1.25 (0.94-1.67) 
Number of samples 168 129 .02 1.36 (1.06-1.73) 
Operative delivery. Table 3.5 shows the indications for the operative deliveries. There was 
a highly significant reduction in total operative deliveries for 'fetal distress' in the ST+CTG 
arm. The method of delivery for these cases is shown in Table 3.6. Both LSCS and non-
rotational forceps ·deliveries have been significantly reduced. Importantly, there are no 
differences in the number of operative deliveries for 'failure to progress'. This group acts as 
an internal control and indicates that there has not merely been a change in the indications 
for operative delivery in the ST+CTG group. 
Table 3.5 Indications for operative delivery. 
CTG ST+CTG p value odds ratio 95% Cl 
n=l215 n=l219 
Abnonnal FBS pH 19 15 .60 1.28 (0.65-5.52) 
Abnonnal trace 92 46 <.001 2.09 (1.45-3.00) 
Total deliveries for 111 61 <.001 1.96 (1.42-2. 71) 
'fetal distress' 
Deliveries for 'failure to 272 283 .69 0.96 (0.96-1.16) 
progress' 
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Table 3.6 Mode of delivery for 'fetal distress'. 
CTG ST+CTG p value odds ratio 95%CI 
n=1215 n=1219 
LSCS 30 15 .03 2.03 (1.09-3.80) 
Rotational forceps 13 9 .52 1.45 (0.62-3.41) 
Vacuum 10 5 .30 2.01 (0.68-5.91) 
Non rotational 58 32 .007 1.86 (1.20-2.88) 
forceps 
Total 111 61 <.001 1.96 (1.42-2. 71) 
Neonatal outcome. 
There were more cases of cord artery metabolic acidosis (13 versus 5) and more low 5 
minute Apgar scores (32 versus 20) in the CTG arm. Although these differences did not 
achieve statistical significance (p=.09 and .12 respectively) the odds ratios and 95% 
confidence intervals (2.63 [0.93-7.39] and 1.62 [0.92-2.85] respectively) show a trend to 
improved short term neonatal outcome in the ST+CTG arm. There were no other 
significant differences in outcome (Table 3.7). 
Table 3. 7 Neonatal outcome. 
CTG ST+CTG p value odds ratio 9S%Cl 
n=l215 n=l219 
Cord artery pH<7 .15 101 llO .58 0.91 (0.69-1.21) 
Cord artery pH<7.05 25 23 .86 1.09 (0.62-1.94) 
Metabolic acidosis; 13 5 .09 2.63 (0.93-7.39) 
cord artery pH <7.05 
& BDecf> 12mmolll 
Apgar at 5 min. <7 32 20 .12 1.62 (0.92-2.85) 
SCBU admissions 31 24 .41 1.30 (0.76-2.23) 
Birth asphyxia 4 3 
Birth asphyxia. The cases of birth asphyxia which occurred in trial entries are summarised 
in Table 3.8. (IPPV =intermittent positive pressure ventilation). 
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Table 3.8. Sununary of birth asphyxia cases which occurred in trial entries. 
Cue No., parity Intrapartum trace Mode of Weight artery & vein Apgars at 1 Resuscitation Neonatal course 
& gestation delivery (grams) pH&BDecf 5' & 10' 
(mmolll) 
CTGarm 
251 Multip, 40 W 1st stage; reduced variability 2hr SVD 3200 6.87, 16 5, 7, 8 4 min. IPPV Hypoglycaemia 
2nd stage: 5 min. only, bradycardia. 7.08, 17 
1129 Primip, 40 w 1st stage: tachycardia, decreased variability LSCS 2380 7.03, 13 5, 6, 8 5 min. IPPV Ventilated 48h. 
& late decelerations on admission at 3cm dilation. 7.10, 13 Spastic hemiplegia 
at 1 year 
1591 Primip, 37 W 1st stage: variable decelerations 90 min., LSCS 3850 6.81, 16 3, 7, 9 4 min. IPPV Fitted at 10 hours 
tachycardia & reduced variability 30 min. Cord prolapse 7.20, NA 
2009 Primip, 37 w 1st stage: late decelerations 90 min., tachycardia SVD 2610 7.04, 13 3, 6, 9 8 min. IPPV Hypoglycaemia 
& reduced variability 30 min. FBS at 8cm pH 7.07. 7.08, 13 
Rapid progress. 
ST+CTGarm 
106 Multip, 38 W 1st stage: normal2 hours. 2nd stage: tachycardia, SVD 2800 NA 4, 6, 7 15 min. IPPV Hypoglycaemia 
?IUGR reduced variability, late decelerations. NA Jittexy 48 hr 
Negative T wave, T/QRS ratio negative 40 minutes. 
1372 Primip, 40 W ARM, syntocinon: heart rate 160, absent variability, LSCS 2880 NA Stillborn 
Absent fetal late decelerations then bradycardia. Wide QRS, ST NA 
movement 24 h segment depressed, T wave & T/QRS ratio positive. 
abnormal CTG 
1699 Primip, 40 W lst stage: syntocinon, variable decelerations 50 min., Forceps 3600 6.88, 16 Stillborn Attempted 
T/QRS ratio 0.9. FBS at 9cm, pH 7.34. Then severe Cord tightly 7.38, 4 resuscitation 
variable decelerations 120 min., tachycardia & reduced around neck 30min 
variability 30 min., rise in T/QRS ratio to 0.32, 
terminal bradycardia. 
Retrospective review. 
Four entries in the CTG arm could not be assessed due to poor quality heart rate signals. All 
had normal outcome. Twelve entries in the ST+CTG arm had ECG signals of such poor 
quality that the ST waveform could not be assessed but the CTG was satisfactory. All but 
one of these had normal CTGs and all had normal outcome. One developed a bradycardia 
late in the second stage and had a forceps delivery. The cord artery pH was 7.24, BDecf 4 
mmol/l and the Apgars were 8 at 1 and 9 at 5 minutes. The 34 cases who did not receive the 
allocated method of monitoring (detailed above) were also excluded from the review. Thus, 
retrospective review of recordings according to the trial protocol was carried out on 1208 
entries in the CTG arm and 1176 in the ST+CTG arm (Figure 3.1). 
3 non-
compliance 
with allocated 
recorder 
1215 
CTGarm 
4 
poor quality 
2434 
Total entries 
1219 
ST+CTG arm 
12 
poor quality 
31 non-
compliance 
with allocated 
recorder 
Figure 3.1 Flow chart to demonstrate how the cases assessed in the retrospective review 
were obtained. 
Intervention for 'fetal distress'. 
The CTG and ST+CTG arms of the trial had similar numbers of recordings with normal, 
intermediate and abnormal CTGs (Table 3.9). Operative intervention for 'fetal distress' in 
the normal recordings was significantly reduced in the ST+CTG arm. The proportion of 
operative deliveries for 'fetal distress' in the intermediate and abnormal recordings was also 
reduced in the ST+CTG arm, but the difference was not statistically significant. 
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Table 3.9 Proportion of operative intervention for 'fetal distress' by retrospective review. 
Retrospective CfG ST+CTG pvalue odds ratio 9S%CI 
classification n=l208 n=1176 
Normal 
nwnber (%of total) 953 (78.8) 950 (80.8) .27 0.89 (0.73-1.09) 
'fetal distress' 
deliveries (%) 26 (2.7) 3 (0.3) <.001 8.94 (2.57-25.3) 
Intermediate 
nwnber (%of total) 113 (9.4) 93 (7.9) .26 1.20 (0.89-1.59) 
'fetal distress' 
deliveries (%) 22 (19.5) 9 (9.6) .07 2.26 (0.92-5.64) 
Abnormal 
nwnber (%of total) 142 (11.8) 133 (11.3) .78 1.04 (0.81-1.35) 
'fetal distress' 
deliveries (%) 63 (44.4) 47 (35.3) .16 1.46 (0.87-2.44) 
Negative ST waveform. 
There were a total of 13 cases identified with negative ST waveforms. Seven had good 
outcome with no acidosis; three had normal CTGs (one breech with abnormal shaped ECG 
complexes, one with an error in the fiducial point calculation and one fetus at 34 weeks), 
and four had abnormal CTGs (one error in the fiducial point calculation and three with only 
intermittently negative waveforms in the second stage). 
The remaining six cases all had persistent waveform changes and included two of the three 
cases of birth asphyxia in the ST+CTG arm. All asphyxiated cases except one (case 1372) 
had acute second stage changes in association with an abnormal CTG pattern. Three had 
negative T waves and a negative T/QRS ratio while three had biphasic ST waveform 
changes (negative ST segment, positive T wave) with a positive T/QRS ratio. All were 
depressed at birth and required resuscitation (one minute Apgar scores three to six). Cord 
artery data was available in three cases (pH 6.97, BDecf 16 mmol/1; pH 7.03, BDecf 10 
mmol/1; pH 7.08, BDecf 11 mmol/1). 
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Cord artery pH and extracellular base deficit at delivery. 
The cumulative frequency distribution for cord artery pH and BDecf according to the 
retrospective CTG classification are shown in Figure 3 .2. Both arms had similar frequency 
distributions for each classification (nonnal, intennediate and abnonnal). The mean pH and 
BDecf are shown in Table 3.10. 
The ST+CTG ann was divided into 2 subgroups for each classification; those where the ST 
wavefonn remained nonnal (T/QRS <0.25) and those where it was elevated (T/QRS ~ 
0.25). The small number of cases with negative wavefonns were excluded from this 
analysis. Figures 3.3 and 3.4 show the cumulative frequencies of cord artery pH (Fig. 3.3) 
and BDecf (Fig. 3.4} for the CTG ann and for each subgroup in the ST+CTG ann for 
nonnal (A), intennediate (B) and abnonnal (C) retrospective CTG classifications. The mean 
pH and BDecf and their 95% confidence intervals are also tabulated in Table 3.10. 
Significance testing was by ANOV A and these results are given and discussed on page 82. 
Table 3.10 Mean arterial pH and extracellular base deficit (BDect) and 95% confidence 
intervals by retrospective trace classification. 
Retrospective CTGarm ST+CTGarm 
CTG 
classification Total ST normal ST raised 
Normal 7.26 (7.26-7.27) 7.26 (7.26-7.27) 7.26 (7.26-7.27) 7.29 (7.27-7.30) 
pH n=723 n=728 n=681 n=47 
BDecf (mmoiJI) 2.0 (1.8-2.2) 2.1 (1.9-2.3) 2.1 {1.9-2.4) 1.1 (0.3-1.9) 
n=693 n=686 n=643 n=43 
Intermediate 7.21 (7.20-7.23) 7.21 (7.19-7.23) 7.21 (7.19-7.24) 7.21 (7.14-7.28) 
pH n = 93 n = 68 n = 59 n = 9 
BDecf (mmoiJI) 3.9 (3 .2-4.6) 3.6 (2.9-4.3) 3.5 {2.7-4.2) 4.6 (2.0-7.1) 
n=90 n=61 n=53 n=8 
Abnormal 7.14 (7.12-7.16) 7.16 (7.14-7.18) 7.19 (7.17-7.20) 7.05 (7.02-7.08) 
pH n=ll5 n=l08 n=88 n=20 
BDecf (mmoiJI) 5.2 (4.5-5.9) 4.8 {3 .8-5.2) 3.8 (3.1-4.5) 7.6 (6.1 -9.1) 
n=llO n=102 n=84 n=18 
See page 82 for significance tests. 
The frequency distribution for pH and BD in the CTG nonnal, ST raised group was shifted 
to the right of the CTG nonnal, ST nonnal group (Figure 3.3A & 3.4A). This ST raised 
group had the highest mean pH and lowest mean BDecf compared to all other groups in 
either ann. In all the T/QRS ratio was persistently elevated (0.25-0.35} for the duration of 
labour, all had very reactive heart rate patterns with excellent neonatal outcome. 
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Figure 3.3 Cumulative frequencies for cord artery pH for 
A. normal, B. intermediate and C. abnonnal retrospective CTG classifications. 
• CTG arm, ST+CTG arm; 0 ST normal, V ST raised. 
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Figure 3.4 Cumulative frequencies for cord artery BDecf for 
.... 
A. normal, B. intermediate and C. abnormal retrospective CTG classifications. 
• CTG arm, ST+CTG arm; 0 ST normal, V ST raised. 
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The frequency distributions in the CTG intermediate groups overlapped (Figures 3.3B & 
3.4B) and no effect of ST waveform change could be seen. This was probably because 
there were only 8 cases in the CTG intermediate, ST raised group and the 95% Cls for the 
means were very wide. 
The frequency distributions for each ST waveform subgroup in the CTG abnormal group 
were clearly different (Figures 3.3C & 3.4C); the ST normal subgroup has been shifted to 
the right of the CTG ann frequency distribution (to higher pH and lower BDecf values) 
whilst the ST raised subgroup has been shifted to the right (to lower pH and higher BDecf 
levels). The CTG abnormal, ST raised group had the lowest mean pH and highest mean 
BDecf compared to all other groups. In these cases the ST elevation occurred during the 
second stage in parallel with progressive CTG abnormalities. 
Statistical analysis. The significance of the interaction between CTG and ST waveform 
change on pH and BDecf was tested by ANOV A The results are shown in the foUowing 
Tables. 
Table 3.11 Results of ANOVA to test the effect ofCTG classification on pH and BDecfin 
both anns of the trial. 
Factor Degrees pH BDecf 
of 
Freedom p value p value 
CTG classification 2 <0.0001 <0.0001 
(normal, intermediate or 
abnormal) 
Arm of trial 1 0.235 0.184 
(CTG or ST+CTG) 
CTG/ Arm interaction 2 0.190 0.532 
In this analysis the the effects of two variables (CTG classification and which form of 
monitoring was used) on pH and BDecf were tested. Any interaction between the two 
variables was also assessed. These results show a significant effect of CTG classification on 
both pH and BDecf in both anns but no effect of trial ann for each CTG classification and 
no interaction between trial ann and CTG. This can be illustrated in the foUowing Figures. 
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Figure 3.5 Mean pH at each CTG classification in both anns of the trial. Vertical bars 
show 95% confidence intervals. 
As the CTG became more abnormal, the mean pH in each trial ann fell. The pH values for 
each ann of the trial virtually overlap and there was no significant difference between the 
values for each CTG classification in each arm. 
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Figure 3.6 Mean BDecf at each CTG classification in both anns of the trial. Vertical bars 
show 95% confidence intervals. 
As the CTG became more abnormal in each trial arm, the mean BDecf rose. The BD 
values in each ann at each CTG classification were not significantly different. 
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The next analysis was performed on the ST+CTG arm data only. It tested the effects of 
two variables (CTG classification and ST waveform pattern) on pH and BDecf Any 
interaction between the two variables was also assessed. 
Table 3.12 Results of ANOVA to test the effect of CTG and ST waveform classification 
on pH and BD in the ST+CTG arm. 
Factor Degrees of pH BDecf 
Freedom p value p value 
CTG classification 2 <0.0001 <0.0001 
(normal, intermediate or 
abnonnal) 
STwaveform 1 0.001 0.005 
(normal or raised) 
CTG/ST waveform 2 <0.0001 <0.0001 
interaction 
Both CTG classification and ST waveform had a significant effect on pH and BD and there 
was a significant interaction between the two. This can be illustrated in the following 
figures. 
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Figure 3. 7 Mean pH at each CTG classification for ST normal and ST raised subgroups 
of the ST+CTG arm. Vertical bars show 95% confidence intervals. 
As the CTG classification became more abnormal, the pH fell in both subgroups of the 
ST+CTG arm. However, the values are dissimilar (except for CTG intermediate) and the 
slopes of the two lines are different. This illustrates the significant interaction between 
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CTG classification and ST waveform change for pH. 
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Figure 3.8 Mean BDecf at each CTG classification for ST normal and ST raised 
subgroups of the ST+CTG ann. Vertical bars show 95% confidence intervals. 
As the CTG classification became more abnormal, the BDecf rose in both subgroups of the 
ST +CTG ann. However, the values are dissimilar and the slopes of the two lines are 
different. This illustrates the significant interaction between CTG classification and ST 
waveform change for BDecf 
Use of ANOVA assumed that the data was normally distributed with a homogeneity of 
variances, although this was not entirely true. Use of this test can be justified as it is well 
documented that ANOVA is robust for departures from normality (Glass et al, 1972). With 
the overwhelmingly significant effects found here, the conclusions are unlikely to be 
compromised by the moderate departure from normality present. As a cautionary check the 
effect of CTG classification in each column in Table 3.10 was analysed using the Kruskal -
Wallis test, a nonparametric alternative to One Way ANOV A. This showed a highly 
significant (p<O.OOI) effect of CTG classification on pH and a significant effect (p<O.Ol) 
on BDecf with the exception of the CTG intermediate, ST normal and CTG abnormal, ST 
normal subgroups which were not significantly different. It was impossible to test the 
interaction between CTG and ST waveform with nonparametric tests as there was no 
non parametric version of ANOV A which could cope with groups of unequal size. Similar 
results to the ANOVA were found with repeated Mann-Whitney-U tests comparing each 
subgroup of the data with every other group. It is recognised that such multiple 
comparisons would have increased the chance of finding a falsely significant result (a type I 
error) but the analysis was only performed as an additional check on the ANOVA results. 
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Quality assessment. 
There were no differences in the quality scores for heart rate in the first stage between the 
trial arms (Table 3.13). Compared to the ST+CTG recorder, the CTG recorder produced 
significantly better heart rate recordings in the 2nd stage and better contraction recordings 
in both the first and 2nd stage. The ST+CTG recorder produced significantly worse heart 
rate and ECG recordings in the 2nd stage compared to first stage recordings. 
Table 3.13 Subjective assessment of quality of recordings on a scale of 1 (excellent) to 3 
(poor). Figures are given as percentages. 
CTG ST+CTG 
Grade 1 Grade 2 Grade3 Grade 1 Grade 2 GradeJ 
Fetal heart rate 
First stage 88 12 0 87 12 1 
Second stage 841 15 1 712 26 3 
Contractions 
First stage 883 11 1 75 20 5 
Second stage 834 12 5 73 19 8 
ECG complexes 
First stage 73 25 2 
Second stage 565 39 3 
Fetal heart rate; 1 p<0.001, OR 2.13 (1.73-2.62) compared to ST+CTG second stage. 
2 p<0.001, OR 2.83 (2.27-3.51) compared to ST+CTG first stage 
Contractions; 3 p<0.001, OR 2.46 (1.99-3.06) compared to ST+CTG first stage. 
4 p<0.001, OR 1.81 (1.47-2.22) compared to ST+CTG second stage 
ECG complexes; 5 p<O.OOI, OR 2.14 (1.79-2.55) compared to ST+CTG first stage 
All by x2 analysis. 
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Discussion. 
Evaluation of the ST waveform of the fetal ECG has closely followed standard 
pharmaceutical procedures for the introduction of a new drug; with animal studies to 
investigate the basic physiology, observational studies in man to determine a clinical 
protocol, followed by a randomised clinical trial to establish its clinical value and 
practicability. This is the first time a new concept for fetal assessment which involves new 
technology has been tested in a randomised trial before widespread introduction into 
obstetric practice. 
Intervention and outcome. 
The main aim of the trial was to investigate the effects of ST waveform plus CTG analysis 
on operative intervention rates and neonatal outcome. The results show a significant 
reduction both in the total number of FBS samples taken and in the number of operative 
deliveries for 'fetal distress' with no adverse effects on neonatal outcome. 
Fetal blood sampling. There was no difference in FBS in the interim analysis at 1200 
entries (80 samples taken from 58 patients in the CTG arm versus 70 samples taken from 
52 patients in the ST+CTG arm, p=0.56, OR 1.18[0.84-1.67]). By the completion of the 
trial at 2434 entries, the total number of patients who had FBS in each arm was not 
significantly different (114 CTG versus 93 ST+CTG, p=0.14, OR 1.26 [0.94-1.67]) but 
there was a significant reduction in total number of samples taken {168 CTG versus 129 
ST+CTG, p=0.02, OR 1.36 [1.06-1.73]). These findings reflect the deliberately 
conservative trial protocol as it was important to maintain the safety of an FBS option 
during the introduction of a new monitoring concept. Recently, Johansen et al, {1992} 
measured the T/QRS ratio immediately before a FBS was performed for CTG changes in 
88 cases. A T/QRS ratio <0.25 would have correctly reassured clinicians in 38 cases and 
all 3 cases with a metabolic acidosis would· have been identified by a T/QRS ratio > 0.24. 
On the basis of their findings and those from this trial, it would be possible to safely reduce 
the FBS frequency in the CTG abnormal group. 
Operative deliveries. A significant reduction in operative intervention was apparent by the 
interim analysis at 1200 cases (total deliveries for 'fetal distress' were 58 in the CTG arm 
versus 27 in the ST+CTG arm, p<0.001, OR 2.30 [1.44-3.69]) and was maintained at 2400 
cases {111 CTG arm versus 61 ST+CTG arm, p<0.001, OR 1.96 [1.42-2.71]). 
Based on the estimates of Clark et al, {1991) of£ 1172 per emergencey LSCS and £644 per 
operative vaginal delivery, the cost of the 'fetal distress' deliveries in the CTG arm was 
£87,324 and in the ST+CTG arm £47,204. Assuming the same rates of 'fetal distress' 
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deliveries, if all trial entries had been monitored with CTG alone, the cost of 'fetal distress• 
deliveries would have been in the order of £174,650 as compared to £94,410 if all entries 
had been monitored with ST+CTG analysis. Thus a potential saving of £80,240, or £33 per 
monitored patient, could have been possible with ST+CTG analysis. 
The reduction in operative deliveries included both simple liftout forceps and caesarean 
sections and occurred in a hospital with intervention rates which were already low. The 
trial did not merely bias the indications given for operative delivery in the ST +CTG arm as 
there was no difference in the number of deliveries for failure to progress in each arm. In a 
stressful labour ward situation a clinician who is really concerned about a trace is more 
likely to deliver, and alter the indications given for delivery, than not deliver at all. 
The selection of cases for operative delivery was more accurate in the ST+CTG arm. 
Fewer deliveries occurred in traces classified as nonnal or intennediate by the reviewer. ST 
waveform changes did not occur as frequently as CTG changes, therefore the addition of 
ST waveform probably acted as a reassuring variable which prevented interference in the 
majority of cases. 
It is possible that a similar reduction in intervention could have been achieved by the 
addition of any other variable, whatever the source, as long as it reassured the clinician that 
action was not required whenever CTG changes occurred. 
A possible example of such a variable is shown in Figure 3.9. 
This variable may prevent intervention in cases with minor 
CTG changes but, once changes become severe, the 
clinician's anxiety and desire to intervene would overcome 
advice to the contrary. This approach is unlikely to win the 
support of many Ethical Committees or pregnant women. In 
comparison, the use of ST wavefonn analysis in labour has a 
sound physiological basis and the neonatal outcome and cord 
blood gas results in this study demonstrate that the concept 
offers more than non-discriminatory advice to reduce 
intervention. 
Figure 3.9 An example of an additional variable which could reduce operative 
intervention? 
Further, clinical use of the ST waveform in other centres has been associated with 
decreased intervention. For example, Haugesund Hospital in Norway has 1450 deliveries 
per annum and uses CTG analysis without fetal blood sampling. The introduction of one 
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ST ANalyser in 1990 used in high risk labours was associated with a fall in operative 
delivery rates without an increase in perinatal mortality (Eriksen et al, 1992). 
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Figure 3.10 Operative delivery rates(%) at Haugesund Hospital, Norway before and after 
STAN introduction. Modified from Eriksen et al, 1992. 
Neonatal outcome. Although the differences in operative intervention in this trial were 
statistically significant by the interim analysis of 1200 cases, the trial was continued to 
2400 cases to investigate the effect on neonatal outcome. There were trends to less 
metabolic acidosis {13 CTG versus 5 ST+CTG, p=0.09 OR 2.63 [0.93-7.39]) and fewer 
low five minute Apgar scores {32 CTG versus 24 ST+CTG, p=0.12 OR 1.62 [0.92-2.85]). 
These are likely to be related and support the contention that the use of ST waveform to 
delay intervention had no adverse effect on immediate neonatal outcome and, further, 
suggest an improved outcome is possible. Given the numbers in this trial it was unlikely 
that significant differences in outcome would be found, but it is highly unlikely that these 
trends would be completely reversed with increased numbers. Further data from meta-
analysis of other trials is required. 
Patterns of ST waveform and CTG change. 
Several interesting patterns of ST waveform and CTG change were observed in the study. 
1. Persistent, stable ST elevation with a reactive erG. (Figure 3 .11) 
This was seen in 4% of cases and was associated with a significantly higher mean arterial 
pH at delivery. This probably reflects sympathoadrenal stimulation from the general arousal 
of labour (Lagercrantz & Slot kin, 1986) or response to mild but compensated hypoxaemia 
and is in keeping with the animal data (Hokegard et al, 1979) and the increased heart rate 
variability seen in these fetuses. 
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Figure 3.11 An example of a case with a persistent, stable ST waveform elevation and a 
reactive CTG pattern. 
2. Rapid rise in ST waveform and a progressively abnormal CTG. (Figure 3 .12) 
Most of these cases occurred at the end of the second stage with an acute rise in T/QRS 
ratio over I 0 to 20 minutes. The mean artery pH and BD for this group were lower than all 
other groups so this combination of ST and CTG change identified a group of fetuses who 
were developing a metabolic acidosis. These findings are consistent with the experimental 
data which showed that ST elevation was directly related to myocardial glycogenolysis . 
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Figure 3.12 An example of a case with a rapid rise in ST waveform accompanied by a 
progressive deterioration in CTG. 
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Anaerobic metabolism is an important part of the fetal response to reduced oxygen supply. 
A cord artery metabolic acidosis identifies fetuses who have experienced significant 
hypoxia and who are, therefore, at risk of neonatal sequelae (Low, 1988). This group most 
clearly demonstrated the potential for ST waveform change to discriminate CTG changes. 
3. Negative ST waveform and an abnormal CTG. (Figure 3.13) 
These fetuses probably had an ineffective response to hypoxia. Two of the three birth 
asphyxia cases in this study had negative ST waveforms and all 3 cases of negative 
waveforms reported in other studies to date (Rosen & Lindecrantz, 1989, Rosen et al, 
1992 and Murphy et al, 1992) were also asphyxiated with one death. Two were growth 
retarded and one was postmature. This is in keeping with the animal studies in which ST 
depression with and without negative T waves was observed in runted guinea pig fetuses 
during hypoxia (Widmark et al, 1991, Figure 1.11 in the introductory chapter). As a result 
of their reduced myocardial glycogen stores and a blunted sympathoadrenal response, these 
fetuses were unable to compensate adequately during periods of hypoxia and suffered the 
effects of direct hypoxia in the deeper myocardial layers. The accompanying change in cell 
membrane potentials produced a negative ST waveform pattern as illustrated in Figure 
1.12 of the introductory chapter. 
4097K 
Figure 3.13 An example of a case with negative ST waveform change accompanying an 
abnormal CTG (Case 106 in Table 3.8, page 75). 
Why do some fetuses display a biphasic waveform (ST segment depression with a positive 
T wave) and others both a negative ST segment and T wave? In order to investigate this 
further, the ST waveform changes observed in adults during an exercise ECG were 
reviewed. There are differences in myocardial metabolism between the fetus in labour and 
an adult (Su and Friedman, 1973) and global myocardial hypoxia is more likely in the fetus 
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whilst in adults hypoxia is usually localised to an ischaemia area. The acute hypoxic stress 
in the fetus is intermittent (related to contractions) not persistent. Despite these differences 
very similar patterns of ST waveform change were observed in the adult and the fetus. The 
significance of tall peaked T waves (indicative of coronary insufficiency) and ST segment 
depression (evidence of direct myocardial ischaemia) (Schamroth, 1984) was consistent 
with the model of interpretation of fetal ST waveform elevation and depression. In the 
adult the development of a negative ST waveform during the exercise ECG was preceded 
by progressive ST segment depression and T wave flattening until eventually T wave 
inversion occurred. The reverse was seen during the recovery period (Figure 3.14). In 
cases with a normal ECG prior to exercise, negative T waves are not seen without 
preceding biphasic changes (D. Morris, Senior Cardiology Technician, Plymouth General 
Hospital, personal communication). A similar progression from a positive to a biphasic and 
then a negative waveform was observed in a fetus during the trial (Figure 3 .15). 
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Figure 3.14 Exercise ECG changes in an adult male in lead ill. Note how changes 
progress from a positive ST waveform to a biphasic pattern and finally a negative T wave 
at 6 minutes and then gradually reverse. The numbers printed by each complex are a 
measure of ST segment depression. 
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Figure 3.15 An example of a progression from a positive ST to a biphasic and then a 
negative waveform. 
Intermittent negative changes which were related to contractions were more likely to be 
biphasic than negative and frequently just involved a flattening of the ST segment (Figure 
3 .16). A recent follow-up study found that adult men with an isoelectric, flat ST segment 
had higher mortality rates than those with the optimal upward sloping ST segment 
(Schouten et al, 1992). 
Figure 3.16 An example of intermittent biphasic ST waveform changes with ST segment 
flattening. Note how the T/QRS ratio plot becomes negative with the 3rd and 4th 
contractions. 
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In four cases the ST waveform became negative without any obvious transition through a 
biphasic waveform (Figure 3 .13). All of these had flat T waves at the onset of recording. 
This may be a significant observation but more numbers are needed to ensure this was not 
a chance finding. It is possible that a rapid progression of changes from biphasic to 
negative may have occurred but may not have been documented due to the 2Yl minute 
interval between printed ECG complexes. 
On the basis of these observations, it would seem that ST depression with negative T 
waves is indicative of a more severe degree of oxygen deficiency than biphasic changes. 
The difference in ST waveform appearance may reflect the fact that the ECG is an average 
of potentials across the whole myocardium. A biphasic waveform may indicate that some 
areas are still able to produce energy by anaerobic metabolism whilst a negative T wave 
may indicate that the majority of the myocardium is hypoxic. 
The occurrence of biphasic ST waveform changes highlights the need to examine the 
whole waveform and not just the T/QRS ratio. Important ST segment depression may be 
missed unless this is done. Clearly the T/QRS ratio is only one aspect of ST waveform 
assessment, although it has the merit of being more easily quantifiable. ST waveform area 
combined with the number of times the waveform crosses the isoelectric line may provide 
additional information (Greene, 1983). This highlights the necessity for an automated 
analysis of ECG waveform shape (N. Outram, PhD project, University of Plymouth). 
Previous observational studies. 
A number of small observational studies had been performed prior to this trial. They served 
two purposes~ firstly to develop and refine the technology required for ST waveform 
analysis (Greene, 1983, Lilja et al, 1985, Lilja et al, 1988, 1989) and secondly, to test and 
further develop the model of interpretation for ST waveform change in the human fetus 
(Arulkumaran et al, 1990, Rosen et al, 1992). None of these studies included many cases 
with poor outcome. Arulkumaran et al (1990) had 3 cases of clinical birth asphyxia (Apgar 
<4 at 1 minute and <7 at 5 minutes) in 201 entries. Newbold et al (1991), using the 
Southampton system, found no relationship between T/QRS ratio and CTG pattern or cord 
artery pH in 105 fetuses. But their study did not include any cases with significant acidosis 
and no case with metabolic acidosis. The mean cord artery pH of their CTG abnormal 
group was the same as that of their overall population (7.24). The fact that no ST 
waveform changes were noted in this study is a positive finding (Westgate & Greene, 
1991) and not a negative one as the authors have suggested. Many studies have attempted 
to correlate T /QRS ratio and cord artery pH over the normal range for both which is 
clearly inappropriate and does not test the model of interpretation. Several workers have 
not reported any cases with negative or biphasic waveforms, possibly because they did not 
have any or, possibly, because they confined analysis to the T/QRS ratio only and therefore 
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did not notice any biphasic changes (Newbold et al, 1991, MacLachlan et al, 1992). The 
randomised trial was the first study in which a group of fetuses with persistent elevation of 
the ST waveform have been described. The fact that this change is associated with an 
excellent outcome may explain the lack of correlation between T/QRS ratio and outcome 
measures found in other studies (Murphy et al, 1992, MacLachlan et al, 1992). 
Randomised trial methodology. 
Randomised trials have become widely accepted as the best method with which to compare 
alternative forms of care (Chalmers, 1991). Random allocation of patients between 
different treatments is used in order to balance both known prognostic factors and 
unrecognised and unmeasurable factors which may affect trial results (Health Care 
Advisory Group, 1992). Important methodological aspects of this trial will be discussed. 
The randomisation process produced comparable groups for analysis. There were 
significantly more inductions in the ST+CTG arm at the 5% level and the number of 
postdates pregnancies and patients with epidural analgesia also approached significance. 
These variables are likely to be related. One could expect a few significant results purely by 
chance as a result of the large number of variables compared but this does not invalidate 
the comparability of the groups (Chalmers, 1991). These differences are more likely to 
have disadvantaged the ST+CTG arm as they are factors associated with increased 
intervention and poorer outcome. The use of sealed envelopes is not the ideal method for 
randomisation as it allows opened envelopes to be switched between patients entered into 
the trial at the same time. A more sophisticated randomisation process using computers or 
the telephone might have been preferable but would have been more costly and would have 
involved more work for clinical staff which would undoubtedly have prejudiced 
recruitment. 
Observer bias. In a trial of this nature it was impossible to blind staff, patients, or the 
observers to the method of monitoring used so it is impossible to exclude any effect related 
to enthusiasm for the new technology. However it is also possible that an opposite effect 
may have occurred; if some staff found the new technology 'threatening', it is less likely 
that they would have followed the trial protocol. The observers were neither providers nor 
recipients of care and the outcome measures were objective 'hard data' - e.g. fetal blood 
sampling, operative deliveries, cord gas data, Apgar scores. This reduced the likelihood of 
observer bias. 
The analysis of trial results has been by intention to treat, irrespective of whether the 
treatment was received or not. This is recommended as the only way that selection bias can 
be excluded (Chalmers, 1991). However, this policy may minimise or obscure differences 
between trial arms if the study is small or the number of cases not receiving the allocated 
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care is large. In the present study less than 3% of cases fell into this category and a 
secondary analysis which excluded those who did not receive the allocated treatment 
confinned the primary results. In the Dublin randomised study of CTG and intermittent 
auscultation, 20% of those allocated to the CTG arm did not receive the allocated 
treatment yet a secondary analysis was not reported (MacDonald et al, 1985). 
The number and nature of the analyses performed in this trial were pre-specified, as was 
the decision to analyse and publish the first 1200 entries. An interim analysis was chosen 
firstly because an effect on operative intervention for fetal distress should have been 
apparent by 1200 entries and, secondly, to ensure there was no obvious adverse effect on 
neonatal outcome. It could be argued that the interim analysis should have been made by 
an independent group, but as the analysis was performed by dedicated research personnel 
who were not involved in day to day labour ward management this was probably 
unnecessary. The results were not made available to clinical staff before the end of the 
study and publication post-dated completion of the study. 
Protocol criticisms. There were two aspects of the trial protocol itself which could be 
criticised. The first is related to the inclusion of immature fetuses (34 to 36 weeks 
gestation). As little is known about ST waveform changes in these fetuses, trial entry 
should probably have been restricted to 36 weeks gestation or more. There is a progressive 
increase in sympathetic innervation of the tissues during development (Phillipe, 1984, 
Slotkin & Seidler, 1988). The cardiovascular and biophysical responses ofthe preterm fetal 
lamb to induced hypoxaemia are much less pronounced than in the more mature fetus 
(Matsuda et al, 1992). Thus, a different and perhaps less marked ST waveform change may 
occur in the immature fetus during labour. This has been noted experimentally; an 
equivalent degree of hypoxia was accompanied by less of a rise in plasma catecholamines 
and T/QRS ratio in the immature fetal lamb compared to the mature fetus (Widmark et al, 
1989). 
There were 26 cases less than 36 weeks gestation in the ST+CTG arm; two showed ST 
changes. One at 34 weeks gestation had persistently negative T waves (T/QRS -{).06 to 
-{).08) with a reactive CTG throughout labour. The neonate was delivered normally and 
was in good condition (cord artery pH 7.38, BDecf2 mmol/1, Apgars 8 at one minute and 
9 at five minutes). The other case was also at 34 weeks gestation and had intermittent 
negative T waves and an abnormal CTG which resulted in a forceps delivery (cord artery 
pH 7.15, BDecf6 mmol/1, Apgars 9 at one, 9 at five minutes). One other immature fetus in 
the ST+CTG arm had a FBS at full dilatation five minutes after a prolonged deceleration to 
90 bpm for 15 minutes. The ST waveform had remained normal (T/QRS ratio 0.10) The 
FBS pH was 7.18, BDecf8 mmol/1 and a liftout forceps delivery was done 30 minutes later 
(cord artery pH 7.23, BDecf 5 mmol/1 , Apgars 9 at one, and 9 at five minutes). All other 
preterm fetuses in the ST+CTG arm and the 26 preterm fetuses in the CTG arm had 
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normal outcomes. As this randomised trial did not include any acidotic preterm fetuses, no 
comment can be made on the pattern of ST waveform change nor on the suitability of ST 
waveform analysis in this group. 
The second criticism of the trial protocol relates to the classification of a recording with 
reduced variability and no accelerations in the absence of sedation for 30 minutes as 
abnormal. This did not allow for physiological sleep states in which variability can be less 
than five beats per minute and may last for more than 45 minutes in up to 5% of recordings 
(Spencer & Johnson, 1986). The recommended action was the same for both arms of the 
trial and therefore did not bias the retrospective review. However, for the purpose of 
future studies the duration of reduced variability required to classify an abnormal recording 
should be extended to 45 minutes. 
Education and training. If new technology is to be compared with existing technology it 
is important that staff are familiar with the use of new equipment and the interpretation of 
results before the comparison occurs. Preparation for this trial took place over a nine 
month period and included written material, lectures and discussion sessions. Staff were 
introduced to the ST+CTG recorder during the study of fetal scalp electrodes. Finally, a 
pilot study was run for a month before the trial proper commenced to familiarise staff with 
the study procedures and to identify any aspects of the protocol which needed clarification. 
No randomised trial of electronic fetal heart rate monitoring performed to date has 
published details of any staff training and preparation for the trial. Given the increase in 
education and training provided during this trial, interpretation of the CTG alone should 
have improved. This makes the differences in intervention rates more surprising. It seems 
that the addition of ST waveform analysis to the CTG improved clinical interpretation of 
CTG traces, probably by reassuring staff that traces were normal, as has already been 
discussed. 
The Hawthome efTecL The performance of a randomised trial may modify staffbehaviour 
and the quality of care given (the Hawthome effect). This effect has already been 
demonstrated in the review of the perinatal and intrapartum stillbirth rates from the Dublin 
randomised trial (Chapter 1, Figure 1.1). The effects of the Plymouth trial on overall unit 
figures were not obvious as only one third of total deliveries were recruited to the study 
and ST+CTG analysis was used in only half of these. Plymouth operative intervention rates 
from 1987 to 1992 are shown in Figure 3.17. It is remarkable that the reduction in LSCS 
for 'fetal distress' in the ST +CTG arm occurred despite the background of a steadily rising 
emergency LSCS rate. The increase in LSCS has been accompanied by an decrease in the 
operative vaginal delivery rate; obstetricians seem less likely to attempt vaginal operative 
deliveries in favour of LSCS. This is probably related to the increasing pressure of 
litigation. 
Chapter Three, page 97 
I ~operative --El-Emergency _,._ Elec:tlve . vaginal LSCS LSCS 
% 
12 
10 
2 
0~----~----~------+-----~----~ 
1887 1888 1888 1890 1881 1982 
Figure 3.17 Operative delivery rates at Plymouth General Hospital. The randomised trial 
ran from mid 1990 to the end of 1991. 
Revised guidelines for clinical action. 
As a result of the observations of ST and CTG change made during this trial, 
recommendations for clinical action have been revised (Table 3 .14). These guidelines apply 
to the mature fetus c~ 36 weeks gestation). 
Table 3.14 ST + CTG clinical guidelines. 
STwaveform 
CTG Normal Hieh & stable 
Normal No Action No action 
Intermediate No action Wait 1 hour 
FBS or deliver4 
Abnormal Wait 1 hour Deliver 
FBS or deliver4 
1 Negative -less than -0.05 for more than 20 minutes. 
Rising - rises more than 0. 40 over 15 minutes 
2 Negative -less than -0.05 for more than 20 minutes. 
Rising - rises more than 0.15 from the baseline over 15 minutes. 
3 Any negative or positive change over 5-10 minutes. 
Neeative or risine 
FBS or deliver! 
Deliver2 
Deliver3 
4 Repeat FBS every hour or earlier if CTG deteriorates. If CTG remains unchanged but ST shows 
acute change, delivery should be expedited. In second stage delivery should occur after 90 
minutes as rapid deterioration can occur after this time. 
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In these revised guidelines the shape of the wavefonn, rather than just the T/QRS ratio, is 
emphasised. For any given healthy fetus the ST waveform (and hence the T/QRS ratio) 
tends to remain stable throughout labour. The impression gained during the retrospective 
review of recordings was that a progressive rise above the normal level for each fetus was 
important, irrespective of whether that rise took the T/QRS ratio above 0.25. The T/QRS 
ratio does have the merit of being quantifiable but assesses mainly T wave height and not 
ST segment changes. These will only be identified if the whole waveform is examined. 
Similarly, signal quality can only be assessed by checking waveform shape. 
Contraction related waveform changes are important but cannot easily be incorporated into 
a simplified scheme such as the one shown here. In addition, the ECG complexes are only 
printed out every 2\-S minutes so it is impossible to examine waveform shape after every 
contraction. However, the changes seen in this study and those found experimentally by 
Greene {1987) and Watanabe et al (1992) suggest that contraction related changes may 
identitY a fetus at risk of decompensation before changes in the baseline ST waveform 
occur. Ideally, some way of presenting this information to the clinician should be found. 
Future development of the ST AN recorder. 
Although the ST AN monitor is satisfactory for clinical use, it is clear that improvements 
can be made. There were significantly more exclusions from the retrospective review 
because of poor signal quality in the ST+CTG arm than in the CTG arm (29 [2.3%] versus 
6 (O.S%], p<0.001, OR 4.9 [2.03-11.87]). Considering the problems associated with 
FECG analysis, a 2.3% failure rate is, in fact, quite encouraging. It is likely that there will 
always be occasions in many labours when FECG quality is inadequate for waveform 
analysis. However, it is of some concern that the quality of STAN FHR recordings in the 
second stage and contraction recordings in both stages were not as good as the Hewlett-
Packard CTG recorder. These signals do not depend on ECG waveform analysis and 
improvements should be possible. 
The technological development of the ST AN monitor now lags behind sound clinical 
evidence of its usefulness. There is a responsibility to correct this but, as yet, no 
commercial company has been willing to further the concept of ST waveform analysis and 
make the necessary improvements to the recorder. This is despite the fact that the concept 
has been developed in a logical sequence and best fulfils the requirements for a method of 
intrapartum fetal surveillance. This randomised trial has demonstrated the ability of ST 
waveform plus CTG analysis to reduce operative intervention rates. It must surely be in the 
best interests of both obstetrician/midwife and patient that the technology is developed 
further so it eventually may become available in clinical practice. The problem is, of course, 
both political and financial. There is little incentive for companies who already have a large 
share of the fetal monitoring market to spend further large sums of money developing a 
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similar product, though it may be a better one, which will give them no further financial 
gain. Given the potential reduction in operative delivery costs associated with the use of 
ST AN in this study, the Department of Health could consider developing the technology 
further itself. Although thorough evaluation of new health care technology is necessary, it 
is ironic that the expense and politics involved may prevent or significantly delay the 
introduction of technology which is proven to be of better health gain than that currently 
used. 
Summary. 
The results of this randomised trial have confirmed the ability of ST waveform change to 
discriminate CTG change during labour. The model of interpretation used is safe and 
depends on the use of both variables (CTG and ST waveform), and also upon adequate 
education and training of staff. Further randomised trials in other units are required to 
confirm these findings and to provide further data to assess the possible effect on improved 
neonatal outcome. 
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Introduction. 
Effective use of the CTG for intrapartum monitoring depends upon appropriate selection of 
cases and the ability of midwives and obstetricians to interpret FHR patterns and take 
appropriate action once changes occur. A selective policy of CTG monitoring in high risk 
cases is usually advised (FIGO, 1987), but nearly half ofUK obstetricians aim to monitor all 
patients continuously (Whebble et at, 1989) despite evidence that it is not beneficial in low 
risk patients (Grant, 1991). There is increasing evidence that staff find interpretation of 
CTG recordings a difficult task; misinterpretation is implicated in a large proportion of birth 
asphyxia cases (Murphy et at, 1990) and is the cause of a substantial proportion of litigation 
for birth related events (Ennis & Vincent, 1990, Chamberlain & Orr, 1990). 
The use ofFBS to discriminate CTG changes has been widely advocated in order to prevent 
unnecessary operative intervention (Sating & Schneider 1967, Beard et at, 1967, Zalar & 
Quilligan, 1979, Haverkamp et at, 1979, Sykes et at, 1983, MacDonald et at, 1985). Despite 
these recommendations less than half of UK units have facilities for its use (Whebble et at, 
1989) and where it is used, FBS rates vary from 1% to 22% (Ciark & Paul, 1985, van den 
Berg et al, 1987). There is surprisingly little information in the literature on when, and how 
effectively, FBS is used in clinical practice. 
The randomised trial ofCTG versus ST+CTG reported in the previous chapter provided an 
opportunity to investigate when and how well CTG plus FBS monitoring was used in 
clinical practice in Plymouth when regular education sessions were available. Three specific 
areas were addressed and will be reported here; firstly, the use of FBS in trial entries, 
secondly, selection of cases for operative delivery for 'fetal distress' and thirdly, the 
distribution of monitoring methods and their relation to outcome. 
Methods. 
The trial methodology was reported in the previous chapter. Additional information on the 
distribution of monitoring methods and neonatal outcome in babies not entered into the trial 
was obtained from review of the Birth Register and SCBU Admissions Book. 
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Results. 
Fetal blood sampling. 
Several aspects of FBS were studied in the retrospective review of CTG and ST+CTG 
recordings. 
Selection of cases for FBS. Cases where FBS was indicated in the first stage of labour 
according to the retrospective review were compared with those who actually had FBS 
during the trial. The results are shown in Table 4.1 . If multiple FBS procedures had been 
performed on the same patient, FBS was considered as appropriate as long as one of the 
samples taken was recommended on the retrospective review. 
Table 4.1 Retrospective review of fetal blood sampling in the first stage of labour. 
CTG ST+CTG 
n=1208 n=l176 
No. of cases where FBS done 114 (9.4%) 90 (7.7%) 
Based on the retrospective review 
FBS was; 
- indicated & done 70 55 
- not indicated but done 44 35 
- indicated but not done 35 21 
Total cases where FBS was 
indicated 105 (8 .7%) 76 (6.5%) 
39% of the FBS cases in each arm were performed unnecessarily, whilst 33% (CTG arm) 
and 23% (ST+CTG arm) of those who should have had an FBS did not have this done. This 
latter group included 3 of the 7 cases of birth asphyxia (1 CTG, 2 ST+CTG) and 6 of the 
total48 cases with a cord artery pH <7.05 (CTG 4, ST+CTG 2). 
pH at FBS and FBS response times. In order to check the accuracy of the retrospective 
review, scalp pH at the first FBS and the indication for FBS as assessed in the retrospective 
review were examined (Figure 4.1). The response times from onset of CTG change to FBS 
are shown in Figure 4.2. 
The two arms of the trial have been combined as there were only 3 cases when ST 
waveform change contributed to the indication for FBS (1 intermediate CTG with a 
negative waveform; pH 7.28, 2 abnormal CTGs with a raised T/QRS ratio pH 7.29 and 
7.33). One case with a clearly erroneous pH of 7.82 ('severely abnormal' group) was 
excluded from Figure 4. 1 and the calculations for mean pH as the value obtained was not in 
the physiological range. No repeat sample was taken. The 'not indicated' group included 
many with minor changes (e.g. early decelerations) which did not require FBS. The 
Chapter Four, page 103 
'severely abnormal' group had a combination of abnormalities (e.g. tachycardia, reduced 
variability and late decelerations). In the 'abnormal <30 mins' group the abnormal CTG 
persisted for <30 minutes and hence did not fulfil the criteria for FBS. 
7.6 ~----·-·------------------·--------------------------
pH 
7.5+-----·----·~-----·--------------·---·-·-·-·-----·-·------·-·------------
•• 
Figure 4.1 pH at the first FBS according to the indication determined by the retrospective 
revtew. 
l These two values were not used for calculation of mean pH as they were not in the physiological 
range. 
2 Mean pH is less than 'not indicated', 'intermediate' and 'abnormal <30 rnins' groups (p<O.OOl). 
3 Mean pH is less than all other groups (p<O.OOl). 
Significance testing by One Way Analysis of Variance. 
Time (minutes) _ mean 
250 0 
200+-----·---------·----·--------------------------·--·-----·--------
Figure 4.2 Response time from onset ofCTG change to first FBS. 
l Mean time is significantly longer than the 'abnormal' group (p<0.05). 
2 Mean time is significantly shorter than all other groups (p<O.OOl). 
Significance testing by One Way Analysis of Variance. 
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It is encouraging for the reviewer to note that none of the cases where the FBS was 'not 
indicated' had a pH <7.25. This indicates the review was accurate. Although the mean pH 
fell as CTG changes progressed from normal to abnormal and then to severely abnormal, 
the majority of cases still had a pH in the normal range. The mean pH of cases with a CTG 
abnormality which had been present for <30 minutes was significantly higher than those in 
which an abnormality had been present for a longer period of time. This is consistent with 
the finding that a fetus may maintain a normal pH for some time in the presence of late 
decelerations (Beard et al, 1971, Fleischer et al, 1982) as a consequence of the fetal 
compensatory mechanisms discussed in the introductory chapter. 
The range of response times is very similar for all categories, and it is of particular interest 
that a severely abnormal CTG did not prompt earlier intervention than occurred in the other 
groups. Similar findings have been reported in a review of the management of birth asphyxia 
cases (Murphy et al, 1990). 
Interpretation of results and subsequent management. An understanding of acid-base 
balance and the normal range of results for blood gas values is necessary to interpret FBS 
results accurately. Three cases in which non-physiological values for pH were accepted as 
valid readings have already been presented. Full acid-base status needs to be assessed if a 
transient respiratory acidosis is to be distinguished from a more significant metabolic 
acidosis (Sating & Schneider, 1967, Ingemarsson & Arulkumaran, 1986), yet 22% of the 
FBS samples taken in this study had an unreliable pC02 result. Half of these cases were due 
to an inadequate size blood sample and in the rest the pC02 readings were suspiciously low 
for the pH value obtained. There are two possible reasons for this~ a combination of 
operator and machine error (this will be discussed in the following chapter), or C02 may 
have diffused out of scalp blood exposed to air during sample collection. In one case an 
erroneous pC02 reading (16 mm Hg) resulted in a similarly erroneous BDecf calculation 
(17 mmol/l) despite a pH of 7.27. This high BDecf result was given as one of two 
indications for LSCS (the other was slow progress - at 4cm dilatation). In 3 cases a mild 
respiratory acidemia (caused by a transient bradycardia related to a known precipitating 
event) led to a rotational forceps delivery for 'fetal distress' -the umbilical cord gases were 
normal in each case. 
Sixteen cases (8% of the total, 6 CTG, 10 ST+CTG) had a low cord pH at delivery (artery 
<7.10 or vein <7.15) despite having a FBS performed at some stage during labour. Two of 
these were asphyxiated at birth. Contributing factors in these 16 cases were~ delay in 
performing the initial FBS (n=2), delay between abnormal FBS and delivery (n=4), failure to 
repeat FBS despite deterioration in trace (n=3), failure to record FHR adequately in second 
stage despite previous abnormal trace (n=2), prolonged bradycardia during rotational 
forceps delivery (n=l), and rapid deterioration in pH between FBS and delivery (n=4). 
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Operative delivery for 'fetal distress'. 
The proportion of 'fetal distress' deliveries in the CTG normal, intermediate and abnormal 
classifications has been given in tabular form (Chapter Three, Table 3.9) and is shown 
graphically below. 
p=0.16 
&OT-·--·~==~,_-----··--·---·--~·•·~·-·-------
40 
30+-·-·------------------~------
% 
20 +----·-- -·------
10 +---=-=------· 
o~-----
normal lntennedlate abnormal 
Retrospective CTG classification 
Figure 4.3 Percentage of CTG normal, intermediate and abnormal recordings in which an 
operative delivery for 'fetal distress' was performed. 
43% of 'fetal distress' operative deliveries in the CTG arm were considered unnecessary 
compared to 5% in the ST+CTG arm. Further analysis revealed that 14 (18%) of abnormal 
traces in the CTG arm and eight (9.5%) of those in the ST+CTG arm should have had 
operative intervention or FBS for 'fetal distress' but did not (p=. 19, OR 2.0 [0.74-5.74]). 
Although this group only totalled 1% and 0.6% of the total cases reviewed in each arm 
respectively, amongst their number were two cases of birth asphyxia from the CTG ann and 
one from the ST+CTG arm. 
Only 43% (CTG) and 53% (ST+CTG) of the LSCS for 'fetal distress' were preceded by an 
FBS. Their details are shown below (Table 4.2). 
Table 4.2 Details of cases who had an LSCS for 'fetal distress' without an FBS. 
Relevant clinical details. CTG ST+CTG 
n=17 n=7 
Abnormal trace in early labour, 3 0 
FBS impossible 
Intrapartum abruption 2 1 
Cord prolapse 1 0 
Prolonged bradycardia, 4 1 
no recovery 
Temporary bradycardia, 4 1 
overhasty intervention 
Abnormal trace with one normal FBS- 1 2 
later repeat FBS attempted but failed 
No obvious reason why FBS not done 2 1 
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Many of these cases were explained by the clinical circumstances but some were clearly not. 
This occurred despite the trial protocol recommendations and the fact that FBS was a weU 
established technique in the hospital long before the trial began. 
Selection of cases for CTG monitoring. 
The hospital has a policy of selective continuous CTG monitoring with an FSE in high risk 
cases. During the time of the randomised trial6798 women of at least 34 weeks gestation 
went into labour and were monitored as shown in Figure 4.4. 
6798 pregnancies of at least 
34 weeks gestation In labour 
during the trial period. 
I 
Intermittent Continuous Continuous CTG 
Auscultation Elclemal CTG via FSE 
28'!6 33'!6 39'!6 
Entered Into Less then 30 
Random !sed minutes of first 
Trial stage available 
36'!6 3'!6 
Figure 4.4 Proportion of labours monitored by different techniques during the 
randomised trial. 
Birth asphyxia review. 
The seven cases of birth asphyxia which occurred in randomised trial entries were detailed 
in Table 3.8 in the previous chapter. Asphyxia occurred in a further nine labours of at least 
34 weeks gestation who were not entered into the trial. Details of these cases is given in 
Appendix Four. The distribution of birth asphyxia according to the method of intrapartum 
monitoring is shown in Table4.-3. 
Obvious FHR changes (on intermittent auscultation or CTG) occurred in aU but three cases; 
in two the FHR was not monitored at all for a period in the second stage and in the other 
(classified as intermediate on retrospective review) there was reduced variability in the first 
stage. It should be stressed, however, that in the remaining 13 cases the FHR changes were 
so astoundingly obvious that it is of some concern that they apparently went unnoticed or 
did not prompt earlier action. It was adjudged that appropriately timed action occurred in 
only one of these 13 cases, appropriate but significantly delayed action in six cases and no 
action at all in the remaining six. 
Chapter Four, page 107 
Table 4.3 Distribution of birth asphyxia cases according to the method of intrapartum 
monitoring. 
Birth asphyxia Intermittent Continuous Continuous CTG 
auscultation external CTG withFSE 
% of oooulation 28% 33% 39% 
Severity; 
mild 2 1 3 
moderate 2 0 2 
severe (died) 0 4 2 
Total 4 5 7 
The timing of the major FHR abnormalities detected on the retrospective review are shown 
in Table 4.4. 
Table 4.4 Timing ofFHR abnormalities in asphyxia cases. 
Time of FHR abnormality Number of cases Outcome 
and relevant events (total =16) 
Antenatal (includes 1 antenatal 4 -3 died, 1 spastic hemiplegia 
abruotion) 
First stage; 
cord prolapse I -fitted, nonnal follow-up 
abruption 1 -spastic quadriplegia 
no obvious precipitating event 2 -hypoglycaemia, then nonnal 
Second stage 
possible vasa praevia 1 -died 
nuchal cord s -1 died, 2 spastic quadriplegia, 
1 fitted then nonnal, 2 
hypoglycaemia then nonnal. 
no obvious relevant finding 2 -hypoglycaemia then nonnal 
The likely asphyxial insult occurred in the second stage in 50% of cases. Most of these 
babies had birth weights in excess of 3200g, compared to the low birth weights of those 
damaged in the antenatal period (birth weights 1993g and 3100g [36 weeks] and 2300g and 
2880g [40 weeks]) and 3 of the 4 first stage cases (all around 2600g at term). The cord 
prolapse baby weighed 3850g. 
The definition of 'birth asphyxia' used in the randornised trial did not require evidence of 
significant intrapartum hypoxia but clearly should have done as asphyxial damage occurred 
prior to the onset of labour in 25% of cases. It can be difficult to separate antepartum from 
intrapartum events, but where the distinction can be made readily (as in the 4 cases here), it 
should be. 
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Discussion. 
The previous published randomised trials of CTG and intermittent auscultation (referenced 
in Chapter One) only assessed the effects of CTG monitoring as it was used in clinical 
practice in each unit. Only one group attempted to document the accuracy of interpretation 
and management (MacDonald et al, 1985), but this was only done in a random survey of 
1 0% of trial entries. In the trial reported in this thesis the quality of data interpretation and 
management was reviewed in every case. Even so the review may not reflect everyday 
clinical practice as it is likely that the performance of the trial altered the way midwives and 
clinicians reacted to CTG changes. In addition, management protocols and twice weekly 
CTG teaching sessions were available where there had been none before, which should also 
have improved the use of the CTG. 
It is also acknowledged that a retrospective review of this nature could not mimic the 
clinical situation; it was largely performed during daylight hours in a relatively stress free 
environment. Many factors which influence clinical decision making were unknown. For 
example, details specific to each patient, e.g. fetal growth retardation, maternal blood 
pressure, the effectiveness of maternal analgesia, how busy the unit as a whole was and 
what emergencies and other cases staff had to deal with at the time. As a result the review 
has not been a definitive audit of care but, nevertheless, has highlighted some important 
points about clinical practice in a large district general hospital which are likely to be 
representative of clinical practice in the UK. 
Fetal blood sampling. 
This review has revealed significant problems with the selection of patients for FBS, the 
timing of the initial FBS and subsequent repeat samples and the interpretation of results. 
Many of the problems highlighted here were described by Sating in 1967 in his review of 
intermittent auscultation plus FBS (Sating & Schneider, 1967). Three main factors 
contribute to these difficulties; 
I. FBS is an intermittent variable which requires an extra invasive procedure. There are 
many practical problems associated with the technique, not least of which is the discomfort 
both clinician and mother can experience during the process. These problems undoubtedly 
contribute to its infrequent use in practice and highlight the need for simple additional 
variables which reflect fetal condition during labour. 
2. The decision to obtain an FBS is dependant upon interpretation of the CTG. FBS 
and the CTG are not independent variables. If the level of CTG interpretation is sub-
optimal, the value of FBS will be limited (as it was here). One possible solution to this 
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problem is to have very high FBS rates in the hope of ensuring that all acidotic fetuses are 
identified (van den Berg et al, 1987, Murphy et al, 1990). There is some evidence that 
higher rates of sampling are associated with higher mean cord arterial pH at delivery (Steer, 
1987) but there is no evidence that an increased sampling rate will result in a reduction in 
birth asphyxia. 
3. Correct use of the infonnation obtained at FBS requires an understanding of the 
events of labour and of the physiology of acid-base balance during labour. There is 
plenty of scope for misinterpretation of FBS data (as illustrated here). Of particular concern 
was the tendency for clinicians to be reassured by one normal FBS result and, despite 
continued CTG abnormalities, fail to repeat the FBS at a later stage. This was a contributing 
factor in one asphyxia case during the study (Case 1699) and has subsequently occurred in 
at least one other asphyxia case since completion of the study. Much has been made of the 
high false positive rate of CTG changes and the fact that FBS can reduce unnecessary 
intervention (Steer, 1987). However, this should not be misinterpreted to mean that the 
CTG does not contain useful information, for clearly it does. The retrospective review of 
randomised trial recordings showed that there was a significant decrease in cord arterial pH 
and a rise in BDecf as the CTG became more abnormal (Table 3.10, Chapter Three). FBS 
should not replace the CTG, but should be used as an additional variable. A normal FBS 
does not mean abnormal CTG findings can be totally ignored. Labour is a dynamic process 
in which both the severity and the duration of hypoxic stress will affect how well and for 
how long any given fetus will be able to compensate for hypoxia. In the cases mentioned 
above this important point was not recognised and, instead, undue weight was placed on a 
single pH value, taken at a single point in time, with disastrous consequences. An increase 
in FBS rates without an improvement in knowledge of how the information should be used 
may not be as successful as proponents of this approach hope. 
These findings have important implications for new technology; the use of extra, 
intermittent, time consuming, inconvenient and difficult techniques is unlikely to have a 
major impact, simply because they will not be used frequently enough in routine practice. 
ST waveform analysis has many advantages over FBS. It does not require extra invasive 
procedures and it provides continuous information. It is therefore more likely to influence 
decision making, as suggested by this study. However, the need for correct understanding 
and use of the available information is just as important for ST waveform analysis as it is for 
FBS. 
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Low risk/high risk classification. 
You are more likely to die on the first day of your life 
than on any other, except the last. 
An unattributed truism. 
The Plymouth policy of continuous internal CTG monitoring for high risk pregnancies is 
consistent with current recommendations (FIGO, 1987). However, the incidence of birth 
asphyxia in the supposedly low risk group monitored externally or by intennittent 
auscultation was 2.44/1000, not significantly lower than the 2.47/1000 in the high risk 
group monitored internally. It is likely that some cases in the low risk group were, in reality, 
high risk, but the opposite is also true. A large proportion of cases were only monitored 
internally because they requested epidural analgesia and had no other risk factors. 
The whole concept of deciding intmpartum risk, and therefore the method of monitoring, on 
the basis of antenatal events cannot be supported. As early as 1973 it was obvious that 
intrapartum events were far more significant in predicting outcome than antenatal risk 
factors (Hobel et al, 1973). In a summary of five risk assessment papers Wilson & Schifrin 
{1980) found that patients with low antenatal risk contributed 58% of perinatal mortality 
and morbidity cases compared to the 42% contributed by high risk groups. In Murphy's 
review ofbirth asphyxia 26 of64 cases {40%) were low risk and had not been monitored by 
CTG {Murphy et al, 1990). A case-controlled study of intrapartum stillbirths in Western 
Australia failed to identifY any antenatal risk factors which predicted these deaths 
(Alessandri et al, 1992). The only factors which are consistently associated with perinatal 
morbidity and mortality are low birthweight for gestational age and the presence of 
meconium liquor (Low et al, 1978). 
Continued use of this unsafe distinction has important implications for the application of 
monitoring techniques, particularly the introduction of new techniques. Limitation of these 
techniques to 'high' risk cases will mean that a significant proportion of cases with poor 
outcome will never have the possible benefit of any improvements afforded by new 
technology. 
The importance of the second stage of labour has also been highlighted by this review. 
Contraction frequency and strength increases in the second stage so that the time available 
for placental gas exchange is reduced and fetal hypoxaemia increases. This is also the time 
when fetal reserves may have been reduced by the events of the first stage. Obstruction of 
flow in a nuchal (or otherwise coiled) cord or in a very twisted cord (Collins & De Angelis, 
1993) is also most likely in the second stage. This is the time that healthy babies are most at 
risk during labour, and therefore is the time when intmpartum monitoring is most important. 
The value of any method of intrapartum monitoring which is not practicable for use in the 
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second stage may be limited. Loss of signal or failure to monitor in the second stage were 
contributing factors in many asphyxia cases monitored by intennittent auscultation and 
external CTG. The deteriomtion of ECG waveform signal quality recorded by the STAN 
monitor in the second stage is therefore also of some concern. 
CTG (mis)interpretation. 
Previous studies have shown that the combination of CTG plus FBS resulted in a reduction 
in opemtive intervention compared to CTG used alone (Haverkamp et al, 1979, MacDonald 
et al, 1985). However, in this study, even with this combination, a significant number of 
unnecessary operative deliveries still occurred. 
It is of more significance to note that the majority of birth asphyxia cases had what could be 
described as 'barn door' changes yet did not receive appropriate or timely management. 
Murphy et al (1990) found similar results in their review of birth asphyxia cases in Oxford. 
A recent audit of the labours of women ( >37 weeks gestation, birth weight >2500g) whose 
babies required admission to SCBU in Manchester found the most common factor 
associated with avoidable perinatal morbidity was CTG misinterpretation (Hamilton & 
Maresh, 1992). 
The most significant conclusion of this revtew is that the major problem with CTG 
monitoring is not that the CTG does not contain useful information, but that the available 
information is not interpreted correctly. Why is this? 
The key to this problem lies in the use of the terms 'monitor' and 'monitoring' which imply a 
degree of automatic surveillance. In fact this is not the case. The surveillance or 'monitoring' 
is performed by the clinician or midwife who interprets the output of the machines which 
merely record FHR and uterine contractions. 
In this country, most monitoring is performed by midwives, Senior House Officers and 
Registrars, usually in that order. It is salutary to note the level of training each receives. In 
Plymouth, in accordance with the national curriculum, midwives receive two hours teaching 
on CTG interpretation during their 18 months of training. One hour is provided by a 
midwife teacher who is unlikely to have worked on a labour ward for a number of years, 
and the other session is usually given by one of the registrars. Next in the line of command 
are the Senior House Officers (SHOs). In Plymouth they usually receive a 20 minute CTG 
session in the first week of their attachment but then are expected to receive guidance from 
midwives and Registrars. Registrars were once SHOs and their level of expertise varies 
enormously. This is in contrast to the Swedish situation, where consultants are always 
present on the labour ward during the day and frequently sleep in during the night (Lilja, 
personal communication). A comparison of Swedish and English perinatal mortality rates 
Chapter Four, page 112 
made by Albennan in 1980 is shown in Table 4.5. Whilst the mortality rates for birthweights 
<2500g are comparable, there is a clear excess of deaths in larger birthweight babies in 
England. 
Table 4.5 Perinatal deaths observed in England in 1978 compared with the expected deaths 
if Swedish birth weight-specific rates were applied (modified from Albennan, 1980). 
Birthweight Observed Expected 
<2500g 5984 5983.3 
>2500g 3223 1905.9 
It should be noted, in passing, that the neonatal paediatric medical staffing situation is very 
similar to obstetrics; i.e. the least experienced member of the team is the first called to an 
emergency. It is significant that Albennan's recommendations for improvement included the 
need for both on-site trained obstetric cover and on-site trained personnel skilled in neonatal 
resuscitation. 
The Royal College of Obstetricians have recently recommended that consultants should 
cover labour ward on a regular basis and should make regular visits to the Labour Ward 
when on call to enable them to make a more fonnal contribution to the management of 
patients and the training of junior staff (RCOG, 1991). However, they also note that "in 
many units current staffing will not allow this at present". If it is difficult to provide trained 
(as opposed to training) obstetric cover during working hours in most units, then the ideal 
of24 hour trained cover must be even further away. 
The medicolegal implications of these conclusions are significant. A considerable proportion 
of litigation cases may be entirely justified - over 60% of 112 active litigation cases 
reviewed by Symonds were indefensible (Symonds, 1993). As has recently been pointed out 
by a High Court Judge, obstetricians cannot complain about the amount of litigation they 
face when labour wards continue to be staffed with inexperienced and inadequately trained 
personnel (Kennedy, 1993). As well as advocating changes to the present adversariallegal 
system, obstetricians need to do more to rectifY contributory problems in their own 
discipline. 
The implications of this conclusion for new methods of intrapartum fetal assessment are 
also important. Possible solutions to this problem are discussed in Chapter Six. 
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Introduction. 
An assessment of acid-base status at birth can be made by analysis ofumbilical cord arterial 
and venous blood. The cord vein carries oxygenated blood to the fetus whilst the two 
smaller arteries carry blood from the fetus to the placenta. Cord arterial blood therefore 
normally reflects fetal acid-base balance while venous blood reflect a combination of 
maternal acid-base status and placental function. The important defence mechanisms which 
enable the fetus to compensate for periods of reduced oxygen supply were reviewed in the 
introductory chapter. If cardiovascular and behavioural adjustments fail to maintain oxygen 
delivery to central organs anaerobic metabolism of glycogen and glucose to lactic acid 
occurs in order to provide the energy to maintain cellular and organ function. The presence 
of a metabolic acidemia in cord arterial blood is therefore indicative that significant oxygen 
deficiency has occurred and should provide important information about the effects of 
labour on the fetus. Despite the relative ease with which this information may be obtained, 
there is much debate about the value of umbilical cord blood sampling. A summary of the 
benefits and problems follows. 
Benefits of cord acid-base assessment. 
1. It provides an objective measure of neonatal condition at delivery and enables a group 
of fetuses at risk of neonatal morbidity to be identified by the presence of a metabolic 
acidemia (Low, 1988, Sykes et al, 1982, 1983, Goldaber & Gilstrap, 1993). 
2. The percentage of cases born with a low pH or a metabolic acidemia can be used as 
an audit of the quality of intrapartum care (Eskes et al, 1983, Yudkin et al, 1987, 
Richards & Johnson, 1993). 
3. Knowledge of acid-base status at delivery encourages a physiological approach to 
CTG interpretation and is useful for training and education and in litigation cases 
(Thorp et al, 1989, Gregg & Weiner, 1993, Goldaber & Gilstrap, 1993). 
Problems with cord acid-base assessment. 
1. There is a lack of consensus as to what levels of pH and/or BD constitute acidemia 
and metabolic acidemia. 
2. There is a lack of correlation with measures of immediate neonatal outcome (Apgar 
scores, resuscitation, neonatal morbidity) in some studies (Dijxhoorn et al, 1985, 
Ruth & Raivio, 1988, Winkler et al, 1991) but not in others (Gilstrap et al, 1989, 
Low et al, 1988, 1990, Goldaber et al, 1991). 
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3. There is a lack of correlation with long-term neurological outcome (Low et al, 1983, 
Lauener et al, 1983, Dennis et al, 1989, Fee et al, 1990). 
The key question is what levels of pH and BD indicate that significant hypoxia has 
occurred? The levels of cord artery pH used to define acidemia in a selection of studies in 
the literature are summarised in Table 5.1. In view of the wide range, it is not surprising 
that the value of the procedure remains a topic for debate. 
Table S.l Levels of cord artery pH used to define acidemia in a survey of the literature. 
Level of cord arterial Justification References 
pH chosen to define 
acidemia 
<7.20 ? Suidan & Young, 1985, Winkler et al, 1985, 
Page et al, 1986 
<7.16 <2SD Ruth & Raivio, 1988 
below mean 
<7.15 ? Lauener et al, 1983, Vintzileos et al, 1992 
<7.12 <lSD Sykes et al, 1982, 1983 
below mean 
<7.10 ? Huisjes & Aarnoudse, 1979 
<2SD Silverman et al, 1985, Thorp et al, 1989 
below mean 
<7.05 relation to neonatal Goldaber et al, 1991 
morbiditv 
Although not stated, the pH value of 7.20 used in many studies probably comes from the 
work of Bretcher and Sating, (1967). They derived the 'normal' range of fetal scalp pH 
during labour from repeated FBS in 306 labours which resulted in the birth of healthy, 
vigorous babies. They described a pH of less than 7.20 as 'acidotic' as this value was less 
than two standard deviations below the mean. Two interesting aspects of their study 
should be noted. Firstly, all fetuses with an FBS pH of less than 7.20 were excluded from 
the study and secondly, a pH of7.20 was <2 SD below the mean during labour but not at 
delivery. The mean cord arterial pH at delivery was 7.27; two SD below the mean was 
7.12. There would appear to be little justification for using a pH value of 7.20 to define 
cord arterial acidemia at delivery. 
In some studies the mean of a highly selected subgroup of the population was used to 
define the normal range for cord pH at delivery (Thorp et al, 1989, Yeomans et al, 1985, 
Young 1989), whilst others used non-selected population data (Eskes et al, 1983, Low, 
1988, Sykes et al, 1982, 1983, Yudkin et al, 1987). 
The majority of workers define acidemia by pH only and do not distinguish between 
respiratory and metabolic components. A respiratory acidemia frequently occurs during 
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labour, particularly during the second stage, as a result of cord compression which can 
cause C02 accumulation without impairing 0 2 delivery to vital organs. A metabolic 
acidemia, however, is much more significant as it indicates that 0 2 delivery to the fetus has 
been insufficient for aerobic metabolism. The metabolic component of an acidemia can be 
assessed by examining the base deficit (BD), but relatively few studies do so. Only Sykes et 
al (1982) and Ruth & Raivio (1988) used both pH and BD to define metabolic acidemia 
whilst Low's group in Canada use another measure, the Buffer Base, calculated from a 
Buffer Base Chart (Low et al, 1974). 
The BD value most commonly used is that calculated from the blood compartment of the 
whole of the extracellular fluid. This is the value calculated by most blood gas analysers 
and is suitable for use in adults but not in the perinatal period. The fetus and neonate have 
lower plasma protein concentrations and a relatively larger extravascular fluid 
compartment than adults so relatively more of their buffering capacity is outside the blood 
compartment. It is, therefore, more correct in the perinatal period to calculate the BD of 
the whole extracellular fluid (BDect) rather than just that from the blood compartment 
(BDblood) (Siggaard-Andersen, 1976, Rooth. 1988). This is particularly important when 
pC02 levels are high, as calculations based on the blood compartment alone will result in 
erroneously high levels of BD and will thus overestimate the metabolic component of any 
acidemia (Rosen & Murphy, 1991). 
Most studies report umbilical artery results but some have advocated using venous values 
because the artery can be difficult to sample (Huisjes & Aarnoudse et al, 1979). 
Occasionally, no vessel is specified (Halligan et al, 1992). Both artery and vein values are 
required to identifY sampling errors (Silverman et al, 1985) but only two studies have 
specified a minimum acceptable venous-arterial pH difference (Huisjes & Aarnoudse, 
1979, Eskes et al, 1983). In many studies where blood was only taken from the umbilical 
artery, it would have been impossible to identifY erroneous results (Lauener et al, 1983, 
Page et al, 1986, Steer et al, 1989, Maclachlan et al, 1992). 
In an attempt to understand these problems, a detailed analysis of the blood gas data from 
the randomised trial was performed. Data from both arms of the trial have been combined. 
The aims of the analysis were firstly, to address the specific practical problems related to 
umbilical cord sampling and to assess the reliability of the results, secondly, to determine 
the normal ranges for pH, pC02 and BDecf, thirdly, to investigate the relationships 
between BDecf and BDblood, BDecf and pH, and arterial and venous values and finally, 
to examine the relationships between Apgar scores and neonatal encephalopathy and blood 
gas values. 
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Methods. 
In the first 400 randomised trial entries cord artery and vein cord blood samples were 
collected from selected patients (FBS during labour or any operative delivery) by research 
personnel. All of the next 2000 entries had samples taken by midwives and nursing 
auxiliaries. 
A segment of cord (minimum recommended length 10 cm) was double clamped 
immediately after delivery. Extra cord clamps were included in all delivery packs to 
facilitate this. Cord segments were separated from the placenta, placed into a kidney dish 
and passed out of the delivery room for sampling. In this way the placenta did not have to 
be delivered before sampling so the third stage could continue without further interference. 
Blood was taken first from the artery and then from the vein using preheparinised syringes. 
Sampling within the first 10 minutes was recommended. If this was impossible the cord 
was placed on an ice pack until the samples could be withdrawn (blood does not clot while 
still inside the cord). Analysis was usually achieved within 30 minutes of delivery. Prior to 
the study serial analysis of cord specimens over a 60 minute period confirmed that no 
significant changes in cord blood gas parameters occurred during this time. Syringes were 
preheparinised on-site by adding one drop of liquid heparin (1:5000 units) from a 1ml 
tuberculin syringe into a 2ml plastic syringe and moving the plunger up and down before 
capping with a 21 gauge needle. All syringes were prepared by research personnel who 
were careful not to use more than one drop of heparin as changes in pC02 and pH can 
occur if heparin makes up more than 10% of the volume of any blood gas sample 
(Duerbeck et al, 1992). Results from non-heparinised and heparinised syringes were 
compared before the study and no difference in results was found. 
A Coming 178 (CiliA Coming UK. Ltd) was used throughout the study. The machine is 
self calibrating (one point calibrations every 30 minutes and two point calibrations every 
two hours). During analysis, a reading is taken from each electrode (pH, p02 and pC02) 
twice a second for a maximum of2Vz minutes, or until30 consecutive stable readings have 
been obtained. If stable readings cannot be obtained, two asterisks (* *) are printed beside 
the value to indicate an unreliable result (CiliA Coming Diagnostics Corporation, 1981). 
The analyser was serviced daily by Medical Physics Department engineers. The sampling 
error was checked by analysing 110 pairs of consecutively introduced samples. The 
standard deviation of errors was the same as that reported in the Coming Manual; pH 
0.002 units, pC02 0.55 mmHg, p02 0.4 mmHg (See Appendix 5). 
The Coming Analyser provided BDblood calculations. During the trial BDecf was 
calculated manually from pH and pC02 using a Siggaard-Andersen Acid Base Chart 
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(Siggaard-Andersen, 1971) but once the results were entered into a database, a fonnula 
was used to automatically calculate BDecffrom pH and pC02 (see Appendix 5). 
The reliability of the results was checked by recording errors identified by the Blood Gas 
Analyser (BGA) and examining frequency plots of arteriovenous (A-V) differences. Once 
erroneous results had been excluded, histograms of the data were drawn and the nonnal 
range for pH, pC02, BDecf and BDblood for each vessel was detennined. Both methods 
for BD calculation were compared and the differences assessed. The relationship between 
arterial pH and BDecf and arterial and venous pH and BDecf values were examined in 
various graphical presentations of the data. The relationship between arterial pH, pC02, 
BDecf and the A-V BDecf differences for one and five minute Apgar scores were 
determined. Finally the cord gas data for all cases of neonatal encephalopathy which 
occurred in trial entries were reviewed. 
Results. 
Reliability of cord blood results. 
Errors identified by the BGA. Cord blood gas results were available in 2104 trial entries. 
A single vessel only was sampled in 65 of2104 cases {3.1%). In another 28 pairs {1.3%) of 
results a reliable pH was only obtained from one vessel. This left 2011 paired results with a 
reliable pH in each sample. The lowest pH was always assumed to have come from the 
artery. Unreliable(**) pC02 readings were obtained in 18 pairs (0.9%); 17 from the artery 
and one from the vein (this was actually a printer error). Unreliable p02 results occurred in 
75 pairs {3.7%); 47 in the artery, 15 in the vein and 13 in both. 
A-V differences. In order to further identifY erroneous results the A-V differences were 
examined. Figures 5.1-3 show the frequency histograms for venous-arterial pH and p02 
differences, and the arterio-venous pC02 difference. 
There were a number of paired samples in which the A-V differences were very small, 
absent or (for pC02 and p02) opposite to the expected values (i.e. arterial pC02 lower 
than venous pC02, arterial p02 higher than venous p02). It was difficult to provide a 
physiological explanation for these results, and it was most likely that the samples were 
either from the same vessel or that an unmarked error in analysis had occurred. 
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Closer examination of Figures 1.1-3 revealed that the frequency distributions were 
bimodal; as smaller A-V differences were approached, each frequency distribution rose to a 
second modal point around or just above an A-V difference of zero. There was no obvious 
statistical test to separate out real from erroneous results (D. Wright, Principal Lecturer, 
Department of Mathematics & Statistics, University of Plymouth, personal 
communication). As a result, the minimum allowable A V difference was chosen from the 
nadir between the two modal points. The value obtained for the pH A-V difference was 
0.02, for the pC02 difference 3.5 mmHg and for the p02 difference 2 mmHg. 
Paired results from the same vessel would have similar pH, pC02 and p02 readings so all 
three differences could be examined when attempting to identifY results from the same 
vessel. However, the accuracy of measurement of these variables was not comparable. pH 
and pC02 measures were most reliable with only 0.8% and 0.5% unreliable results(**) 
respectively. In comparison 2.3% of all p02 results were unreliable and a further 47 (1.1 %) 
had p02 values > 50 mmHg which were clearly erroneous. In view of these findings, only 
pH and pC02 A-V differences were used to identifY results from the same vessel. 
Of the total 2011 paired samples, 101 (5%) had an A-V pH difference of<0.02, of these 
91 (90%) had an A-V pC02 difference of <3.5 mmHg and 6 (6%} had an A-V p02 
difference <2 mmHg. Three of the 4 remaining cases had low A-V pC02 differences (3.5, 
4.0, and 4.3 mmHg), and the final case had a pC02 difference of 10.5 mmHg but a pH 
difference ofO. 
189 cases (9.3%} had a pH difference of ~.02 but a pC02 difference of <3.5 mmHg; of 
these, 113 ( 60%) also had a p02 difference of <2 mmHg and 16 (8%) had very low arterial 
pC02 (values <35 mmHg). The majority of pH values from these 189 cases were probably 
reliable but, in order to examine pH and BD values and their relationships in both the 
artery and vein, all paired samples which did not meet both the pH and pC02 difference 
criteria were excluded from further analysis. This left 1719 pairs of results with an A-V pH 
difference ~.02 and an A-V pC02 difference 8.5 (and excludes 2 pairs with no venous 
pC02 result due to printer errors). However, on a final examination of the data, 3 cases 
had venous pC02 values which were very low and gave rise to very large venous BDecf 
values so were excluded from further analysis. A summary of the exclusions made is shown 
in Figure 5.4. 
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2104 cases had cord sampling 
'- 65 single vessel only sampled 
1'-. 28 error in pH of one vessel ., 
2011 paired samples 
[\._ 18 (0.9%) error In arterial 
pC02 
1993 paired samples 
[\._ 101 (5%) A-V pH difference 
<0.02 
~ 189 (9.4%) A-V pH difference ~0.02 but pC02 difference 
<3.5 mmHg 
"-- 3 with very low venous pC02 
1716 paired samples for final 
analysis (81 .6% of2104) 
Figure 5.4 A summary of the exclusions made to identifY reliable paired artery and vein 
cord data. 
pC02 errors. Most of the samples rejected on the basis of a low A-V pC02 difference had 
unusually low arterial pC02 values. Why was this? The answer lay in the BGA The 178 
Analyser does not have automated sampling from either syringe or capillary. Syringe 
samples had to be injected by the operator and as a result two errors occurred. Firstly, air 
bubbles formed if the sample was injected too rapidly and produced an unreliable (**) 
result. The second error occurred as a result of back flow of blood once the syringe was 
removed from the injection port. If insufficient blood had been injected, the pC02 
electrode (the last of 3 electrodes in series - pH, p02 and pC02) was no longer covered 
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with blood. As long as there were no gas bubbles in the fluid over the electrode, a stable 
reading for pC02 was obtained which was therefore not marked as unreliable by the 
analyser. However, the pC02 result obtained was invariably low (20 to 35 mmHg) and 
resulted in a falsely elevated BDecfvalue. CffiA Coming report that this problem has been 
obviated by the introduction of automatic sample aspiration in later models of their BGAs. 
Identification of 'normal' ranges for pH, pCOz and BD. 
The frequency distributions for pH, pC02, BDecf are shown in Figures 5. 5-7. 
The frequency distributions are markedly skewed and therefore any statistical description 
of the results should use the median and centile values. This is important because use of the 
mean and standard deviation (SD} is not only statistically incorrect but will also result in an 
underestimate of the lower limit of 'normal' for pH and an overestimate for the upper limit 
of'normal'. For example, the mean arterial pH for the data shown in Figure 5.5 is 7.24, 2 
SD below the mean is 7.08. However, the median pH is 7.26 and the lower 2.5th centile 
pH is 7.04. The same will apply to the p02 'normal range' and the reverse to pC02. 
The cumulative frequency distributions are shown in Figures 5.8-10. The 'normal' range as 
defined by the median and 2.5th to 97.5th centiles is shown in Table 5.2. The results for 
BDecf and BD blood are given for comparison. 
Table 5.2 The median and 'normal' range (2.5th to 97.5th centiles) for cord artery and vein 
pH, pC02 and BD. 
artery, n=l716 vein, n= 1716 
median & median& 
(2.5th -97.5th centiles) (2.5th -97 .5th centiles) 
pH 7.26 (7.04-7.38) 7.35 (7.16-7.47) 
pC02(mmHg) 55.0 (37-81) 40.0 (27-59) 
BDecf (mmol/l) 2.3 (-2.8-9.4) 2.9 (-1.4-8.8) 
BDblood (mmol/l) 3.7 (-1.7-12.4) 2.9 (-1.5-9.6) 
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Figure 5.6 Frequency distribution of cord artery and vein pC02, n=l716. 
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Figure 5.7 Frequency distribution of cord artery and vein BDecf, n=l716. 
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Figure 5.8 Cumulative frequency of cord artery and vein pH, n=1716 . 
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Figure 5.9 Cumulative frequency of cord artery and vein pC02, n=1716. 
~ 75 +---~---+---+--~~--~~~--~---+--~r---+---~---+---4-­
~ --·-
" •
" l 50 +--+--i---+----'-!f-'--+--+-+---+--+---+-~i---+-----t-
t ~ ~~~rff~~~~~~ 
~~t=~;.:J~~f;l=-F~~3=-=:!~l=l~=l~ 
0 
·2 0 2 4 e a 10 12 14 18 18 20 
IIDecf IIWIIOM 
Figure 5.10 Cumulative frequency of cord artery and vein BDecf, n= 1716. 
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The relationship between BDecf and BD blood. 
Figure 5.11 shows the frequency distribution for BDecf and BDblood in both artery and 
vem. 
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Figure 5.11 The relationship between BDecf and BDblood for A. cord artery and B. cord 
vein. n=1716. 
The BDecf and BDblood values were very similar in the vein but different in the artery. 
Why was this, when the only difference between the two BD calculations was the 
concentration of haemoglobin (Hb) used in the formulae (see Appendix 5)? In an attempt 
to explain this the relationship between BD and pH at different pC02 levels was examined 
graphically (Figure 5.12). The BD values were calculated from the formulae given in 
Appendix 5. 
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Figure 5.12 Comparison ofBDecf and BDblood values for two different pC02 levels. 
There was little difference between the BDecf and BDblood values at a pC02 of 40 mmHg 
(median venous pH) over the range of pH values commonly seen in the vein (7.25 -7.50). 
However at a pC02 of 55 mmHg (median arterial pH) the BDblood was higher than the 
BDecf over the range of pH values commonly seen in the artery (pH 7.10-7.30). Because 
BDblood is calculated from just the blood compartment, as pC02 rises, BDblood increases 
more than BDecf which is calculated from the whole extracellular fluid volume. This can 
be explained further in the following figures (Figures 5.13 & 5.14). 
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Figure 5.13 Normoxia. Glucose is metabolised aerobically to produce energy and carbon dioxide 
and water. This produces a large amount of carbonic acid (H2C03) which must be excreted. The 
W is buffered by reduced haemoglobin in red blood cells and is carried to the placenta in the 
umbilical arteries. In the placenta, C02 rapidly diffuses into maternal blood {whereas the transport 
of W ions is much slower). Bicarbonate (HC03·) is distributed throughout the extracellular fluid 
compartment and largely determines the base deficit of the extracellular fluid. Modified from 
W estgate & Rosen, 1993. 
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Figure 5.14 Respiratory acidemia. In this example cord occlusion has reduced the amount of C02 
returning to the placenta resulting in an increase in blood C02 levels. Tills in turn increases H2co3 
concentration and results in more HC03- leaving the red blood cells to enter the blood 
comparbnent. HC03- then leaves the blood compartment to equilibrate with the interstitial fluid. 
There is a relative loss of HC03- from the blood compartment (thus BDblood will rise) but no 
change in HC03- or buffering capacity in the whole extracellular fluid compartment (thus BDecf 
remains unchanged). Modified from Westgate & Rosen, 1993. 
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The relationship between pH and BDecf. 
In order to examine what level of arterial pH was associated with a significant elevation in 
BDecf, the relationship between the two was examined in the following scatter diagram. 
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Figure 5.15 Scatter diagram of cord artery pH and BDecf(mmol/1), n = 1716. 
The majority of results with a BDecf>10 mmol/1 had a pH < 7.05 but not exclusively so. 
Nine values had an arterial pH well into the normal range but had high BDecf Details of 
these cases are shown in the following Table. 
Table 5.3 Blood gas values for cases with high pH and high BDecf divided according to 
size of A-V difference. (na = not available). 
artery vein 
pH pC02 p02 BDecf pH pC02 p02 BDecf 
mmHg mmHg mmol/1 rnmHg rnmHg mmol/1 
large A-V BDecf difference (>3 .5) 
7.12 54.5 19.1 10.2 7.33 47.3 23 .3 0.6 
7.12 53.4 na 10.5 7.31 39.6 31.8 5.4 
7.15 37.5 28.6 14.0 7.44 26.5 34.9 5.2 
7.18 44.8 22.0 10.2 7.32 36.4 25.8 6.3 
7.20 42.4 na 10.1 7.32 34.4 24.7 7.3 
7.20 42.0 30.0 10.2 7.37 33.0 42.0 5.3 
7.20 35.3 15.5 11.7 7.42 30.8 23 .9 3.7 
small A-V BDecfdifference (< 1.5) 
7.08 59.0 18.8 11.0 7.18 39.3 30.8 12.1 
7.15 49.9 19.6 10.1 7.21 41.5 27.3 9.9 
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There appeared to be three possible explanations for the 7 cases with large A-V BDecf 
differences. 
1. The arterial pC02 results may have been erroneously low. However, the venous pC02 
values were also low and the venous BDecf values were in the normal range. This 
suggested that the pC02 values were probably correct. 
2. A period of obstruction in cord flow could have occurred immediately before delivery 
and caused a fetal metabolic acidemia. However, if this was the case the arterial pC02 
values should have been high, and not low, as pC02 levels would have risen during cord 
occlusion. 
3. The final, and most likely scenario was that a combination of maternal hyperventilation 
and fetal acidemia occurred prior to delivery. Maternal hyperventilation would have 
lowered both maternal and fetal pC02 levels but fetal hypoxia would have resulted in an 
increase fetal BDecf. Unfortunately maternal blood gas results at delivery were not 
available and knowledge of maternal analgesia was not helpful as epidurals were frequently 
left to wear off before pushing commenced. However, there was some evidence that fetal 
hypoxia may have been present; 4 cases had operative deliveries for fetal distress, 2 had a 
persistent bradycardia of 8 to 1 0 minutes duration prior to delivery and in the remaining 
case the FHR for the last 15 minutes before delivery was not recorded. 
There were two cases with a small A-V BDecf difference where both arterial and venous 
BDecfvalues were high. Both venous pHs were less than the 7.5th centile. One case was 
in the ST+CTG arm of the trial and, interestingly, had meconium liquor and an abnormal 
CTG with a biphasic ST waveform in the second stage. The baby required 2 minutes of 
bag and mask ventilation following a normal delivery (Apgar scores 51 & 95). The other 
case was in the CTG arm and had an emergency LSCS under general anaesthetic for an 
abnormal FBS (FBS pH 7.14, pC02 38.7 mmHg, BDecf 14 rnmol/1). Apgars were 61 & 
95. Neither had any neonatal problems. Knowledge of maternal acid-base status would also 
have been helpful here. Both fetuses appear to have had a non-acute mixed acidemia, but 
neither had problems in the neonatal period. 
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The relationship between arterial and venous results. 
Figure 5.16 shows the A-V BDecf differences grouped according to arterial pH. 
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Figure 5.16 Median and 95% CI values for A-V BDecf differences by arterial pH groups, 
n = 1716 
As cord artery pH decreased, BDecf difference increased. It is probable that large A-V 
BDecf differences (high arterial BDecf, low venous BDecf) reflect an acute onset of fetal 
metabolic acidernia as placental transfer of non-volatile acids is much slower than the 
volatile carbonic acid (C02). As a result it takes time for the placental extracellular fluid 
compartment to become saturated with lactic acid from the fetus. If both the artery and 
vein have a high BDecf the acidernia is not acute as equilibration has occurred with the 
fetal H+ load being sufficient to saturate placental buffering capacity. 
Large A-V BDecf differences are usually the result of cord entanglement (Rosen & 
Murphy, 1991) or a stasis of umbilical cord flow secondary to cardiac failure (Brar et al, 
1988). The most notable example in the trial was one ofthe birth asphyxiated cases who 
developed severe variable decelerations and then a prolonged tenninal bradycardia in the 
second stage as a result of a tight nuchal cord and unfortunately died (Case 1699, artery 
pH 6.88, BDecf 16 mmol/1, vein pH 7.38, BDecf 4 mmol/1). It is important to recognise 
that such large A-V differences are possible and that a nonnal venous pH and BDecf does 
not exclude the possibility of significant arterial metabolic acidernia. 
An example of two cases from the trial which illustrate the significance of A-V differences 
are shown in Table 5.4 overleaf. 
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Table 5.4 An example of two cases with similar arterial results but different A-V 
differences. Case A (Trial number 1129) required resuscitation at birth, was ventilated for 
48 hours and has a spastic hemiplegia at one year of age. Case B (Trial number 2009) had 
a 5 minute Apgar score of 8 with no neonatal problems. 
Case A CaseB 
artery vein artery vein 
pH 7.03 7.10 7.04 7.32 
pC02 (mrnHg) 63.3 49.7 66.4 38.1 
p02 (mrnHg) 7.0 19.4 13.2 33.5 
BDecf (mmolll) 13 13 12 7 
One other interesting observation can be made from Figure 5.16. When arterial pH was ~ 
7.15, the A-V BDecfdifference was negative; i.e. the vein had a higher BD than the artery. 
There are two possible explanations for this; firstly, the venous BDecf may reflect placental 
metabolism which is only obvious when the fetus is not producing any lactic acid or, 
secondly, it may reflect the fact that reduced Hb in the umbilical artery has more buffering 
capacity than oxidised Hb in the umbilical vein. 
Cord gases and Apgar scores. 
The relationship between Apgar scores and cord artery pC02, BDecf and A-V BDecf 
difference are shown in the following figures. 
A. 1 minute Apgar scores 
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B. 5 minute Apgar scores 
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Figure 5.17 Percentage of 1 and 5 minute Apgar scores 0 to 3, and 4 to 7 by cord artery 
pH at delivery, n = 1716. 
As cord artery pH decreased, a significantly higher proportion of babies had lower Apgar 
scores at both 1 minute (r = 0.39 [0.35-0.43], p<0.001) and 5 minutes (r = 0.45 [0.41-
0.49], p<0.001, Speannan Rank Correlation). Although these correlations are statistically 
significant because of the large numbers involved, the relatively low r values show that the 
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correlations are not particularly strong. At a cut-off level for cord artery pH of 7.05, 
significantly more babies with a pH<7.05 had 5 minute Apgar scores <8 (x.2 =23.64, 
p<0.001, OR 8.59 [3.38-21.8]). 
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Figure 5.18 Percentage of 1 and 5 minute Apgar scores 0 to 3, and 4 to 7 by cord artery 
pC02 at delivery, n = 1716. 
pC02 was poorly correlated with 1 minute (r = -0.08) and 5 minute Apgar scores (r = 
0.29), but significantly more babies with an arterial pC02 >70 nunHg had a 5 minute 
Apgar score <8 (x.2 =17.62, p<0.0001, OR 4.3 [2.02-8.92]). 
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Figure 5.19 Percentage of 1 and 5 minute Apgar scores 0 to 3, and 4 to 7 by cord artery 
BDecfat delivery, n = 1716. 
BDecfwas also poorly correlated with 1 minute (r = 0.03) and 5 minute Apgar scores (r = 
0.34) but significantly more babies with a BDecf >9 mmol/l had 5 minute Apgars score <8 
(x.2 =3.81, p<0.05, OR 3.81 [1.01-10.72]). 
There was no obvious relationship between Apgar scores and A-V BDecf difference 
(Figure 5.20). However, this was not unexpected as the level of cord artery pH was not 
considered in the analysis so A-V difference was also examined for cases with arterial 
acidernia (pH<7.05) (Figure 5.21). 
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Figure 5.20 Percentage of 1 and 5 minute Apgar scores 0 to 3, and 4 to 7 by cord A-V 
BDecf difference at delivery, n = 1716. 
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Figure 5.21 Scatter diagram of 1 and 5 minute Apgar scores and A-V BDecf difference for 
cases with arterial pH<7.05, n=44. 
The numbers were small and the correlations were not significant (r = 0.14 for 1' Apgar 
and r = -0.4 for 5' Apgar). There was one outlying case, an asphyxiated baby (trial number 
1699), who was stillborn with a large A-V difference. If this case was excluded from the 
calculations, the correlations became a little stronger and approached statistical 
significance (r = 0.26, p=0.09 for 1' Apgar and r = .24, p = 0.12 for 5' Apgar). 
Cord gases and neonatal encephalopathy. 
There were 5 cases of encephalopathy in the study (0.2%). The clinical details and cord gas 
data are shown in Table 5.5. Only one had a metabolic acidemia and fulfilled the 
requirements for the definition of birth asphyxia used in the randomised trial (case No. 
1591, cord artery pH <7.05, BDecf >12, Apgar at 5 minutes <8, >4 minutes active 
resuscitation, neonatal problems). In one other case (case No. 1971} only a venous sample 
was obtained, so an arterial acidemia cannot be excluded, but the baby did not require any 
resuscitation at birth. 
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Table 5.5 Details of trial entries with neonatal encephalopathy. 
Case CTG Meconium Mode of Cord Apgar scores & Neonatal details 
No. delivery pH&BDecf Resuscitation 
682 Normal No LSCS (GA) artery pH 7.29, 41, 9.) ISh; right-sided fitting progressed to generalised fits. 
(CTG) failure to BDecfl.S 4 mins active with Abnormal EEG. Developed NEC and DIC. Ventilated. Died 
progress vein pH 7.32, intubation and IPPV. day 3. Peritoneal fluid grew Clostridium perfringes. 
BDecf 1.9 Naloxone given. 
1586 Abnormal yes Vacuum artery pH 7.15, 81, 10.). 20h; right-sided twitching then right-sided and generalised 
100 mins extraction BDecf 7 rnrtl.ol/l. No resuscitation. fits for 4 days. Abnormal left hemisphere EEG. Moderately 
second stage failure to vein pH 7.26, severe left hemiparesis at 18 months. 
(ST+CTG) progress BDecf 6 mmol/l. 
1971 Abnormal yes LSCS (GA) Artery not available 61, 9=>. Symptomatic hypoglycaemia for 6 hours following delivery. 
S hours first fetal distress (NA) No resuscitation. Did not respond to oral carbohydrate feeds. Generalised 
stage abnormal FBS vein pH 7.20, fitting for 4 hours. At 14 months; height on 50th centile, 
3xFBS result BDecfl.l weight on 3rd centile, global developmental delay, failed 
(CTG) (pH 7.13) hearing tests, intermittent tits. 
1591 Abnormal yes LSCS (GA) artery pH 6.81, J1, 7=>. Sh; generalised fitting. Controlled on iv phenobarbitone. 
120 mins cord prolapse BDecf12.2 4 mins active Discharged well. No follow-up. 
(CTG) vein pH 7.20, BDecf resuscitation with 
NA (printer error) intubation and IPPV. 
2072 Normal yes non-rotational artery pH 7.30, 91, 9~. 24h; irritable, 27h; right sided tits. EEG showed bilateral 
(CTG) forceps BDecf2.3 No resuscitation. irregularities. Normal at 3 months. No further follow-up. 
failure to vein pH 7 .39, 
progress BDecf0.7 
Discussion. 
This review was performed in an attempt to clarify some of the confusion about cord blood 
gas sampling and outcome. Perhaps, rather predictably, although some questions have been 
answered, many more have been raised. 
Reliability of cord results. 
Some of the confusion about the value of sampling must be related to erroneous results. It 
is imperative that samples are taken from both the artery and the vein and that the results 
are screened to ensure separate vessels have been sampled. Nearly 20% of all paired 
samples in this study were rejected. Research workers were far more accurate in sampling 
than midwifery staff. The first 144 cord samples were taken exclusively by research 
workers (one of whom was a midwife), a single vessel sample was obtained in 7 cases 
( 5% ), but in the next 1960 samples taken mainly by midwifery staff, 3 81 (20%) of samples 
came from a single vessel or had pC02 errors. Neither midwifery staff nor doctors were 
very good at identifYing sampling or analysis errors. This was the first time that cord 
sampling had been performed in the hospital and success rates may have improved since 
then. Regrettably, lack of computerised labour ward records has not allowed this to be 
assessed. Others have reported 10% error rates with routine sampling by midwives (Riley 
& Johnson, 1993). 
In this study the necessity for adequate BGA maintenance was recognised, and analyser 
function was checked before the study commenced. However, the urunarked error in pC02 
values caused by back flow with small samples was only recognised during the study and 
was responsible for half of the rejected samples. Since then probable errors in pC02 values 
in other studies where the same BGA was used have been noticed (e.g. Newbold et al, 
1991). It would not be unexpected to find similar (or additional) quirks in other BGAs and 
it has been impossible to find a recent comparison of currently available machines. 
There is very little information on the normal range of A-V differences. The minimum A-V 
pH difference found by Rooth {1988) in his review of 4 studies was 0.04. Huisjes & 
Aarnoudse (1979) chose 0.03 units as a minimum allowable pH difference while Eskes et 
al (1983) used 0.02 units, but neither group provided support for the levels chosen. Egan 
et al (1992) accepted negative venous-arterial pH differences (i.e. venous pH lower that 
arterial pH) if the pC02 and p02 results were appropriate for each vessel (pC02 higher 
and p02 lower in the artery compared to the vein). It has been a surprise to find that these 
values have not yet been established and the most recent review of cord sampling managed 
to discuss sample collection and analysis without addressing this problem (Riley & 
Johnson, 1993). 
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There is some debate as to whether sampling should be routine (Thorp et al, 1989) or 
selective (Page et al, 1986, Duerbeck et al, 1992). Routine sampling occurred during most 
of the trial (2034 entries). Sampling was missed in 3.6% of cases either because staff 
forgot or were unable to take blood from the cord. During this phase, 27 (56%) of the 48 
babies born with an arterial pH <7.05 had neither an FBS nor an operative delivery and 
would not have been detected by selective sampling. If cord gas data is to be used to 
identify neonates 'at risk' of neonatal morbidity or as a quality of care measure or for 
litigation defence, sampling will have to be routine. 
Interpretation of results. 
The main area of confusion lies in the definition of acidernia. Statistically low (or high) 
levels should be defined by centile values rather than mean and SD but only Eskes et al, 
(1983) have done so. Even then, are these the levels which are physiologically significant? 
In attempting to answer this question, several points have to be considered. Firstly, the 
relationship between pH and [H+] is not linear but logarithmic (Figure 5.22). A decrease in 
pH from 7.30 to 7.20 is only associated with a rise in [H+] of 13 nmolll, but with a fall of 
pH from 7.00 to 6.90, [H+] rises by 26 nmol/1 - a twofold increase. This means low pHs 
are more significant in terms of increased [H+] than the fall in pH units would suggest. 
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Figure 5.22 Relationship between pH and [H+]. 
It is clear that the level of pH chosen to indicate acidosis in many studies was far too high 
(Winkler et al, 1991, Gilstrap et al, 1989, Goldaber et al, 1991) so it is not surprising that 
no relationship has been found between pH and neonatal outcome. There is increasing 
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evidence from larger studies that the cut-off levels for a significant metabolic acidemia are 
a pH <7.05 and a BDecf>12 mmolll. These figures are very close to those determined in 
this study on statistical grounds (pH <7.05, BD <?:10 mmol/1). Low et al, (1984) followed 
up 60 children with a metabolic acidosis (Buffer Base <34 mEq/1) at birth. At one year of 
age the degree of handicap was related (but not statistically significantly) to the degree of 
cord artery acidemia with key pH and BDecf values of 7.06 and 12 mmolll respectively. 
Gilstrap et al (1989) found a significant increase in low Apgar scores at 1 and 5 minutes 
and a significant increase in neonatal morbidity with an arterial pH <7.00 in 2738 singleton 
pregnancies at term. Goldaber et al (1991) reviewed neonatal morbidity and mortality in 
1270 term new-horns with an arterial pH <7.15 from a total population of over 30,000 
cases. They found a significant increase in neonatal morbidity when pH <7.05, and 
particularly if pH <7.00. The neonatal death rate was increased when pH <7.05 (p=0.06). 
In their study two thirds of the new-boms with a pH <7.00 had a metabolic component to 
their acidemia with a BDblood >15mmolll. This is comparable with a BDecf of 12 to 13 
mmolll. Seven of 8 babies with unexplained seizures had a metabolic contribution to their 
acidemia. Despite the statistical significance of these findings, the majority of babies with a 
cord artery pH <7.05 did not have poor neonatal outcome. 
Secondly, a linear relationship between pH or BD at delivery and outcome should not be 
expected. The ability to mobilise glucose from glycogen and metabolise it anaerobically 
depends both on the availability of substrate and on the effectiveness of the beta-adrenergic 
mediated response to hypoxia. If substrate is lacking, as in growth retarded fetuses, or the 
appropriate response is affected by chronic hypoxic stress or infection, anaerobic 
metabolism may not be as effective at maintaining cell and organ function as in the healthy 
fetus. As a result pH may not fall and BDecf may not rise as much during hypoxia in the 
growth retarded or chronically stressed fetus. But that is not to say they do not display a 
metabolic acidemia at all. There is considerable evidence from cordocentesis studies that 
growth retarded fetuses have higher lactate levels and lower pHs than appropriately grown 
controls (Pardi et al, 1987, Soothill et al, 1987, Nicolaides et al, 1989, Ribbert et al, 1991). 
Low demonstrated some time ago that decreased weight for gestational age was the best 
predictor of metabolic acidemia (Low et al, 1981) and Lin et al, (1980) showed that the 
acid-base status of growth retarded fetuses with FHR decelerations deteriorated more 
quickly than appropriately grown fetuses. Schneider et al, (1988) have also reported an 
increased incidence of arterial pH<7.10 in fetuses who were small for gestational age 
(10%) compared to appropriately grown fetuses (1%). Finally, 5 of the 16 cases ofbirth 
asphyxia presented in this thesis were growth retarded with a metabolic acidemia. It is 
noteworthy that the lowest pHs (6.80, 6.82) were found in appropriately grown fetuses 
whilst the lighter babies tended to have pHs from 6.95 to 7.05. 
Dennis et al, (1989) were unable to find a significant relationship between the degree of 
cord artery acidemia at birth and neurodevelopmental outcome at 4Y:i years of age. In fact, 
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the highest proportion of unimpaired children was amongst those with a cord artery pH 
<7.05 at birth. They suggested the ability to respond to intrapartum stress with a metabolic 
acidosis was a positive finding associated with good future outcome whilst babies who 
were not acidemic but had low Apgar scores at delivery were at most risk of poor 
outcome. Unfortunately, their conclusions are frequently interpreted to mean that some 
fetuses who become hypoxic during labour do not become acidemic but still suffer direct 
intrapartum cerebral damage. Physiologically, it is difficult to see how hypoxia would not 
result in metabolic acidemia, even in growth retarded fetuses, as has been discussed above. 
It may be that some fetuses have structural brain abnormalities which make them more 
susceptible to hypoxaemia so that they suffer neurological damage without major FHR 
abnormalities or acid-base disturbance (Hull & Dodd, 1992). It is known that chronic 
growth retardation affects brain development (Thordstein, 1991) so it would be of interest 
to know the birth weights and lengths of the children with poor neurodevelopmental 
outcome in Dennis et al's study. 
Thirdly, the type and duration of acidemia are important. The scatter diagram of pH and 
BDecf (Figure 5.15) showed that half of the babies with a cord artery pH <7.05 had a 
BDecf<10 mmol/1, i.e. a respiratory acidemia. The respiratory and metabolic components 
of an acidemia will best be separated by BDecf, as it is less affected by high pC02 levels. In 
addition, the duration of metabolic acidemia is an important prognostic indicator (Low, 
1988). Arterio-venous pH and BDecf differences can provide information about the time 
course of an acidemia which may be useful in future studies of long-term outcome. 
Although A-V BDecf difference and Apgar scores were not significantly correlated with 
pH in this study, Low has just reanalysed his data (over 30,000 paired cord blood gas 
results) using A-V Buffer Base differences and found a significantly poorer outcome with 
metabolic acidemia and narrow A-V differences compared to metabolic acidemia and large 
A-V differences (Low, et al, 1993). Chronic antenatal fetal acidemia is associated with 
poor subsequent neurological development. Soothill et al (1992) followed up 38 infants 
who as fetuses had cordocentesis for severe fetal growth retardation; 23 had normal acid 
base status and 13 were acidemic (pH < 2 SD below mean for gestation!). When the 
infants were examined at 12-52 months of age the Griffiths developmental quotient of the 
acidemic group was significantly lower than that of the normal pH group (mean 91.8 
versus 100.3, p=O.Oll). One of the acidemic group infants had cerebral palsy. There was a 
weak correlation between the degree of fetal acidemia and the developmental quotient 
(r=0.41, p=O.Ol2). In contrast, there was no significant correlation between the degree of 
growth retardation (weight for gestational age) and the degree of acidemia or the Griffiths 
score. 
Finally, interpretation of cord gas results will be assisted by knowledge of the clinical 
situation, particularly maternal aid-base status. This is less easy to obtain than cord blood 
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and would require an extra (albeit minimal) invasive procedure for the mother. It may be 
more difficult to obtain these samples on a routine basis. 
Cord gas results and Apgar scores. 
In this study a weak relationship between cord gas parameters and Apgar score was found, 
in keeping with many other studies {Sykes et al, 1982, Silverman et al, 1985, Dijxhoom et 
al, 1986, Ruth & Raivio, 1988, Gilstrap et al, 1989, Steer et al, 1989). Many have been 
confused by this. Silverman et al, {1985) went to great lengths to explain the finding of a 
low cord artery pH and a normal Apgar score as a result of a "maternal infusional 
acidosis". In fact, a strong association between the two should not be expected. The 
catecholamine surge which activates fetal defence mechanisms in response to hypoxaemia 
also has an affect on neonatal behaviour at birth. It is known that catecholamines are an 
extremely important part of the normal adaptation to extrauterine life and produce a 
general neonatal arousal (Lagercrantz & Slotkin, 1986). This arousal will affect most 
components of the Apgar score; a higher heart rate, stimulation of respiration, increased 
reflex irritability and tone, so it should be no surprise to find a high Apgar score where an 
appropriate response to hypoxia has occurred (Lagercrantz, 1982). Similarly, it is no 
surprise that the combination of severe metabolic acidosis and a one minute Apgar score 
<7 is associated with a significant increase in neonatal complications compared to those 
with acidosis and a normal one minute score (Low et al, 1993). 
Cord gas results and neonatal encephalopathy. 
The most recent proxy for birth asphyxia is neonatal encephalopathy. This is a clinically 
defined syndrome of disturbed neurological function in the earliest days of life in the term 
infant, manifested by difficulty with initiating and maintaining respiration, depression of 
tone and reflexes, subnormal levels of consciousness, and often by seizures (Leviton & 
Nelson, 1992). The severity of encephalopathy is a good predictor of both short and long-
term outcome (Finer et al, 1981, Low et al, 1985, Levene et al, 1985, Robertson et al, 
1989). The incidence of death and disability is not only increased in those who have had 
moderate or severe encephalopathy, but it has been shown that survivors of moderate 
encephalopathy without a motor deficit were more likely to have a lower IQ and poorer 
reading, spelling, and arithmetic skills than their peers at eight years of age (Robertson et 
al, 1989). Meta-analysis of all the randomised monitoring trials to date has found that use 
of the CTG during labour is associated with a significant reduction in neonatal seizures 
(Grant, 1991). In the light ofthe evidence from Robertson, et al {1989) this is likely to be 
an important benefit but one which is frequently dismissed as follow-up of cases from the 
Dublin randomised trial (MacDonald et al, 1985) revealed no difference in cerebral palsy 
rates at 4 years of age. However, the learning and behavioural disorders found by 
Robsertson et al may only become obvious in older children and probably require more 
extensive testing than the neurological examination which was performed on the Dublin 
children. 
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Neonatal encephalopathy has varying aetiologies; hypoxia, infection, inborn errors of 
metabolism, hypoglycaemia, trauma or structural abnormalities (Nelson & Leviton, 1991). 
The terms 'hypoxic ischaemic encephalopathy' (HIE, Samat & Samat, 1976, Finer et al, 
1981) or 'post asphyxial encephalopathy' (P AE, Levene et at, 1985) are used to describe 
neonatal encephalopathy occurring as a consequence of 'birth asphyxia'. In these cases the 
diagnosis of asphyxia is usually made on clinical criteria (Levene, 1988). However 
examination of the 'clinical criteria' used by various workers reveals that they are somewhat 
non-specific (Table 5.6). 
Table 5.6 Requirements for the diagnosis of new-born encephalopathy used in various 
studies. Modified from Nelson & Leviton, 1991. The italics have been added by the present 
author. 
Reference Terminology Criteria: encephalopathy plus; 
Samat & Sarnat, Neonatal One of the following two 
1976 encephalopathy - well defined episode of fetal distress (not 
defined) 
- Apgar score <4 at 1 or 5 minutes. 
Volpe, 1976 Hypoxic ischaemic Not defined. 
encephalopathy 
Finer et al, 1981 Hypoxic ischaemic Oneofthree 
encephalopathy - abnonnal FHR. pattern (not defined) 
- Apgar score 9J at I or 5 minutes. 
- need for immediate resuscitation or intubation. 
Amiel-Tison & Hypoxic ischaemic One of four 
Ellison, 1986 encephalopathy - FHR. <120 or >160 once if by auscultation or 
prolonged if by EFM 
- repetitive FHR. decelerations (not defined) 
- presence of meconium 
- Apgar score <6 at 5 minutes. 
Levene et al, 1985, Post asphyxial One of five 
Levene, 1991 encephalopathy - abnonnal CTG (not defined) 
- meconium staining 
- fetal scalp acidosis 
- low Apgar scores 
- delay in establishing respiration 
Lipper et al, 1986 Post asphyxia score Apgar score <6 plus one of the following 
- bradycardia (not defined) 
- variable or late FHR decelerations 
- loss of beat to beat variability 
- scalp or cord pH <7 .20 
- need for resuscitation 
- meconium aspiration. 
Asphyxia with a metabolic acidemia only occurred in one of five cases of neonatal 
encephalopathy in the randomised trial. Others have found the same. In 1985 Low et at, 
reported that 78% of new-horns with severe encephalopathy had normal cord gas values. 
Neonatal respiratory complications and infection were significantly associated with 
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encephalopathy and they estimated that new-born hypoxia was twice as frequent as fetal 
hypoxia in cases with severe encephalopathy. Even Levene et al (1985) reported that 23% 
of infants with PAE had normal Apgar scores and, more recently, Hull & Dodd (1992) 
found 64% of infants with moderate or severe liTE had Apgar scores of >5 at 5 minutes 
and a number did not require resuscitation. 
Use of terms like liTE or PAE which imply an aetiology should be avoided in favour of the 
more accurate descriptive term neonatal encephalopathy. Knowledge of umbilical acid base 
status will help to establish an aetiology for encephalopathy. Normal blood gas results may 
encourage paediatricians to search more vigorously for other non-asphyxial causes. 
Is there a 'gold standard' measurement for neonatal outcome? 
It is better to have absolutely no idea where one is, than to confidently believe that one is 
where one is not. 
CF Cassini de Thury, 18th Century Surveyor. 
Much of the confusion relating to the value of intrapartum fetal monitoring has been 
caused by the difficulty in assessing neonatal outcome. Initially Apgar scores were 
confidently used as a measure of 'birth asphyxia' until they were even more confidently 
replaced by 'hypoxic ischaemic encephalopathy'. Even the term 'birth asphyxia', confidently 
used by most (including the present author), has so many varied definitions it is not a 
useful term for general discussion and should be avoided in favour of descriptive 
statements about neonatal condition. 
This imprecision in assessing outcome makes it very difficult for obstetricians to audit care 
and assess the value of monitoring techniques. When Murphy et al (1990) asked the 
neonatal staff to identify all cases of birth asphyxia during a 17 month period for their 
review of CTGs, they were initially presented with a list of 85 cases. However, when each 
case was reviewed in detail, paediatricians reversed their diagnosis of birth asphyxia in 
25% of these. The important findings of their study may have been very different (or at 
least diluted) had these cases been included in the analysis. 
Clinicians seem obsessed with finding one measure of fetal condition in utero and one 
measure of neonatal condition which accurately reflects preceding events, fetal responses 
to these events and future outcome. Given the complexity of the situation, this approach is 
somewhat naive. The myth of the 'gold standard' should be laid to rest as soon as possible. 
Full use of aD available information should be made in assessing neonatal condition. 
Umbilical cord blood analysis provides an objective measure of fetal condition at birth, 
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which reflects fetal oxygenation prior to delivery and can be used in combination with 
more traditional measures such as Apgar scores. However, the information will only be 
valuable if it is both correct and correctly interpreted. Much of the confusion about the 
value of cord acid-base assessment lies in the use of erroneous data, inadequate definitions 
of acidemia which do not differentiate between respiratory and metabolic components and 
unphysiological expectations about its relationship to other measures of neonatal outcome. 
It is important that this area of confusion is resolved as soon as possible, for without some 
consensus the value of intrapartum monitoring wiU be difficult to establish. 
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Introduction. 
The principle aim of this thesis was to validate a new technology for intrapartum fetal 
monitoring; analysis of the ST waveform of the fetal ECG. Whilst this has been achieved, a 
very important, rather fundamental point has been highlighted by the review of CTG and 
ST+CTG monitoring and cord blood gas analysis; it is the importance of accurate 
interpretation of data. The key question for the effective use of ST waveform analysis is 
whether the requirements for staff education and training will be recognised, met and 
maintained in every labour ward where it is used. It is salutary to realise that this has not yet 
been achieved for the CTG despite 25 years of clinical use. The addition of ST waveform 
analysis may make things more complicated and once other aspects of the ST waveform 
become available, e.g. waveform area or contraction-related changes, the situation may 
become impossible. Education is important but is unlikely to be the complete solution for, 
despite regular teaching sessions, suboptimal use of CTG and ST+CTG information 
occurred in many cases in the randomised trial. Educational attempts were hindered by the 
high turn-over rate of both midwives and junior doctors working on the labour ward and, of 
course, this is a national problem. 
Currently, interpretation ofCTG and ST+CTG recordings relies on a subjective assessment 
of the available information. There are many studies which highlight poor intra- and inter-
observer variations in CTG interpretation {Trimbos & Keirse, 1978, Lotgering et al, 1982, 
Nielsen et al, 1987, Donker, 1991) although experienced active clinicians tended to agree 
more and interfere less than their junior colleagues {Lidegaard et al, 1992). The labour ward 
is a high stress area in which even experienced clinicians may have difficulty with decision 
making. More importantly, senior, experienced staff are usually only called to advise on 
cases when the midwife or junior doctors perceive there is a problem, and furthermore, they 
can only be in one place at one time. 
Given the realities of staffing situations and levels of expertise available in hospitals 
throughout the country, it is most likely that consistent, optimal interpretation of the 
information in the CTG, the ST waveform, or any other new technology used, will only be 
achieved with some degree of automatic data processing and interpretation. 
Computer Assisted Decision Support. 
Background. The need for an objective, standardised interpretation of the CTG was 
recognised in the 1960s. The initial systems were expensive mainframe computers which 
performed their analyses from signals stored on magnetic tapes (Flowers et al, 1971, 
Crawford et al, 1975, Wade et al, 1976). The development of relatively inexpensive 
microcomputers allowed more sophisticated bedside analysis (Wickham et al, 1983) but 
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many workers chose to concentrate on the relatively simpler task of antenatal CTG 
interpretation (Searle et al, 1988, Dawes et al, 1982a, 1982b). Two systems have been 
specifically designed for intrapartum CTG analysis in Japan and Germany (Maeda, 1990, 
Krause, 1990). These systems are essentially aimed at overcoming the inadequacies of 
visual inspection of data. Maeda's system allocates scores to various CTG features and 
calculates a Fetal Distress Index every 15 minutes which classifies the CTG as either 
'normal', 'requires further monitoring', 'suspicious' or 'diagnostic of fetal distress' (Maeda, 
1990). Despite much descriptive information there are few reports of any observational 
studies (Parsons et al, 1985). Krause, from former East Germany, also extracts CTG 
features but combines them to calculate the discriminative function index (DF) based on a 
mathematical model. The CTG recording is not displayed but rather a plot of the DF with 
time is shown. A number of alarms are triggered by different heart rate patterns. In a 
multicentre study which compared 403 patients in labour monitored by this system and 393 
by visual CTG analysis there were significantly more prepathological CTGs and FBS in the 
computerised group but no difference in operative intervention or neonatal outcome 
(Krause et al, 1988). 
Expert systems. Further advances in computing technology have now produced computer 
programs which can simulate expert behaviour. These Expert Systems (ESs) use expert 
knowledge to attain high levels of performance over a narrow problem area or domain. The 
expert knowledge includes both facts - a body of information which is widely available, 
generally agreed upon by experts in the field and heuristics - private, little discussed rules 
of good judgement or intuition which characterise expert-level decision making in the field. 
In other words, ES aim to capture the 'art' of decision making in a specified area. They 
manipulate knowledge while most conventional programs manipulate data and they have 
solved complex tasks in many diverse areas where conventional computing approaches have 
failed (Waterman, 1986). 
ES have wide applications in industry and manufacturing; the British Department of Trade 
and Industry has estimated that manufacturing industries could save £1.3 billion per annum 
by introducing ES techniques into maintenance procedures (Rada et al, 1991). Military and 
aeronautical applications are also extensive; e.g. the NASA space shuttles have three ES for 
navigation. The most famous medical precursor to modem ES was MYCIN, developed in 
the mid~ 1970s to aid physicians in the selection of the most appropriate antibiotics for 
patients with bacteremia and meningitis (Shortliffe et al, 1973). Since then a large number 
of medical ESs have been developed for both diagnosis and treatment for a wide range of 
conditions from chest pain to depression and glaucoma to lung disease (delightfully entitled 
PUFF). Most of these have reached the 'research prototype' stage (Waterman, 1986) and 
have yet to be introduced into routine practice. 
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The ability to incorporate expert knowledge into a computer system for intrapartum 
monitoring is an attractive idea. Computers work consistently 24 hours a day without 
becoming tired. If an effective ES could be designed, improved interpretation of CTG and 
ST waveform recordings and better management advice might increase the effectiveness of 
the CTG or ST waveform in clinical practice. This could also apply to any other 
combination of variables shown to be useful in the future. 
In clinical practice, CTG changes are interpreted in context with labour-associated events 
(e.g. analgesia, uterine contraction frequency) and with knowledge of specific risk factors 
(e.g. growth-retarded fetus). An ES would allow these important factors to be incorporated 
into decision making. These systems can also explain the reasoning behind the advice they 
give and may also have a useful teaching role. 
Several groups have investigated ES for antenatal CTGs with encouraging results (Becksa~ 
et al, 1990a & b, 1991, Devoe et al, 1992). A large ES termed FOETOS with 5 separate 
components; antenatal CTG, fetal biophysical profile, contraction stress test, labour and 
neonatal diagnosis has also been described (Aionso-Betanzos et at, 1989) although 
preliminary assessment of its performance during labour in a smaU series of cases showed 
only 50% agreement with clinical experts. 
The aim of the final two studies reported in this thesis were to assess the feasibility of an 
Expert systems approach to CTG interpretation. This work is one of the main research 
initiatives of the Plymouth Perinatal Research Group. It was performed in conjunction with 
a research engineer, Robert Keith, and forms part of his PhD Thesis (Keith, 1993). A patent 
for the system developed has been applied for. 
Methods. 
The requirements and design of an ES for CTG interpretation and labour management were 
established during structured and unstructured interviews between 3 experienced clinicians 
and the ES engineer over a three month period. A simple block diagram of the system is 
shown in Figure 6.1. 
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Figure 6.1 Simple block diagram of the Expert System designed for CTG interpretation. 
Heart rate and uterine contraction signals are digitised and recorded from a standard CTG 
recorder. The important features (baseline, accelerations, decelerations [type and timing], 
contraction frequency and signal quality) are extracted using algorithms. Additional 
information relevant to each specific pregnancy and events during labour are combined with 
the CTG features and passed to the ES. The Knowledge Base contains long term 
information about CTG interpretation in the form of a series of rules which the ES applies 
to the dynamic knowledge to make an assessment of fetal condition which, along with any 
recommendations for action, is passed to the clinician. 
Off-line assessment of the Knowledge Base. 
Clinical assessment, interpretation and management of intrapartum CTG changes was 
represented in a series of decision tree diagrams. These flow diagrams were incorporated 
into a series of rules and conditions to create the Knowledge Base for the ES (see Figure 
6.2 for an example). The ES was implemented in PROLOG on a 486 IBM compatible PC. 
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The previou& trace was normal NOT the previou& trace was normal 
NOT wa~ 1 o mlns & baseline lmproYed 
Figure 6.2 A section of the decision tree which makes up the Knowledge Base. Some of 
the rules derived from this tree are shown below. A rule is made of a series of conditions 
and has a GOAL. (Modified from Ifeachor et al, 1991). 
Rule 34 
Rule 35 
Rule 36 
IF Baseline <90 AND 
The previous trace was normal AND 
NOTwait 10 mins & baseline improved THEN 
DELIVER 
IF Baseline <90 AND 
The previous trace was normal AND 
Wait 10 m ins & baseline improved AND 
Wait further 10 mins & baseline normal THEN 
Fetus now high risk 
OBSERVE 
IF Baseline <90 AND 
The previous trace was normal AND 
NOTwaitfurther 10 mins & baseline normal AND 
Easy vaginal delivery THEN 
DELIVER 
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At this preliminary stage infonnation about CTG features was entered manually via the PC 
keyboard. This system was evaluated on recordings from 31 labours in the CTG arm of the 
randomised trial. These 31 labours were chosen randomly from the group who had an FBS 
during labour to ensure that a high percentage of abnonnal cases were reviewed. All cases 
were reviewed retrospectively, blind to outcome by the author (JW) who acted as a 'clinical 
expert' and by a midwife using the ES (MW+ES). The midwife used a template which only 
allowed 10 minute sections of the CTG to be seen at one time. She described four features 
for each 10 minute epoch; baseline heart rate, variability, presence or absence of 
accelerations and the presence, absence and type of decelerations. The ES interrogated for 
additional infonnation as required (e.g. progress of labour, drugs administered). The 
management recommended by the MW+ES was compared with that recommended by JW 
and with what actually happened in clinical practice (Ifeachor et al, 1991). 
Preliminary on-line evaluation. 
In the next phase techniques to automatically extract CTG features and present them to the 
ES were developed. Heart rate and contraction signals were obtained from the analogue 
output of a conventional Hewlett-Packard CTG recorder. The signals were digitised and the 
important features (baseline, variability, accelerations and decelerations) extracted using 
algorithms (Keith, 1993, Keith et al, 1993a). 
During the randomised trial the CTGs from 300 patients were digitised and recorded onto 
Optical Discs. One hundred cases were used during development of the feature extraction 
algorithms. From the remaining 200 cases, the nine cases in which clinical intervention for 
'fetal distress' (fetal blood sampling and/or operative delivery) occurred and 21 cases 
without intervention chosen at random were selected for a preliminary on-line evaluation of 
theES. 
The clinical decisions taken in these 30 cases were compared with those recommended from 
a retrospective review of the cases by the system and three experienced clinicians, (A, Band 
C). The reviewers assessed the cases independently, blil)d to outcome and with no 
knowledge of the system's recommendations or each others. The CTGs were exposed in 15 
minute segments and each reviewer was asked to make an assessment of fetal condition 
based on the newly-revealed segment, the previous recording and the clinical infonnation 
known at the time. They were then asked to specifY an appropriate course of management; 
continue with the labour, obtain a FBS or request operative delivery. It was not possible for 
any reviewer to see future segments before the present segment had been assessed. Any 
additional infonnation gained from actual clinical action was only revealed to the reviewers 
if they too had specified the same action. 
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The consistency of reviewer A was also assessed in a second assessment (A2) of the same 
cases five months later with the case order randomised. Reviewers B and C had helped 
compile the results of the first assessment and were thus too familiar with the cases to make 
their subsequent review useful. 
Results. 
Off-line study. 
In each of the 31 cases reviewed at least one FBS had been perfonned in clinical practice. A 
comparison of the intervention and possible outcome made by JW and MW+ES is shown in 
Table 6.1. 
Table 6.1 Comparison ofFBS, operative delivery and outcome in clinical practice with that 
recommended in a review of 31 cases by a clinical expert (JW) and a midwife interacting 
with the Expert System (MW+ES). 
clinical JW MW+ES 
practice recommendations recommendations 
FBS 31 16 13 
Operative delivery for 'fetal 15 12+11 12+1 1 
distress' 
Cord artery pH<7 .15 8 42 42 
5 min Apgar <8 6 22 22 
1 Three fewer operative deliveries were recommended than were actually performed, and one 
additional was recommended but not performed in clinical practice. 
2 Possible reductions due to earlier delivery. 
There was good agreement between JW and MW+ES. Both would have reduced the 
number of patients having FBS by nearly 50%. Discrepancies occurred in only five cases 
(16%) and resulted from differences in visual assessment. In four cases the disagreement 
was in the type of deceleration present and in one case it was the baseline heart rate. The 
omission of an FBS would not have adversely affected the outcome in any case and would 
have prevented a forceps delivery in one of them. This FBS was perfonned within 15 
minutes of a prolonged deceleration accompanying a tonic contraction. The pH was 7.17 
but after a Keillands delivery 15 minutes later the cord artery pH was 7.28, Apgars 9 at one 
minute and 10 at five minutes. An extra FBS was recommended by both JW and MW+ES in 
3 cases and may have reassured clinicians sufficiently to prevent two subsequent forceps 
deliveries for 'fetal distress' (cord artery pH 7.32 and 7.35). 
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JW and MW+ES both identified the same three cases for whom an operative delivery for 
'fetal distress' was not required (cord artery pH 7.27, 7.28, 7.30, Apgar 8 at one and 9 at 
five minutes). However, both identified the same additional case where an operative 
delivery was indicated 20 minutes before a spontaneous delivery occurred (cord artery pH 
6.95, BDecf9 mmoVI, Apgars 6 at one and 9 at five minutes). 
In seven cases both JW and MW+ES specified that action (FBS or delivery) was required 
20 to 70 minutes earlier than actually happened. Three cases had low cord artery pH (7.01, 
7.05, and 7.13) and required three to four minutes resuscitation at birth. Two of these were 
admitted to SCBU. 
On-line study. 
In 18 of the 30 cases studied, no action was taken clinically nor was recommended by any 
reviewer or the system. Neonatal outcome was good in every case with no metabolic 
acidemia and normal Apgar scores at five minutes. 
The 12 remaining cases where intervention occurred clinically or was recommended by the 
system or a reviewer, are shown in Table 6.2. 
Table 6.2 Details of cases where intervention was specified or occurred. 
Cue Number orretal blood 18111pla Operative deUvery 
No ES AI B c A2 din ES AI B c A2 
I 2 I 2 
2 I I I 
3 I 0 0 
4 0 0 0 
3 I 0 I 
6 0 0 0 
7 0 0 0 
8 0 0 0 
9 0 0 0 
10 I I I 
11 0 0 0 
12 2 2 2 
A I lin;t case n:view by A 
A2 se<lOIId case n:view by A 
2 I 2 
0 I I 
I 0 0 
I 0 0 
0 0 I 
0 0 I 
0 0 0 
0 0 0 
2 0 2 
I 0 0 
0 0 2 
2 2 2 
CS CS CS 
CS .. CS 
. . . 
. . . 
for for for 
. . . 
for for for 
for for for 
. . . 
CS CS CS 
. . . 
CS CS CS 
cs caesarean sec:tioo 
for forceps deUvcry 
CS CS 
. CS 
. 0 
. . 
for for 
. . 
for for 
for for 
. . 
CS CS 
. 0 
CS CS 
Cord pH 
clin artery vein 
CS 7.21 7.31 
CS . 7.26 
0 7.26 7.29 
. 7.13 7.21 
. 7.07 7.27 
. 7.29 7.36 
for 7.23 7.33 
. . 7.12 
. 7.27 7.36 
CS 7.07 7.12 
. 7.20 7.38 
CS . 7.29 
CordBDed Appn 
artery vein I' 3' 
6.1 7.1 7 10 
. 7.1 7 9 
1.2 2.8 6 8 
8.8 10 8 9 
7.4 7.0 9 9 
4.6 4.1 7 9 
1.8 0.9 6 9 
. 11.2 9 9 
0.9 1.1 8 9 
7.2 5.2 3 8 
3.3 4.0 8 9 
. 3.9 9 9 
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All actions recommended by the system were also recommended by at least one reviewer. 
All reviewers and the system recommended earlier delivery in the three cases with lowest 
cord pHs (cases 5, 8 and 10); in cases 5 and 8 a forceps delivery was recommended, 30 and 
50 minutes respectively, before a spontaneous vaginal delivery occurred. In case 10, a FBS 
was recommended by all reviewers and the system (except A2) 40 minutes before the CTG 
severely deteriorated and an emergency caesarean section was performed. Further, 
operative intervention was recommended in the same seven cases by the system and all 
reviewers within 15 minutes, with one exception. The difficulty in this case (case 2) was 
with identification of the baseline heart rate. The system and reviewers A and B interpreted 
the recording as having a normal baseline with late decelerations and recommended a FBS, 
whilst reviewer C alone thought the baseline was low with accelerations. (Figure 6.3). It 
may be significant that C reviewed the cases for the study late at night whilst the others did 
so during daylight hours. In clinical practice an FBS was performed and the pH of 7.15 
obtained precipitated immediate delivery by caesarean section. This case illustrates the 
importance of accurate identification of baseline heart rate for the correct classification of 
periodic changes. 
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Figure 6.3 What is the baseline heart rate? CTG from Case 2 of the on-line study in which 
reviewers A and B and the Expert System thought the baseline was 140 bpm with 
prolonged decelerations to l 00, whilst C thought the baseline was 100 bp m with 
accelerations to 140 bpm. 
The actions recommended by the system, the reviewers, and the actual clinical management 
of the 30 cases were further compared. An agreement in management was said to occur 
when all recommendations for fetal blood sampling and recommendations for operative 
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delivery were specified within 15 minutes. The number of case agreements are shown 
below. 
Table 6.3 Number of cases with complete agreement (maximum 30). 
Number of agreements 
ES Al B c clinical 
ES - 27 29 25 22 
Al 27 
-
28 25 22 
B 29 28 - 24 23 
c 25 25 24 - 21 
clinical 22 22 23 21 -
The actions recommended by reviewer A in his two reviews (AI and A2) were entirely 
consistent in both action and timing in 28 out of 30 cases. Differences in fetal blood 
sampling occurred in cases 1 0 and 12, however operative delivery was still recommended 
in the same 15 minute segment in both reviews. 
Discussion. 
These studies have demonstrated the feasibility of an Expert Systems approach to CTG 
interpretation. The ES performed as well as clinical experts and better than clinical practice 
in both studies. In the on-line study, every action recommended by the ES was also 
recommended by at least one experienced reviewer. The highest level of agreement was 
with reviewer B (the author) whose knowledge had principally been incorporated into the 
system. 
The on-line study also found that the experienced reviewers tended to agree on their 
interpretation of the CTG and subsequent management. These results are consistent with a 
larger study (Murphy et al, 1990), which obtained good inter-observer agreement (Kappa 
statistic 0.74, p < 0.0001) from a comparison of the recommendations of three experienced 
clinicians in a retrospective review of 158 cases. Many more studies have found poor 
agreement between reviewers (Trimbos & Keirse, 1978, Lotgering et al, 1982, Nielsen et 
al, 1987, Donk:er, 1991) but the true expertise of their reviewers could be questioned. The 
reviewers in this study and that of Murphy et al were active clinicians who regularly 
reviewed CTG recordings whilst those in Donk:er's study were heads of Department or 
Professors, many of whom were no longer active in intrapartum obstetrics. 
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The aim of an ES is not to replace experts but to guide inexperienced staff toward 
appropriate decision-making. Expert Systems can do this 24 hours a day, in every labour 
room and will not be affected by stress or tiredness. Because these systems can explain the 
reasoning behind their recommendations they can also contribute to staff education. 
As yet no medical ES has achieved widespread acceptance but their increasing use in non-
medical applications is sure to eventually have a 'knock-on' effect into medical areas. The 
acceptability of these 'expert' systems to clinicians, midwives and women in labour should 
be considered. Computer technology is now widely available in schools, homes and 
hospitals and many people are becoming more computer-literate. But the key question is 
whether clinicians and midwives accept advice from a machine? The impression gained 
during the studies reported in this thesis is that junior doctors and midwives find the labour 
ward a stressful place and would be grateful for all the help they can get. Of course, the 
acceptance of any computerised system must depend on the quality of the advice it 
provides, how robust it is and on evidence obtained from randomised trials that its use is 
appropriate in the clinical situation. 
Future work. 
Whilst these studies have confirmed the potential of an ES for CTG interpretation, a full 
validation procedure will need to be carried out before it is introduced into clinical practice. 
This work is now in progress and involves 17 clinical experts in 16 UK centres who are 
reviewing 50 complete labour records blind to outcome (Keith, 1993). Their 
recommendations for management will be compared with that of the ES and the actual 
clinical outcome. The user-interface will be developed and the system further tested in 
observational studies. Ultimately, the ES will be assessed in randomised clinical trials. In the 
future an ES for the interpretation of ST waveform changes will be developed and linked 
with the CTG system. An ES to aid clinicians in the interpretation of cord blood gas results 
is also under development by our group (Keith et al, 1993b). 
In summary, staff training and education in the interpretation of intrapartum CTG changes 
has failed to provide a consistently high level of expertise in every labour ward 24 hours a 
day. The addition of other variables which reflect fetal condition may make training and 
interpretation more complicated. An Expert Systems approach to data processing and 
interpretation may be the only way in which the full potential of electronic fetal monitoring 
will be realised in clinical practice. 
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Sum,mary andi~Conchasions 
Chapter, Seven, page 156: 
Summary. 
• Dissatisfaction with the electronic recording of fetal heart rate and uterine contractions 
has resulted in a search for new techniques for monitoring the fetus during labour. It is 
important that each method has a sound physiological and pathophysiological basis, a model 
for the interpretation of changes and is thoroughly evaluated before introduction into 
clinical practice. 
• Analysis of the ST waveform of the fetal electrocardiogram is the most advanced of the 
new techniques under investigation. Experimental studies have shown that elevation of the 
ST waveform occurs with a switch to myocardial anaerobic metabolism and that a negative 
waveform occurs during direct myocardial ischaemia. Human observational studies have 
suggested that a combination of ST waveform and CTG analysis may improve the 
specificity of intrapartum monitoring and reduce unnecessary intervention. 
• A high quality FECG signal is necessary for waveform analysis; rubbish in, rubbish out. 
The FECG can be recorded from a fetal scalp electrode (FSE) during labour. The suitability 
of 5 commonly available FSEs for waveform analysis was compared. Single spiral FSEs had 
the most favourable physical and electrical properties and produced the best quality signals 
in a randomised clinical trial of 50 fetuses in labour. 
• The on-line microprocessor system for ST waveform analysis (the ST ANalyser, ST AN, 
Cinventa AB, Sweden) was validated before it was used in clinical studies. The filter 
characteristics of the system were appropriate for FECG waveform analysis. A number of 
adjustments to the ST AN were recommended to improve signal quality and user-
friendliness. 
• Intervention rates and neonatal outcome in labours monitored with CTG alone were 
compared with those monitored with the combination of ST waveform analysis plus CTG 
(ST+CTG) in a randomised clinical trial of2434 high risk labours over an 18 month period. 
There was a 46% reduction in operative intervention for fetal distress in the ST +CTG group 
(p<0.001, OR 1.96, [1.42 to 2.71]). There was a trend to less cord arterial metabolic 
acidemia (p = 0.09, OR 2.63 [0.93 to 7.39]) and fewer low five minute Apgar scores (p = 
0.12, OR 1.62 [0.92 to 2.85]) in the ST+CTG arm. 
• All recordings from the trial were reviewed retrospectively, blind to outcome and 
classified as normal, intermediate or abnormal according to the trial protocol. There was no 
significant difference in the proportion of recordings in each category between the trial 
arms. Operative intervention in the ST +CTG arm was significantly reduced in recordings 
classified as normal and intermediate by the review (1211043 ST+CTG arm versus 48/1066 
CTG arm, p <0.001, OR 0.25 [0.12 to 0.48]). 
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• Three patterns of ST+CTG change were identified. 
1. Normal CTG, persistent stable ST waveform elevation. These fetuses had a good 
outcome and a significantly higher mean pH (7.29 [7.27-7.30]} and lower BDecf (1.1 
mmol/1 [0.3-1.9]} at delivery. The raised ST waveform may reflect sympathoadrenal 
stimulation from the general arousal of labour or a response to mild but compensated 
hypoxaemia and is in keeping with experimental data. 
2. CTG abnormal, progressive elevation in ST waveform. All cases occurred towards the 
end of the second stage. These fetuses had a significantly lower mean pH (7.05 [7.02-7.08]} 
and higher base deficit (7.6 mmol/1 [6.1-9.1]} than all other groups. This combination 
identified fetuses who were developing a metabolic acidosis as a result of significant 
hypoxia. 
3. Abnormal CTG and a negative ST waveform. All cases with persistently negative 
waveforms were depressed at birth, required resuscitation and had low arterial pHs (where 
available}; one died and one had transient neurological abnormalities. This high risk group 
probably had depleted myocardial glycogen reserves and suffered direct myocardial 
hypoxia, as seen in animal studies. 
• These findings indicate that ST waveform analysis can discriminate CTG change during 
labour. The protocol is safe and depends upon adequate education and training of staff. The 
combination can result in a reduction in unnecessary intervention and has the potential to 
more accurately identifY fetuses at risk of neonatal morbidity. Use of this technology also 
offers significant health care gain in terms of reduced morbidity and reduced delivery costs 
due to lower operative intervention rates. Further randomised trials in other units are 
required to confirm these findings and to provide further data to assess the possible effect 
on improved neonatal outcome. 
• The retrospective review of trial recordings revealed significant difficulties with fetal 
blood sampling. Patient selection had been poor with 39% of FBS cases in each trial arm 
performed unnecessarily whilst 33% {CTG arm) and 23% (ST+CTG arm) of those who 
should have had a FBS did not have this done. The severity of CTG abnormality had no 
effect on the time from the onset of CTG change to FBS. Only 43% {CTG) and 53% 
(ST+CTG) of the emergency LSCS performed for fetal distress were preceded by a FBS. 
The use ofFBS did not prevent subsequent poor outcome. 
• FBS provides an intermittent variable which requires an extra invasive procedure which 
is inconvenient and uncomfortable for both mother and obstetrician and thus is infrequently 
used in clinical practice. FBS and the CTG are not independent variables. The decision to 
obtain a FBS depends upon interpretation of the CTG. If this is suboptimal, the value of 
FBS will be limited. Correct use of the information obtained at FBS requires an 
understanding of the events of labour and of the physiology of acid-base balance during 
labour. 
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• The second stage was identified as a crucial time for a fetus in labour. Half of the birth 
asphyxia cases studied in the review were associated with problems in the second stage. 
Most were weU grown and supposedly 'low' risk. Cord problems were associated with the 
majority of cases. In the second stage contraction strength and frequency increase so there 
is less time for placental gas exchange and fetal hypoxaemia increases. Fetal reserves may 
have been depleted during the first stage, particularly if this has been long or associated with 
uterine hyperstimulation. The second stage is also the time when obstruction in a nuchal or 
very twisted cord is most likely to occur further impairing gas exchange. 
• Despite the high level of training and education associated with the trial, the majority of 
birth asphyxia cases in this study had very obvious CTG abnormalities which should have 
precipitated intervention or more timely intervention. The term 'monitoring' implies a degree 
of automatic surveillance but this is not the case. Current intrapartum CTG monitoring 
relies on subjective interpretation of the available information, frequently by junior, 
inexperienced staff. 
• The randomised trial also demonstrated the lack of appropriate measures of neonatal 
outcome with which to judge the effectiveness of fetal monitoring. The use of generic 
terminology such as 'birth asphyxia' or 'acidosis' which have varying definitions has caused 
much confusion and should be avoided. There is unlikely to be one 'gold standard' measure 
ofneonatal condition at delivery. 
• Analysis of cord artery and vein blood gas status at delivery can provide useful 
information about fetal oxygenation prior to delivery but currently the information is poorly 
used, if at aU. Use of erroneous data, inappropriate measures of 'acidemia', failure to 
distinguish between respiratory and metabolic components and unphysiological expectations 
about relationships to other measures of neonatal outcome were some of the problems 
highlighted in a review of cord blood gas data from the trial. 
• The importance of accurate interpretation of data was ·highlighted by the retrospective 
review. Given the realities of staffing situations and the levels of expertise available in 
hospitals throughout the country, it is most likely that consistent, optimal interpretation of 
the information in the CTG, ST waveform analysis, or any new technology, will only be 
achieved with a degree of automatic data processing and interpretation. 
• The use of Expert Systems technology may aUow the knowledge of expert clinicians to 
be incorporated into a computerised system which can support the decision making of 
junior or inexperienced clinicians. These systems can explain the reasoning behind their 
recommendations so may have a useful teaching role. The feasibility of representing expert 
clinical knowledge to provide consistent, accurate interpretation of the CTG has been 
demonstrated in two clinical studies. 
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Conclusions. 
The work of this Thesis has attempted to place the clinical interpretation of electronic fetal 
monitoring on a more scientific basis. Intrapartum monitoring is a somewhat emotive 
subject so it is not too surprising to find that the CTG was first heralded as the key to 
preventing fetal death and handicap. Now the pendulum has swung almost as far in the 
opposite direction so that it is regarded as disappointing and unsatisfactory and is blamed 
for much unnecessary operative intervention. The truth of the matter probably lies in the old 
saying 'a poor workman blames his tools' - either because he has chosen the wrong tool for 
the job or because he is not using it as skilfully as is required. 
The CTG is a useful, but rather blunt tool. This thesis has shown that ST waveform analysis 
of the fetal ECG provides the obstetrician with an additional and more specific tool which 
reflects the function of a vital central organ, the heart. Furthermore, it is a continuous 
variable which is available from the same signal source as the CTG. This has been the first 
time that a new concept for intrapartum monitoring has been tested in a randomised trial 
prior to introduction into clinical practice. The importance of ST waveform shape has been 
highlighted. Contraction related changes should be investigated further and the technology 
of the ST ANalyser should be updated. 
The CTG and fetal blood sampling are currently used rather poorly in clinical practice. 
There is little point in providing clinicians and midwives with large amounts of complex 
information, be it CTG, ST waveform or acid-base status, if they are unable to interpret it 
correctly. Education and training in CTG interpretation have not produced satisfactory 
results despite 25 years of clinical use. Given the realities of labour ward staffing situations 
and the levels of expertise available in hospitals throughout the country, it is most likely that 
consistent, optimal use of the information provided by electronic fetal monitoring will only 
be achieved with some degree of automatic data processing and interpretation. The 
feasibility of a computerised expert system for the interpretation of CTG changes has been 
demonstrated. This work will be extended in further studies and eventually will include an 
expert system for ST waveform analysis. 
There is a lack of appropriate measures of neonatal outcome with which to judge the 
effectiveness of electronic monitoring tools. Many of the current measures are inappropriate 
because they are used in isolation. Analysis of cord artery and vein blood gas status at 
delivery can provide useful information about fetal oxygenation prior to delivery but 
currently the information is poorly used, if at all. The use of generic terminology such as 
'birth asphyxia' or 'acidosis' which have varying definitions has added to this confusion and 
should be avoided. There is unlikely to be one 'gold standard' measure ofneonatal condition 
at delivery. 
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Appendix One. Summary of new and existing methods for intrapartum fetal surveillance. 
Modified from Greene & Rosen, Plymouth Perinatal Asphyxia Meeting, 1992. 
Each method has been assessed according to three important requirements; the pathophysiology, available technology and potential 
clinical usefulness. A summary of how well each requirement is fulfilled is given by the symbol allocated in each category; 
? -unknown,(+)- possibly,+- fulfils some requirements,++- fulfils most requirements and +++-best fulfils the requirements. 
Method Patbophysiolo!Y Technolo2Y Clinical usefulness References 
Continuous CTG + ++ ++ Court & Parer, 1984 
Empirical knowledge Robust Long experience, routine use MacDonald et al, 1985 
Limited experimental data Requires subjective Identifies normal Parer, 1990 
Complex interpretation Randomised trials Murphy et a1, 1990 
Primary variable ? C' •· , y of interpretation 
ECG time constants (+) (+) (+) Murray, 1986 
Relationship ofPR to RR Patented technology ? Deceleration discriminator Widmark et al, 1991 
intervals. Not widely available Limited observational data 
Heart rate dependent 
ST waveform analysis +++ +(+) +(+) Greene, 1987 
Reflects myocardial metab- Available Observational data Rosen et al, 1992 
olism; elevation- glycolysis & Improvements 
catecholamines; biphasic & necessary 
ne_gative- direct hypoxia 
Fetal blood sampling +(+) + +(+) Saling & Schneider, 1967 
Reflects placental function Intermittent Not widely used Beard et al, 1967 
Mixed variable Cumbersome ? Interpretation Clarke & Paul, 1985 
Gives a figure Whebble et al, 1989 
Continuous tissue pH + (+) ? Weber & Hahn-Pedersen, 
As above ? Attachment Some observational data 1979 
Does not distinguish metab- ? Calibration Tonsure effect Nickelsen & Weber, 1991 
olic and respiratory acidosis ? Significant level 
? Trend analysis useful 
Continuous tissue + (+) ? Hansen et al, 1984 
pCOz Mixed variable ? Attachment Tonsure effect, compression Schmidt & Sating, 1987 
Respiratory acidosis ? Calibration effect. ? Significant level Nickelsen & Weber, 1987 
? Trend analysis 
Pulse Oximetry +(+) (+) ? Johnson 1991, et al, 1991 
Reflects degree of Patented technology Limited observational data Jongsma et al, 1991 
hypoxaemia but not organ ? Attachment ? Level of sl.gnificance Swedlow, 1991 
Oz supply. ? equivalence of ? Signal processing ? Trend analysis 
animal studies ? Signal quality 
Near Infrared +? (+) ? Delpy, 1991 
Spectroscopy Measure of cerebral blood ? Attachment Neonatal use Reynolds et al, 1991 
flow - high priority organ ? Signal quality Scant observational data Peebles et al, 1992a & b 
? Level of significance 
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1. Raw data from randomised trial. 
My supervisor was very anxious that I should include evidence of the raw data from the 
randomised trial in an Appendix. Due to the vast amount of data collected the only way this 
could be achieved was to include a photograph of the case record forms which are stored in 
98 lever arch files in the Perinatal Research Group offices. Each patient record contains a 
completed case record form (see next page for a copy of this form), the original CTG or 
STAN recording and the printout ofthe cord blood gas results from the blood gas analyser. 
Appendix Two, page 164 
Appendix Two. 
2. Case record form used in randomised trial. 
Date 
Patient ID 
Study number 
Date Ol birth 
Parity 
1 Alive at 26 days 
2 Neonatal deaths 
3 Stillbirths 
Best estimate ol gestational age (completed weeks) 
Confirmed by uhrasound between 16 and 24 weeks 
1 Yes 
2 No 
Antenatal complications 
1 Normal 
2 Protelnuric pre·eclampsla 
3 Diabetes 
4 Suspected IUGR 
5 Antepartum haemorrage 
.6 Others 
Drugs In pregnancy (Specny generic names) 
Presentation 
1 Cephalic 
2 Breech 
Onset ol labour 
1 Spontaneous 
2 Induced 
Time ol onset ol tabour 
. Rupture ol membranes 
1 Spontaneous 
2 Artificial 
Time ol membrane rupture 
Drugs 
1 Oxytocin 
2 PG 
3 Both 
Liquor 
1 Clear 
2 Meconium 
3 None 
Analgesia tor labour 
1 None 
2 TENS 
3 Pethidine 
YYMMDD 
I I 
I I 
I I 
I I 
D 
DD 
0 
D 
D 
D 
I I 
I I 
DDHH MM 
I I I I 11 I 
D 
HHMM 
I I I I I 
D 
D 
D 
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4 Epidural 
5 Others (specHyJ 
Time first given (D,O,H,H,M,M) 
CTG record (lime ol onset) 
STAN record 
Time begun 
Time ended 
FBS: 
Tirrie (H,H,M,M) 
Cxdil 
pH 
pCO, 
pO, 
BE (eel) 
Time stan second stage 
Time or delivery 
MOde ot delivery 
1 svo 
2 Ventouse, for rotation 
3 Veillouse, non-rotation 
4 Forceps, tor rotation 
5 Forceps, non-rotation 
6 Caesarian, epidural 
First 
7 Caesarian, general anaesthesia 
Reason tor operative delivery 
1 Abnormal CTG 
2 pH 
3 Failure to progress 
4 Other 
5 Abnormal ECG waveform (specHy) 
Complications or delivery (specHy) 
Blnh weight, grams 
Blnh welght·cantlle or S.D. 
SGA 
Sex 
1 Yes 
2 No 
1 M 
2 F 
Placemal weight (if available), grams 
second 
I I 
0 
HHMM 
I I I I I 
Third 
0 
0 
I I I 
m 
0 
0 
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Cord Arterial 
pH 
pCO, 
pO, 
BE (eel) 
Cord Vein 
pH 
pCO, 
pO, 
BE (eel) 
Apgar scores 
1 min 
5 min 
10 min 
Time to first breath (min) 
Time· Onset of regular breathing (min) 
Paediatrician present at delivery? 
1 Yes 
2 No 
Resuscitation 
Time of onset (min after delivery) 
Duration (min) 
Mat hod 
1 Facemask only 
2 IPPV 
Drugs tor resuscitation (specify) 
Admission to SCBU? 
1 No 
2 Yes 
Age when admitted to SCBU 
Reason 
1 Asphyxia 
2 Hypothermia 
3 SGA 
4 Congennat abnormalny - specify 
5 Apnoea 1 Cyanosis 
6 Others - specify 
First neonatal blood gas 
Time 
Route 
pH 
pCO, 
pO, 
1 Capillary 
2 Arterial 
3 UA catheter 
BE (eel) 
rn 
rn 
rn 
rn 
SJ 
rn 
rn 
0 
0 
DOH HMM 
1111111 
0 
HHMM 
I I 11 I 
0 
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Respiratory suppon (day) 
1 None 
2 0 2 alone 
3 CPAP 
4 IPPV 
Reason for respiratory suppon 
1 Apnoea 
Sedation 
1 Yes 
2 No 
Neurology 
2 Cyanosis 
3 Olher (specily) 
Reactivity 
1 Normal 
2 Apathy 
3 Hyperexltabte 
Seizures 
Tonus 
1 None 
2 Focal 
3 General 
1 Normal 
2 Hypotonic 
3 Hypertonic 
Hypoglycaemia 
1 Yes 
2 No 
Lowest blood glucose 
Main feeding pattern (day whilst In hospHal) 
1 Breast 
2 Bonle 
3 Tube 
4 IV 
Date of discharge from SCBU (M,M,D,D) 
Date or discharge from hospnal (M,M,D,D) 
Diagnosis on discharge (specify) 
Paediatric follow-up 
1 Yes 
2 No 
Post monem requested 
1 Yes 
2 No 
Remarks ... 
12 34567 
DDDDDDD 
DDDDDDD 
DDDDDDD 
DDDDDDD 
D 
D 
D 
D 
D 
D 
1234567 
DDDDDDD 
DDDDDDD 
DD D DODO 
DDDDDDD 
I I I I I 
I I I I I 
D 
D 
Appendix :fwo, page 168 
Appendix Three. 
Secondary analysis of randomised trial entries who 
recieved the allocated treatment. 
Table l. Randomisation details. 
CTG ST+CTG pvalue Odds ratio (95o/oCI) 
n=1212 n=1188 
Maternal age (years) mean 26.5 26.3 >.05 (-0.23-0.63)1 
SD 5.4 5.3 
Gestational age (weeks) mean 39.6 39.6 >.05 (-0.13-0.13)1 
SD 1.6 1.6 
Primigravidae 821 805 .97 0.99 (0.84-1.19) 
Antenatal complications Total 230 256 .13 0.85 (0.70-1.04) 
- preclampsia 33 39 .49 0.83 (0.52-1.32) 
- previous LSCS 17 17 .91 0.99 (0.51-1.95) 
- growth retardation 27 24 .83 1.11 (0.63-1.93) 
- antepartum haemorrhage 19 12 .30 1.56 (0. 75-3.23) 
- post dates (<!:4 2 weeks) 76 97 .09 0.75 (0.55-1.03) 
-others2 58 63 .63 0.90 (0.62-1.29) 
Breech 25 270 .83 0.91 (0.52-1.57) 
Inductions 393 437 .03 0.83 (0.70-0.98) 
Epidural analgesia 663 689 .11 0.88 (0.74-1.03) 
Meconium liquor 202 196 .96 1.01 (0.82-1.26) 
Birth weight (grams) mean 3364 3386 >.05 (-97.3-53.3) 1 
SD 502 517 
Birth weight < 1Oth centile 43 36 .51 1.18 (0.75-1.85) 
1. 95% Cl for dtfferences between means. 
2. hypertension, diabetes, reduced fetal movements, urinary tract infection, asthma, 
polyhydramnios, anaemia. 
Table l. Fetal blood sampling by numbers of cases and number of samples. 
CTG ST+CTG p value odds ratio 95%CI 
n=l212 n=ll88 
Number of cases 114 90 .13 1.27 (0.95-1.69) 
Number of samples 168 125 .02 1.37 (1.07-1.75) 
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Table 3. Indications for operative delivery. 
CTG ST+CTG p value odds ratio 95%CI 
n==l212 n==ll88 
Abnormal FBS pH 19 15 .65 1.25 (0.63-2.46) 
Abnonnal trace 92 45 <.001 2.09 (1.45-3.01) 
Total deliveries for 111 60 <.001 1.88 (1.45-2.60) 
'fetal distress' 
Deliveries for 'failure to 267 269 .76 0.97 (0.80-1.17) 
progress' 
Table 4. Mode of delivery for 'fetal distress'. 
CTG ST+CTG p value odds ratio 95%CI 
n==l212 n==ll88 
LSCS 30 15 .04 1.98 (1.06-3.710) 
Rotational forceps 13 9 .55 1.42 (0.61-3.34) 
Vacuum 10 5 .32 1.97 (0.67-5.78) 
Non rotational 58 31 .006 1.88 (1.20-2.92) 
forceps 
Total 111 60 <.001 1.88 (1.36-2.60) 
Table 5. Neonatal outcome. 
CTG ST+CTG p value odds ratio 95%CI 
n==l212 n==ll88 
Cord artery pH<7.15 101 107 .61 0.92 (0.69-1.22) 
Cord artery pH<7.05 25 22 .82 1.12 (0.62-1.99) 
Metabolic acidosis; 13 5 .11 2.57 (0.91-7.22) 
cord artery pH <7. 05 
& BDec£> 12mmolll 
Apgar at 5 min <7 32 20 .12 1.58 (0.90-2.79) 
SCBU admissions 31 23 .41 1.33 (0.77-2.29) 
Birth asphyxia 4 3 
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Appendix Four. 
Cases of birth asphyxia in babies of at least 34 weeks gestation who delivered during the trial 
period but who were not entered into the trial. 
Parity & gestation Intrapartum trace Mode of Weight artery & vein Apganatl Resuscitation Neonatal course 
delivery (grams) pH&BDed 5& 10' 
(mmolll) 
Primigravida, 36 w Antenatal CTG; absent variability, shallow late LSCS 3100g NA stillborn 20 minutes 
backache, unwell decelerations. ARM & synto, bradycardia 2hrs failed 
tense uterus later. 
Primigravida, 36 w Antenatal CTG; absent variability, shallow late LSCS 1993g 6.85,NA 0, 0, 3, 20miniPPV Fitted, DIC, died day 6. 
absent fetal decelerations. ARM & synto, bradycardia 10 7.05, NA 515 520 
' 
movements 24 hrs mins later. 
Multigravida, 38 W Monitored by intermittent ausculation. LSCS 2635g 6.93, 22 0, 0, 3 20miniPPV Fitted, DIC, 
Intrapartum abruption. 6.99, 18 51.s 620 spastic quadriplegia at 
' 
1 ye3.!_ 
Primigravida. 37 w External CTG normal 60 min, then sudden LSCS 2615g vein 6.98, 15 2, 6, 8 .5 miniPPV Hypoglycaemia 
small APH at 37 W bradycardia. 
Multigravida, 41 W Induction ARM, small APH. External CTG, forceps 3535g NA 1, 5, 6 20miniPPV Ventilated, cardiovascular 
record lost at second stage.FSE applied 30 min NA collapse, Hb 6g/L. Died 
later, FHR 60/min. at 6 hours. 
Primigravida, 40 w Spontaneous labour, first stage external CTG, SVD 2615g NA 3, 5, 8 5 miniPPV Hypoglycaemia 
second stage intermittent auscultation. 45 min NA 
decelerations & bradycardia, cord around neck. 
Multigravida, 40 W Induced, external CTG, first stage normal, SVD 3340g 7.04,13 3, 5, 6 5 miniPPV 
Fitted and ventilated 2 
raised BP, on second stage poor quality, bradycardia, 7.10, 10 
days. Normal at 3 months. 
methlydopa cord around neck. 
Primigravida, 40 w Spontaneous onset, first stage external CTG, SVD 3180g vein 6.82, 18 2, 5, 7, 15 miniPPV 
Ventilated, fitted 14 days. 
second stage intermittent auscoltation. 815 Spastic quadriplegia at 
40 min bradycardia, cord around neck. 1 year. 
Multigravida, 40 W Spontaneous onset, intermittent auscoltation. SVD 3785g vein 6.80, 20 3, 3, 6 15 miniPPV Fitted for 8 days. 
Bradycardia end first stage & second stage Spastic quadriplegia at 
35 min. Cord around neck. 1 year. 
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1. Blood Gas Analyser sampling error. 
This was checked by analysing 110 pairs of consecutively introduced samples and 
comparing pH, pC02 and p02 results for each pair. The results are shown in Figures I A, B 
and C on the following page. 
Estimation of the standard deviation of the sample errors was based on the following 
assumptions; 
sample Yl =X+ El and 
sample Y2 = X + E2 
where Yl and Y2 are the values given for sample 1 and 2 of each pair, X is the true value 
and El and E2 is a measure of the sampling error for each sample. 
Therefore; 
El- E2 = Yl- Y2 
so an estimate of the standard deviation of the errors SDE = ~ (SD IYI- Y21). 
The values obtained from the 110 paired samples are comparable with those quoted in the 
Coming Manual as can be seen from the following Table. 
Plymouth SDE Coming Manual SDE 
pH 0.002 0.002 
pC02mmHg 0.55 0.5 to 0.6* 
p02mmHg 0.40 0.6to 0.7t 
• varies according to pC02 level, t varies according to p02 level. 
The advice of Dr D Wright, Principal Lecturer, Department of Mathematics and Statistics, 
University ofPiymouth in analysing this data is acknowledged. 
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Figure A4.1 Relationship between A. pH, B. pC02 and C. p02 for results from samples 1 
and 2 of consecutively introduced paired samples. 
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2. Formulae used for calculation of BDecf and BD blood. 
A. BDecf. 
BDecf =-(1-0.023 xHb)(HCO; -24.1)+[(2.3 xHb+1.1)(pH -7.40)] 
where; 
logHCO; =log pC02 +pH- pK +logS 
and Hb = 3.7 g/dl, pK = 6.1 and S = 0.0303 
so; 
HCO; =0.0303 X pC02 X IO(pH-6.1) 
and; 
IBDecf =-0.9149 x[ (0.031 x pC02 x IO(pH-6J>)-24.1+ 16.21 x(pH -7.40)]1 
Derived from Siggaard-Andersen, 1976, pages 32 & 32 and Siggaard-Andersen, 1971. 
B. BDblood 
BDblood =- (1- o.oi4 x Hb)[nco;- 24+(9.5 + 1.63 x Hb)(pH -7.4)] 
where; 
nco; = o. 03I x pC02 x 1 o<pH-6_.> 
and Hb = 15.0g/dl 
so; 
IBDblood = -0.79 X [(0.031 X pC02 X IO(pH-6.1))-24.1 +33.95 X (pH -7.40) 11 
Obtained from CffiA Coming 178 pH/Blood Gas Analyser Instruction Manual. CffiA 
Coming Diagnostics Corporation, 1981, pages 6 & 7. 
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